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Abstract 
Genome stability is a central aspect of cellular homeostasis and is facilitated by 
numerous protein networks that repair DNA damage and maintain chromosomal 
integrity. Human single-stranded DNA-binding protein 1 (hSSB1) is a protein with 
known roles in the repair of double-strand DNA breaks and oxidative lesions, as well 
as the stabilisation and restart of stalled replication forks. In response to these insults, 
hSSB1 associates with chromatin to promote cell cycle checkpoint signalling, as well 
as the localisation of other proteins directly required for DNA repair. The 
physiological relevance of these roles is highlighted by the hypersensitivity of 
hSSB1-depleted cells to DNA damaging agents, including ionising radiation, 
oxidative compounds and the chemotherapeutics camptothecin and hydroxyurea.  
 
The detection of damaged DNA by hSSB1 is facilitated by its evolutionarily 
conserved oligonucleotide/oligosaccharide-binding fold, which may bind directly to 
single-stranded DNA exposed at sites of DNA damage, as well as to poly ADP-
ribose and double-stranded DNA containing oxidised guanine nucleotides. In 
addition, functionality of hSSB1 most likely requires association with other 
components of the sensor of single-stranded DNA protein complex. 
 
Previous studies have indicated that hSSB1 may also be regulated by post-
translational modifications. This includes phosphorylation of threonine residue 117, 
which may promote DNA repair signalling in response to double-strand DNA-break 
formation. In addition, hSSB1 may be degraded by poly-ubiquitination mediated 
targeting to the proteasome. Acetylation of hSSB1 lysine 94 has also recently been 
characterised and may promote hSSB1 protein accumulation following DNA 
damage. In this project, the characterisation of hSSB1 post-translational 
modifications was further explored with the aim of uncovering novel regulatory 
mechanisms.  
 
In the first results chapter of this thesis, the poly-ubiquitination of hSSB1 was 
demonstrated by a nickel agarose pull-down of hexa-histidine-tagged ubiquitin, 
followed by immunoblotting of eluted proteins. As likely residues of ubiquitination 
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were initially unclear, site-directed mutagenesis was used to prepare hSSB1 
constructs where each lysine residue was individually mutated to arginine. The 
disruption of no single lysine residue could however prevent hSSB1 ubiquitination 
and so further constructs were prepared containing multiple lysine to arginine 
mutations. Only the complete removal of lysine residues was however able to 
prevent ubiquitination of exogenously expressed 3x FLAG hSSB1, suggesting that 
each lysine residue of the protein may be ubiquitinated. Indeed, even the 3x FLAG 
epitope tag was found to be ubiquitinated under conditions where all other lysine 
residues were disrupted. As part of this work, mass spectrometry was also employed 
to analyse immunoprecipitated hSSB1 from cells treated with or without the 
replication inhibitor, hydroxyurea. In doing so, numerous potentially phosphorylated 
serine and threonine residues were detected, including serine residue 134 (S134). 
 
The phosphorylation of hSSB1 S134 was further explored in the second data chapter 
and included the validation of a novel phospho-specific antibody, raised against a 
phosphorylated S134 peptide. Using this antibody, phosphorylation of 
immunoprecipitated endogenous hSSB1 was observed, as well as of transiently over-
expressed hSSB1, which was enhanced following hydroxyurea treatment. Specificity 
of the antibody was confirmed by expression of a S134A phosphomutant, treatment 
of whole cell lysates with lambda phosphatase and by use of a phosphorylated 
peptide to block antigen recognition by the antibody. Phosphorylation of hSSB1 
S134 was also observed following replication inhibition with aphidicolin and 
camptothecin. An increase in hSSB1 S134 phosphorylation was however not 
observed following ionising radiation exposure and the formation of double-strand 
DNA breaks. The functional importance of hSSB1 S134 phosphorylation was 
demonstrated by the inability of exogenously expressed S134A hSSB1 to rescue cells 
from the hydroxyurea and aphidicolin sensitivity caused by hSSB1 depletion, as 
assessed by clonogenic survival assays.  
 
hSSB1 S134 is part of a serine-glutamine (SQ) motif, a common substrate of the 
major DNA repair PI3K-like kinases, ataxia telangiectasia mutated (ATM), ataxia 
telangiectasia and Rad3 related (ATR) and DNA-dependent protein kinase (DNA-
PK). To explore if one of these kinases may phosphorylate S134, specific chemical 
inhibitors against each enzyme were employed. Although the inhibition of ATM and 
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ATR caused a small decrease in phosphorylation of hSSB1, this was almost 
completely reduced following inhibition of DNA-PK. In addition, an ~90% reduction 
in S134 phosphorylation was observed following depletion of the DNA-PK catalytic 
subunit (DNA-PKcs) from cells. DNA-PKcs also co-immunoprecipitated with 
hSSB1 from whole cell lysates and purified DNA-PK was able to phosphorylate 
hSSB1 S134 in vitro.  
 
As PPP-family serine/threonine protein phosphatases are involved in the 
dephosphorylation of numerous DNA damage repair proteins, cells were also treated 
with chemical inhibitors against these proteins and their effect on hSSB1 S134 
phosphorylation assessed. Strikingly, the inhibition of these enzymes resulted in a 
dramatic increase in S134 phosphorylation within minutes of treatment, which was 
comparable with 20 hours of hydroxyurea exposure. Phosphatase inhibitor induced 
phosphorylation was however predominantly suppressed by the co-inhibition of 
DNA-PK. Together these data suggest that in undamaged cells, S134 
phosphorylation is dynamically regulated by DNA-PK and PPP-family phosphatases. 
 
hSSB1 has previously been suggested to associate with stalled replication forks. It 
was therefore interesting to consider that S134 phosphorylation may alter hSSB1 
binding to such substrates. To test this, electrophoretic mobility shift assays were 
performed using WT or S134E phosphomimetic hSSB1 and either ssDNA or a fork 
junction substrate. While WT and S134E hSSB1 bound ssDNA similarly, a 
significant reduction in fork junction binding was observed for the S134E mutant. 
These data therefore suggest that S134 phosphorylation may regulate the DNA-
binding function of hSSB1. 
 
Despite these advancements in understanding the regulation of hSSB1 following 
replication inhibition, the role of hSSB1 at sites of stalled replication forks remains 
unclear. To further elucidate these functions, mass spectrometry was used to detect 
proteins that may associate with chromatin-bound hSSB1. Unexpectedly, numerous 
chromatin-remodelling complexes were identified, including each component of the 
NuRD and WICH remodelling complexes. The detection of numerous of these 
components was further validated by immunoblotting of hSSB1-associating proteins.  
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The data presented in this thesis provide novel insight into the regulation of hSSB1 
by post-translational modifications, as well as suggest a number of additional 
proteins with which hSSB1 may associate. These findings thereby contribute to a 
greater understanding of hSSB1 biology, the continued characterisation of which will 
be important for a full understanding of eukaryotic genome stability maintenance.  
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Chapter 1:  Introduction, Literature Review and Contextualisation 
of the Research Project 
 
1.1 Genomic stability 
DNA repair is essential for the prevention of chromosomal instability, a condition 
resulting from the incomplete maintenance of genetic material, which may lead to 
cell death, malignant transformation or other deregulation of cellular function (Polo 
and Jackson, 2011). This can manifest in a variety of disorders including 
neurological degeneration, premature ageing, developmental defects and cancer 
(Khanna and Jackson, 2001). The prevention and repair of DNA damage is a 
continuous process, with thousands of lesions occurring every day in each human 
cell (Jackson and Bartek, 2009). The vast majority of these lesions occur through 
endogenous cellular functions (De Bont and van Larebeke, 2004; Marnett and 
Plastaras, 2001), however environmental conditions such as exposure to radiation 
and various chemicals (e.g. carcinogens, chemotherapeutics) may also cause further 
damage (Poirier, 2004; Willers et al., 2004). 
 
The major aim of this PhD project is to further characterise the post-translational 
regulation of human single-stranded DNA binding protein 1 (hSSB1), a genome 
stability protein with roles in the repair of oxidative lesions (Paquet et al., 2015), the 
stabilisation of stalled replication forks (Bolderson et al., 2014) and the repair of 
double-strand DNA breaks by homologous recombination (Richard et al., 2008). The 
DNA repair pathways in which hSSB1 is known to function are therefore described 
below, with a special emphasis placed on post-translational signalling. 
 
1.2 Oxidative base excision repair 
Base excision repair (BER) is a major mechanism through which the cell is able to 
remove a variety of small base lesions, such as those caused by endogenous 
oxidation and alkylation events (Hsu et al., 2004). These base lesions are recognised 
by one of a number of DNA glycosylases, the identity of which is specific to the 
lesion type (David et al., 2007). Deamination of the damaged base by the glycosylase 
then leaves an abasic residue, which is recognized by endonuclease 
apurinic/apyrimidinic endonuclease 1 (APE1). APE1 nicks the phosphodiester 
backbone 5` to the abasic residue, creating a free 3`-hydroxyl site (Wilson and 
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Barsky, 2001). Removal of the 5'-terminal deoxyribose phosphate residue and 
closure of the strand break is then accomplished by either short- or long-patch repair. 
While short patch repair results in replacement of only the damaged base, up to 10 
nucleotides downstream of the lesion are replaced by long-patch repair (Petermann et 
al., 2006).  
 
Eleven DNA glycosylases are known to function in BER within mammalian cells, 
two major classes of which may be broadly defined: 1) mono-functional glycosylases 
and 2) bi-functional glycosylases (Brooks et al., 2013). While both classes possess a 
conserved helix-hairpin-helix motif and an invariant aspartate in their active site, 
their catalytic mechanisms differ greatly (Choi et al., 2004). In the instance of mono-
functional glycosylases, the conserved aspartate residue acts to deprotonate and 
thereby activate a water molecule, which then nucleophilically attacks carbon 1 of 
the N-glycosidic bond; resolution of the reaction then yields the damaged base and a 
free abasic site (Mol et al., 1995). Unlike mono-functional glycosylases, which only 
posses glycosylase activity, the bifunctional glycosylases also possess lyase activity 
to cleave the phosphodiester backbone 3` of the abasic residue (Krokan et al., 1997). 
Here, the conserved aspartate residue seems to deprotonate a similarly conserved 
lysine residue in the catalytic domain, forming a nucleophilic amine (Dodson et al., 
1994). Attack of the deoxyribose carbon 1 and the resulting rearrangements then 
leads to formation of a covalent Schiff-base, whereby the damaged base is released 
from the DNA, although it is held in position to assist in the lyase reaction (Sun et 
al., 1995). Here, proton transfer between the glycosylase and the abasic residue is 
apparently promoted by the excised base, leading to strand cleavage and regeneration 
of the enzyme (Fromme et al., 2003). Subsequent to cleavage of the damaged base, a 
number of glycosylases do however remain bound to the abasic site, and indeed, 
many glycosylases show higher affinity for the abasic site than they do to their 
substrate base (Parikh et al., 1998). As abasic sites are chemically unstable, it has 
been suggested their continued association with the glycosylase may help to protect 
the cell from their mutagenic effects (Banerjee et al., 2005). In keeping, several 
glycosylases appear to be removed only following association of the APE1 nuclease 
(Waters et al., 1999). 
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Cellular oxidative stress may result in the formation of either purine or pyrimidine 
adducts (Burrows and Muller, 1998). Guanine bases, however, seem to be 
particularly susceptible to damage, where attack of carbon 8 (C8) by a hydroxyl 
radical leads to formation of the intermediate compound 7,8-dihydro-8-
hydroxyguanine (8-OHG). 8-OHG may then tautomerise to form two major 
products, 2,6-diamino-5-formamido-4-hydroxy-pyrimidine (FapyG) and 8-oxo-7,8-
dihydroguanine (8-oxoG) (Kirpota et al., 2011). Of these, 8-oxoG is particularly 
mutagenic, as it is capable of base-pairing with both cytosine and adenine (Cheng et 
al., 1992). This occurs as 8-oxoG maintains the capacity to form correct Watson-
Crick base-pairing with cytosine, however due to protonation of nitrogen 7 (N7), 
may also act as a hydrogen donor for interaction with adenine (Bjorâs et al., 1997). 
Sustainment of these lesions into S-phase may therefore result in base transversion, 
where the replicative polymerases (Pols α, δ and ε) incorporate adenine into the new 
strand in place of guanine (Cheng et al., 1992; Hsu et al., 2004). Such conversions 
may however be suppressed by the X-family DNA polymerase Pol λ, which 
incorporates cytosine opposite 8-oxoG with a 1000-fold preference to adenine 
insertion (Maga et al., 2007). Furthermore, in cases where adenine:8-oxoG 
mismatches occur, the human adenine DNA glycosylase homologue MutY, is 
capable of excising the incorrectly paired adenine base (Williams and David, 1998). 
The abasic residue is then removed and replaced by the concerted efforts of APE1, 
DNA Pol λ, and DNA ligase 1 (van Loon and Hubscher, 2009).  
 
Despite the existence of a mismatch repair pathway that can remove 8-oxoG post-
replication, the cellular response to oxidative lesions is still largely reliant on their 
earlier removal (Arai et al., 2002; Kunisada, 2005). The human 8-oxoguanine DNA 
glycosylase (hOGG1) facilitates the direct removal of 8-oxoG lesions in human cells 
and is thus required for the efficient response to oxidative insult (German et al., 
2013; Roldán-Arjona et al., 1997). As with most DNA glycosylases, hOGG1 is 
thought to detect its substrate base by migrating along the undamaged duplex DNA, 
forming a series of non-specific interactions through which it ‘senses’ 8-oxoG 
lesions (Blainey et al., 2009; Friedman and Stivers, 2010). This seems to form a ‘pre-
selection’ process, whereby the enzyme is able to identify and discount non-substrate 
bases through superficial contacts. Once an 8-oxoG adduct is detected, the base is 
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flipped out of the double helix, into the hOGG1 active site (Banerjee et al., 2005). 
Here, the glycosylase binding energy itself seems sufficiently high to accomplish this 
task, including the breaking of the Watson-Crick base pairs, disruption of aromatic 
stacking bonds, and rotation of the phosphodiester backbone. Potentially, this energy 
cost may however be less than originally considered, based on a recent 
thermodynamic study that suggested nucleotides immediately 5` to the 8-oxoG are 
energetically less stable (Kirpota et al., 2011). Alternatively, these results may 
support a model of base-scanning, in which pre-selection is facilitated by ‘breathing’ 
of the area immediately surrounding the lesion (Friedman et al., 2009). Of further 
interest is the observation of high-specificity of hOGG1 for 8-oxoG base-paired with 
cytosine (Bjorâs et al., 1997; Zharkov et al., 2000). Indeed, while a single hydrogen 
bond exists between hOGG1 G42 and the protonated N7 of the 8-oxoG, 5 hydrogen 
bonds are formed between R204, N149 and R154 of hOGG1 and the opposing 
cytosine (Bruner et al., 2000).  
hOGG1 is generally considered as a bifunctional glycosylase, containing the catalytic 
residues, D268 and K249 (Brooks et al., 2013). As described for the general model 
above, D268 is here thought to deprotonate the K249 ε amino group, which forms a 
Schiff base with carbon 1 of the N-glycosidic bond, resulting in β-elimination (Nash 
et al., 1997). This view has however been challenged regarding the enzyme’s activity 
in cells, based on the suggestion that APE1 may promote the glycosylase activity of 
hOGG1, then bind and excise the non-cleaved abasic site (Hill et al., 2001).  
Through whichever means hOGG1 functions in vivo, further processing of the 
damaged site requires cleavage of the phosphodiester backbone 5` to the abasic 
residue, generating a free 3` hydroxyl site for polymerase mediated synthesis 
(Wilson and Barsky, 2001). While Pol β functions as the major BER DNA 
polymerase in mammalian cells, other polymerases may also have ancillary roles. 
For instance, Pol δ and Pol ε may act in long-patch BER, Pol ι, Pol λ and Pol θ may 
function in short-patch BER, and Pol γ may facilitate BER in the mitochondria 
(Dianov and Hübscher, 2013). During short-patch BER, the DNA polymerase 
catalyses the synthesis of a new base from the free 3` hydroxyl group generated by 
APE1 cleavage. Where lyase activity of the glycosylase has not nicked the 
phosphodiester backbone downstream of the adduct, end processing by the 
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polymerase must act to restore a 5` phosphate group, prior to XRCC1-DNA ligase III 
(LIG3)-mediated closure of the gap (Kubota et al., 1996; Wei et al., 1995). While 
this mechanism may be sufficient for the majority of BER events, in some instances, 
5` end processing by the polymerase seems unable to restore a 5` phosphate group, 
potentially as a result of complex, incidental damage to these ends (Frosina et al., 
1996). In addition, Pol δ and Pol ε do not possess apparent end-processing activity. 
In these instances, repair may be accomplished by long-patch BER (Matsumoto et 
al., 1994). Here, Pol δ or Pol ε acts to extend the first nucleotide added by Pol β in a 
reaction dependent on proliferating cell nuclear antigen (PCNA), displacing a ‘flap’ 
of 2-12 nucleotides (Dianov, 1999; Podlutsky et al., 2001). Flap structure-specific 
endonuclease 1 (FEN1) then degrades the displaced strand, leaving a single nick in 
the phosphodeister backbone, which is sealed by DNA ligase 1 (LIG1) (Kim et al., 
1998; Liu et al., 2005; Ranalli et al., 2002).  
In response to oxidative stress, the Ataxia telangiectasia mutated (ATM) kinase is 
activated as a disulphide cross-linked dimer, resulting from oxidation of cysteine 
2991 (Guo et al., 2010a; Guo et al., 2010b). Interestingly, recent data suggests this 
may include dimerisation of cytoplasmic ATM (Kozlov et al., 2016). Activation is 
marked by its auto-phosphorylation of serine 1981 (S1981), an important 
modification that stimulates ATM kinase activity (Bakkenist and Kastan, 2003; 
Canman et al., 1998). Here, dimeric ATM is required to activate p53 through 
phosphorylation of serine 15 (S15) (Guo et al., 2010b). Activated p53 then seems to 
stimulate BER by directly binding DNA pol β, stabilising the interaction between the 
polymerase and the abasic residue (Zhou et al., 2001). 
A role for hSSB1 in the response to hydrogen peroxide-induced oxidative stress has 
recently been suggested (Paquet et al., 2015). In these studies, hSSB1 was found to 
accumulate at chromatin following oxidative damage, likely by binding directly to 8-
oxoG lesions. hSSB1 was also required for the efficient recruitment of the OGG1 
glycosylase, as well as for the efficient removal of 8-oxoG post damage. In addition, 
the depletion of hSSB1 from cells suppressed the proper phosphorylation of ATM 
and p53. Further data from our group (Paquet et al., 2016) has also suggested that, in 
response to oxidative stress, hSSB1 may form a stable disulphide-linked dimer that is 
required for hSSB1-dependent cell survival.  
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1.3 DNA replication and replication stress 
Although the base and nucleotide excision repair pathways are able to remove the 
majority of small adducts prior to initiation of replication, in some instance, lesions 
are able to persist into S-phase. This is especially true of lesions such as inter-strand 
cross-links, most likely due to their chemical complexity, as well as their inefficient 
recognition in highly condensed chromatin (Deans and West, 2011; Mu et al., 2000). 
 
During eukaryotic replication, the mini-chromosome maintenance protein (MCM) 
helicase is responsible for unwinding the dsDNA helix, and the concurrent exposure 
of ssDNA (Bell and Dutta, 2002). These stretches are rapidly bound by replication 
protein A (RPA), a trimeric complex consisting of ~70 kDa (RPA70), ~32 kDa 
(RPA32) and ~14 kDa (RPA14) subunits (Waga and Stillman, 1998). At sites of 
replication, RPA both prevents formation of ssDNA secondary structures, as well as 
stabilises the DNA polymerase α-complex (Pol α) (Dornreiter et al., 1992; 
Yuzhakov et al., 1999). Pol α is required for the synthesis of short oligonucleotide 
primers from which the more processive polymerases δ and ε may synthesise new 
ssDNA strands complementary to those exposed by fork migration (Burgers, 2009).  
Here, removal of Pol α is facilitated by replication factor C (RFC), an essential 
clamp loader, which also recruits PCNA (McNally et al., 2010). PCNA here acts as a 
processivity factor for DNA polymerase δ (Burgers, 1988). In addition, PCNA 
interacts with various replication factors, tethering them to sites of replication 
(Schurtenberger et al., 1998).  
 
While replication of undamaged DNA occurs both rapidly and continuously, 
endogenous and exogenous stresses can disrupt migration, causing the fork to stall. 
In these instances, the cell will firstly pause replication, before either repairing or 
bypassing the damage, processes which are facilitated by the concerted activities of 
the DNA replication and damage repair pathways (Petermann and Helleday, 2010). 
In general, the replication fork may stall for two major reasons: 1) a sustained bulky 
adduct may inhibit the processive DNA polymerases (Washington et al., 2010), or 2) 
covalent crosslinking of the opposing strands may prevent helicase-unwinding ahead 
of the fork (Nakano et al., 2013). In an artificial setting, the polymerase inhibitors 
hydroxyurea and aphidicolin may also disrupt the replication fork, where they cause 
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uncoupling of the replicative polymerases and the MCM helicase, leading to the 
generation of long ssDNA stretches (Byun et al., 2005). 
 
Two major pathways are known to facilitate the re-initiation of replication following 
fork stalling, translesion repair, and homology-directed repair. While the former 
utilises a number of ‘low-fidelity’ polymerases to synthesise past the lesion, 
homology-directed repair makes use of a homologous region in the newly 
synthesised opposing strand (Burrows and Elledge, 2008; Friedberg, 2005). In 
addition, replication forks stalled following polymerase inhibition must be ‘re-
wound’ and replication restarted, either by fork remodelling, or by D-loop formation 
using the opposing nascent strand (Petermann and Helleday, 2010). 
 
1.3.1 Stabilisation and restart of uncoupled replication forks 
Following replication fork stalling, the accumulation of RPA is required to stabilise 
exposed ssDNA, as well as to promote the interaction of a number of other repair 
proteins (Robison et al., 2004; Zou, 2003). Of central importance is the interaction 
with the ataxia telangiectasia and Rad3 related (ATR)-interacting protein (ATRIP), 
which also promotes the recruitment, although not full activation, of the ataxia 
telangiectasia and Rad3 related (ATR) kinase (Ball et al., 2005; Namiki and Zou, 
2006; Xu and Leffak, 2010). While the N-terminal 108 amino acids of ATRIP was 
initially suggested as the sole RPA70 interacting region (Ball et al., 2005), this has 
been contradicted by a latter study which indicated the regions flanking the ATRIP 
coiled-coil domain may also associate with RPA (Namiki and Zou, 2006). 
Recruitment of ATR/ATRIP to RPA-coated ssDNA here seems sufficient to induce 
early activation of ATR by auto-phosphorylation at threonine 1989 (Liu et al., 2011). 
ATR auto-phosphorylation is also dependent on the prior non-DNA damage induced 
phosphorylation of ATR and ATRIP by the Nek1 kinase (Liu et al., 2013). Full 
activation of ATR however also requires topoisomerase II β-binding protein 1 
(TopBP1), a protein that directly binds RPA-coated ssDNA and interacts with both 
ATR and ATRIP (Acevedo et al., 2016; Burrows and Elledge, 2008; Kumagai et al., 
2006; Mordes et al., 2008). Once activated, ATR is responsible for phosphorylation 
of CHK1 at S317 and S345, releasing it from chromatin and allowing it to 
phosphorylate cdc25, facilitating its degradation (Smits et al., 2006; Sørensen et al., 
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2003). The importance of TopBP1 in the activation of ATR is supported by findings 
that in vitro, ATR, ATRIP and TopBP1 are the minimal components required for 
RPA-ssDNA induced Chk1 phosphorylation (Choi et al., 2010).  
 
Independent of the RPA-ATRIP interaction, DNA polymerase α is required for 
recruitment of the Rad17-RFC clamp loader to sites of stalled replication (Byun et 
al., 2005; You et al., 2002). Analogous to its role in replication initiation, the Rad17-
RFC clamp loader recruits the PCNA-like Rad9-Rad1-Hus1 (9-1-1) clamp 
(Bermudez et al., 2003; Ellison and Stillman, 2003; Yan and Michael, 2009a; Yan 
and Michael, 2009b), which may be stabilised through an interaction with the basic 
cleft of RPA70 (Xu et al., 2008). Rad9 may then directly interact with the N-
terminus of TopBP1, facilitating its accumulation at the fork (Delacroix et al., 2007; 
Lee et al., 2007). TopBP1 may then act as a bridging protein between the 
ATR/ATRIP and 9-1-1 complexes (Kumagai et al., 2006). Additionally, the Mre11-
Rad50-Nbs1 (MRN) complex has also recently been suggested to promote TopBP1 
recruitment to stalled forks via a direct interaction between Nbs1 and the TopBP1 
BRCT repeats 3-6 (Duursma et al., 2013). In addition, MRN may interact with the 
RPA70 N-terminal OB-fold (Robison et al., 2004). The significance of MRN at 
stalled replicative forks is further exemplified by the lack of ATR-mediated RPA32 
threonine 21 phosphorylation in cells depleted of Nbs1 (Block et al., 2004; Manthey 
et al., 2007). Mediator of DNA damage checkpoint protein 1 (MDC1) has also been 
found to interact with both Nbs1 and TopBP1 at stalled forks and appears necessary 
for efficient ATR-signalling in response to replicative stress (Chapman and Jackson, 
2008; Wang et al., 2011). 
 
Once activated, the ATR kinase requires the Claspin mediator protein in order to 
efficiently phosphorylate Chk1 (Chini, 2003; Kumagai and Dunphy, 2000; Liu et al., 
2006). This may involve coordination the ATR-Chk1 interaction and indeed ATR 
has a higher affinity for Chk1 when it is bound to Claspin, than when it is free 
(Lindsey-Boltz et al., 2009). Concurrently, Chk1-phosphorylation of Claspin T916 
may promote accumulation of the protein through the suppression of proteasomal 
degradation (Chini et al., 2006). The interaction between Chk1 and Claspin may also 
be promoted by replication-stress-induced phosphorylation of Claspin residues S945 
and S982 by casein kinase 1 (Meng et al., 2011). In addition, Chk1 phosphorylation 
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seems to be promoted by RPA-mediated interaction with Timeless-interacting 
partner (Tipin) (Kemp et al., 2010; Unsal-Kacmaz et al., 2007). Tipin is a component 
of the replication pausing complex (RPC), a protein complex required for the 
coordinated pausing of both the polymerase and helicase components of the 
replicative machinery (Errico and Costanzo, 2012). Here, Tipin and its binding 
partner Timeless (Tim1) form a central heterodimer, which appears essential for 
activation of the intra-S checkpoint (Chou and Elledge, 2006; Gotter et al., 2007; 
Yoshizawa-Sugata and Masai, 2007). 
 
ATR is also responsible for phosphorylation of the DNA-dependent protein kinase 
catalytic subunit (DNA-PKCS) at T2609, facilitating its activation (Yajima et al., 
2006). DNA-PKcs may then assist in the amplification of ATR checkpoint signalling 
(Shimura et al., 2007) where it interacts directly with Chk1 and promotes 
stabilisation of the Chk1-Claspin complex (Lin et al., 2014). In addition, DNA-PKcs 
may act in concert with ATR to phosphorylate RPA32 (Liu et al., 2012). Here, in 
response to prior CDK-mediated phosphorylation of RPA32 S23 and S29 (Anantha 
et al., 2007; Zernik-Kobak et al., 1997), ATR catalyses phosphorylation of RPA32 
S33 (Olson et al., 2006), which in turn promotes phosphorylation of S4, S8 and T21 
by DNA-PKcs (Block et al., 2004; Liu et al., 2012; Niu et al., 1997). Hyper-
phosphorylation of the RPA32 N-terminus seems to be stimulatory for recruitment of 
the proteins Rad51 (Shi et al., 2010) and PALB2 (Murphy et al., 2014). 
 
The restart of stalled replication forks theoretically may occur through two major 
mechanisms, the contributions of which in mammalian cells has remained subject to 
debate: 1) restart by remodelling and 2) D-loop-mediated fork restart (Petermann and 
Helleday, 2010). As replication fork disruption frequently involves the physical 
uncoupling of the replicative polymerases and the MCM helicase (Byun et al., 2005), 
the initial step of either method firstly requires regression of the replication fork and 
re-annealing of exposed ssDNA (Zellweger et al., 2015). This process is most likely 
facilitated through three major helicases, Werner’s syndrome protein (WRN) 
(Constantinou et al., 2000; Sidorova et al., 2013), Bloom’s syndrome protein (BLM) 
(Davies et al., 2007) and the annealing helicase, SWI/SNF-related, matrix-associated, 
actin-dependent regulator of chromatin, subfamily A-like 1 (SMARCAL1) 
(Bansbach et al., 2009; Ciccia et al., 2009; Yusufzai and Kadonaga, 2008). Although 
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SMARCAL1-mediated re-annealing of exposed ssDNA could theoretically allow for 
fork re-start without the need for further processing, the WRN and BLM syndrome 
proteins may cause regression of the fork into a Holliday junction structure referred 
to as a ‘chicken foot’ (Machwe et al., 2006). Here, the fork may be regressed past the 
point of initial replication disruption, displacing the newly synthesised nascent 
strands. In a scenario where the fork is re-initiated by remodelling, the ‘chicken foot’ 
may then be reversed, presumably by the WRN and BLM helicases, separating the 
annealed nascent strands and allowing replication to re-start following the binding of 
these strands to the newly re-exposed parental DNA (Petermann and Helleday, 
2010). Another possible means of fork re-start could involve the Rad51-mediated 
invasion of the nascent leading strand of the ‘chicken foot’ structure into the template 
dsDNA, downstream of the fork (McGlynn and Lloyd, 2002). This would lead to the 
formation of a double-Holliday junction, which could subsequently be resolved by 
Holliday junction dissolution (Li and Heyer, 2008). 
 
Although the majority of hydroxyurea-stalled replication forks may restart after short 
treatments, this potential is gradually diminished over time. Indeed, whilst ~ 80% of 
stalled forks may restart after 2 hours of HU exposure, fewer then 20% may after 20 
hours (Petermann et al., 2010). After sustained fork disruption, replication in the cell 
instead seems to continue predominantly through the initiation of new fork origins 
(Petermann et al., 2010). In addition, whilst the majority of replication forks remain 
structurally stable for greater than 12-18 hours post hydroxyurea treatment, after this 
time, stalled and de-activated replication forks may ‘collapse’ to form double-strand 
DNA breaks (Saintigny et al., 2001). This reaction seems to be catalysed by the 
MUS81-EME1 endonuclease (Hanada et al., 2007). The resulting one-sided double-
strand DNA breaks can then be repaired by homologous recombination (Yeeles et 
al., 2013). 
 
Recent data has also implicated a role for hSSB1 in the stabilisation and re-start of 
stalled replication forks, including the activation of ATR signalling (Bolderson et al., 
2014). Here, hSSB1 was found to localise with sites of replication following fork 
disruption, where it was required for ATR-mediated phosphorylation of Chk1 at 
S317 and S345, as well as subsequent Chk1 auto-phosphorylation at S296. In 
addition, hSSB1-depletion prevented proper localisation of Mre11 and ATR at 
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chromatin following treatment of cells with the polymerase inhibitor, hydroxyurea. A 
requirement for hSSB1 in replication fork restart was found to manifest in 
hypersensitivity of hSSB1-depleted cells to hydroxyurea and camptothecin treatment.  
 
Investigations into the role of mSSB1, the murine hSSB1 homologoue, have also 
lead to similar conclusions regarding a function for these proteins in the suppression 
of replication-associated DNA damage (Feldhahn et al. 2012; Shi et al. 2013). These 
conclusions were inferred by the poor proliferation and loss of genomic integrity 
observed following mSSB1 knock-out. For these studies, conditional knockout mice 
were produced due to the embryonic lethality of mSSB1 germline deletions. Indeed, 
Obfc2b-/- embryos developed severe skeletal defects, most likely associated with 
increased apoptosis (Feldhahn et al. 2012). Similarly to has been observed in human 
cell lines following hSSB1 siRNA-depletion (Li et al. 2009), the conditional 
knockout of hSSB1 was also found to enhance the protein levels of mSSB2 (murine 
homologue of hSSB2). In contrast to hSSB1 depletion studies, it is interesting to note 
that knockout of mSSB1 (or mSSB2) did not however result in deficient initiation of 
a DNA damage response when examined in irradiated murine fibroblasts. These data 
nevertheless support a role for these proteins in the restart of stalled replication forks.  
 
1.4 Double-strand DNA break repair 
Double-strand DNA breaks (DSBs) are often considered the most cytotoxic type of 
DNA lesion, as the failed repair of just one may lead to chromosomal fragmentation 
and rearrangement (Difilippantonio et al., 2000; Weinstock et al., 2006). Two major 
DNA repair pathways are employed for the repair of double-strand DNA breaks in 
cells, non-homologous end-joining (NHEJ) and homologous recombination (HR) 
(Khanna and Jackson, 2001). While non-homologous end-joining may be used at any 
stage during the cell cycle (Mao et al., 2008a), homologous recombination is only 
available during the S and G2 cell cycle phases where a sister chromatid is available 
(Saleh-Gohari and Helleday, 2004). 
 
1.4.1 Repair of double-strand DNA breaks by homologous recombination 
One of the earliest processes in homologous recombination is the recruitment of the 
MRE11-Rad50-NBS1 (MRN) complex to the site of DNA damage (de Jager et al., 
2001; Hopfner et al., 2001). As well as binding single-stranded DNA overhangs, 
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MRN activates the ataxia telangiectasia mutated (ATM) serine/threonine kinase 
(Carson et al., 2003; Lee and Paull, 2005; Uziel et al., 2003). This, in turn, leads to 
the phosphorylation and activation of downstream targets involved in cell cycle 
checkpoint activation (e.g. Chk1, Chk2, p53) and directly in double-strand DNA 
break repair (e.g. NBS1, Exo1 and the histone variant H2AX) (Bolderson et al., 
2010; Burma et al., 2001). One of the direct results of ATM signalling is the 
resection of double-strand DNA breaks to produce 3` single-stranded DNA tracts, the 
availability of which facilitates RAD51 nucleofilament formation and strand invasion 
into a sister chromatid (Garcia et al., 2011). As a result of this invasion, the sister 
chromatid can then be used a homologous repair template (Bekker-Jensen and 
Mailand, 2010). 
 
MRN is a large, highly conserved, multi-protein complex, consisting of an Mre11-
Rad50 DNA-binding clamp, enfolded by an Nbs1 polypeptide (Schiller et al., 2012). 
Formation of the clamp is largely facilitated by an Mre11 dimer, as well as, in 
response to ATP binding, dimerisation of the Rad50 Walker A/B domains (de Jager 
et al., 2001; Hopfner et al., 2002; Lammens et al., 2011; Mockel et al., 2012). While 
not involved in binding DNA directly, crystallography of MRX, the Saccharomyces 
pombe MRN homologue, has suggested the NBS1 N-terminus is oriented such that it 
may interact with other proteins at the site of DSBs, adjacent to the Mre11-Rad50 
clamp (Schiller et al., 2012).  
 
The recruitment of ATM to sites of DSBs is largely reliant on ssDNA binding by the 
MRN complex (Carson et al., 2003). This is facilitated by a direct interaction 
between ATM and the C-terminus of NBS1, and is, at least initially, modulated by 
ATP-binding of the MRN Rad50 head domains (Lee et al., 2013; Nakada et al., 
2003; You et al., 2005). ATP binding seems to cause a gross conformational change 
in MRN, moving the protein from an ‘open’ to ‘closed’ state. As well as pushing the 
Mre11 domains into a close dimer, an alteration which promotes ssDNA interaction, 
ATP-binding seems to promote association of Nbs1 to the complex; this, 
presumably, leads to an increase in ATM localisation (Lee et al., 2013). Interestingly, 
while Mre11 possesses both endo- and exo-nuclease activity, only the endonuclease 
activity appears necessary for DSB processing (Garcia et al., 2011).  
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A direct outcome of the MRN-ATM interaction is auto-phosphorylation of ATM at 
serine residues 267, 1893, 1981 and 2996 (Kozlov et al., 2011; Kozlov et al., 2006). 
In addition, full ATM activation requires acetylation of K3016 by the histone 
acetyltransferase, Tip60 (Sun et al., 2005; Sun et al., 2007). Here, the Tip60 
chromodomain interacts with histone H3 trimethylated on lysine 9 (H3K9me3), 
which seems to activate the acetyltransferase activity of Tip60 (Sun et al., 2009). In 
addition, chromatin-binding of Tip60 also seems to be promoted by c-Abl kinase-
mediated phosphorylation of Tip60 tyrosine residue 44 (Kaidi and Jackson, 2013). 
Together, auto-phosphorylation and Tip60-mediated acetylation cause a 
conformational change in ATM, transitioning the protein from a dimer to an active 
monomer (Bakkenist and Kastan, 2003; Sun et al., 2007).  
 
Once activated, ATM seems to function in a positive feedback loop with MRN, 
whereby phosphorylation of Nbs1 S343 regulates MRN accumulation at DNA breaks 
(Wen et al., 2012). In addition, ATM is required for phosphorylation of H2AX serine 
139 (γH2AX), which allows recruitment of caseine kinase 2 (CK2)-phosphorylated 
MDC1, a protein which appears to anchor MRN onto the chromatin (Spycher et al., 
2008). ATM-mediated phosphorylation of MDC1 threonine 4 then leads to 
dimerisation of the protein, a requirements for proper foci formation (Jungmichel et 
al., 2012). The interaction of MDC1 with γH2AX also seems to promote RNF168-
mediated K63-linked ubiquitination of γH2AX residues K13 and K15 (Gatti et al., 
2012; Mattiroli et al., 2012). Here, the function of RNF168 relies on the prior ATM-
dependent recruitment of the RNF8 ligase to DSB sites (Mattiroli et al., 2012), the 
reason for which remains unclear. The poly-ubiquitination of γH2AX is important for 
localisation of the proteins 53BP1 and BRCA1, both of which seem to act as 
bridging proteins between ATM and MRN (Lee et al., 2010). In addition, the 
activities of both proteins may be promoted by ATM-mediated phosphorylation 
(53BP1 is phosphorylated at S25 and S1778 (Jowsey et al., 2007), and BRCA1 is 
phosphorylated at S1387, 1423, and 1457 (Gatei et al., 2000)), suggesting a possible 
further feedback loop. Interestingly, as well as binding ubiquitinated γH2AX, the 
localisation of 53BP1 at DSB foci also seems to rely on dimethylation of histone H2 
residue K20 (Fradet-Turcotte et al., 2013), as well as K63-linked poly-ubiquitination 
of K1268 by RNF168 (Bohgaki et al., 2013). JMJD1C-mediated demethylation of 
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MDCI may also allow its K63-linked ubiquitination by RNF8, promoting an 
association with the BRCA1 interacting protein RAP80 (Watanabe et al., 2013). 
Here, RAP80 appears to be phosphorylated at serine 205 by the ATM kinase (Yan et 
al., 2008), as well as at serine 677 by cyclin dependent kinase 1 (Cho et al., 2013). 
The interaction between RAP80 and BRCA1 may be further enhanced by the protein 
Abraxas, which, in concert with RAP80, may help to recruit BRCA1 to K63-linked 
ubiquitinated DSB foci (Wang and Elledge, 2007; Wang et al., 2007). Interestingly, 
BRCA1 also interacts with the K63-specific deubiquitinating enzyme, BRCC35, 
which may act to regulate the abundance of these chains at sites of DSBs (Feng et al., 
2010). 
 
The activated MRN complex is required for resection of the DSB 5` strand. For this, 
Mre11 nicks the target strand up to 300 bases from the break site, and resects the 
strand in the 3`-5` direction (Garcia et al., 2011). Concurrently, one of two DNA 
exonucleases, Dna2 helicase/nuclease or exonuclease 1 (Exo1), acts to digest the 
strand in the 5`-3` direction, away from the DSB site (Tomimatsu et al., 2012). Here, 
Mre11 endonuclease activity is stimulated by direct interaction with the CtBP-
interacting protein (CtIP) (Ramírez-Lugo et al., 2011; Sartori et al., 2007). 
Additionally, CtIP interacts with BRCA1 to exclude the TopBP1-interacting protein, 
RIF1, a component of the non-homologous end-joining pathway which limits MRN 
resection (Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Díaz et al., 2013; 
Peterson et al., 2013; Xu et al., 2010a; Zimmermann et al., 2013). The PCNA clamp 
has also been shown to load at sites of double-strand DNA breaks, where it promotes 
resection processivity of Exo1 (Chen et al., 2013b). The DNA-dependent protein 
kinase catalytic subunit (DNA-PKCS), an important P13K-like kinase involved in the 
coordination of DSB repair by non-homologous end joining, has also been suggested 
to promote Exo1 exonuclease activity in response to prior ATM-mediated 
phosphorylation of T2609 and T2647 (Zhou and Paull, 2013).  
 
Unwinding of the DNA helix upstream of the DSB is another important requirement 
for end-resection. Here, the BLM RECQ helicase appears to have an essential role 
(Nimonkar et al., 2011). In response to DSB formation, BLM is recruited to DNA 
damage sites through a direct interaction with MRN, where it is phosphorylated by 
the ATM kinase (Ababou et al., 2000). BLM recruitment may be enhanced by the 
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human heterogeneous nuclear ribonucleoprotein U-like (hnRNPUL) proteins 1 and 2, 
both of which have been shown to bind the Nbs1 C-terminus and to promote efficient 
end-resection (Polo et al., 2012). Subsequent to its recruitment, BLM has been 
suggested to form two separate end resection complexes, where it interacts with and 
stimulates the exonuclease activity of Exo1 or Dna2 (Cejka et al., 2010; Gravel et al., 
2008; Nimonkar et al., 2011). In addition, Mre11 and BLM are also known to 
interact directly with the Fanconi Anemia Group J Helicase (FANCJ) (Paliwal et al., 
2013; Suhasini and Brosh, 2012; Suhasini et al., 2011; Suhasini et al., 2013). Here, 
FANCJ is recruited to sites of DSBs in an MRN-dependent manner, where it seems 
to inhibit Mre11 exonuclease activity, and promote endonuclease mediated end-
resection (Suhasini et al., 2013). Replication protein A (RPA) may also play a 
prominent role in end resection, where it appears to stimulate the exonuclease 
efficiency of Exo1 and Dna2 (Yan et al., 2011). Further, RPA binding of the exposed 
3` DNA strand may prevent the formation of inappropriate hairpin fold-back 
structures, which may present as substrates for Mre11-mediated degradation (Chen et 
al., 2013a).  
 
In addition to preventing the formation of inappropriate DNA secondary structures, 
ssDNA-binding of RPA is important for the recruitment of downstream repair 
proteins (Iftode et al., 1999). This includes, as with the stabilisation of stalled forks, 
the recruitment of ATR kinase via its interacting protein, ATRIP (Zou, 2003).  In 
addition, ATM-phosphorylation of TopBP1 S1131 seems to promote a direct 
interaction between TopBP1 and the BRCT repeats of NBS1 (Yoo et al., 2009), as 
well as with the CtIP N-terminus (Ramírez-Lugo et al., 2011); both interactions also 
seem to further stimulate ATR activity. Interestingly, ATR seems to promote further 
accumulation of CtIP via phosphorylation of T859, leading to increased chromatin 
binding and the promotion of CtIP-dependent resection (Peterson et al., 2013). The 
Rad51 recombinase is another important RPA-interacting protein which, following 
displacement of RPA, rapidly coats the exposed ssDNA strand (Sung et al., 2003). 
Initially, Rad51 seems to be recruited to DSB sites via direct binding to Nbs1, which 
may be promoted by successive phosphorylation, firstly by Polo-like kinase 1 (Plk1) 
at serine 14 (S14), followed by phosphorylation of threonine 13 (T13) by casesin 
kinase 2 (Ck2) (Yata et al., 2012). Phosphorylation of RAD51 S14 may also be 
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promoted by a direct interaction between TopBP1 and Plk1, which presumably 
scaffolds the kinase to sites of repair (Moudry et al., 2016). 
 
The displacement of RPA and the coating of Rad51 may occur through a number of 
mechanisms. Of these, the direct interaction between the RPA70 N-terminal OB-fold 
and the N-terminus of Rad51 is likely to be of central importance (Stauffer and 
Chazin, 2004). By this method, exchange would likely occur as a result of Rad51 
capture of transient RPA binding (Fanning et al., 2006). Rad52 has also been 
suggested to modulate the RPA-Rad51 exchange, whereby it binds both RPA34 and 
70 in response to prior RPA phosphorylation, and seems to stimulate RPA 
displacement. RPA removal may also be promoted by BRCA2, a large ssDNA-
binding protein, which may promote RPA displacement through competitive ssDNA 
interaction (Jensen et al., 2010; Liu et al., 2010; Yang et al., 2002). In addition, 
BRCA2 interacts directly with Rad51 through a series of eight 35 amino acid repeats, 
known as the BRC repeats (Bignell et al., 1997; Bork et al., 1996; Galkin et al., 
2005). Interestingly, crystallography of BRCA2 BRC4 bound to Rad51 has indicated 
this interface may mimic that of the Rad51 homodimer, suggesting a possible 
mechanism through which BRCA2 is able to stabilise monomeric Rad51 for ssDNA 
loading (Carreira et al., 2009; Pellegrini et al., 2002). Further work has suggested the 
BRC repeats may form two distinct classes, BRC1-4, which binds free Rad51 with 
high affinity, and BRC5-8, which strongly interacts with Rad51 once it has bound 
ssDNA (Carreira and Kowalczykowski, 2011).  
 
Once formed, the Rad51 presynaptic nucleofilament is responsible for capturing the 
sister chromatid, where it searches within it for a homologous sequence (San Filippo 
et al., 2008). This is achieved by the ability of Rad51 to hold two DNA molecules in 
close proximity, a feat attained by formation of a dsDNA binding groove on the 
exterior of the nucleofilament (Sung et al., 2003). Homology searching by Rad51 
seems to be promoted by a direct interaction with Rad54, a protein which 
translocates along dsDNA and seems to endow the filament with a means of 
scanning the sister chromatid (Mazin et al., 2010). In addition, once a homologous 
region has been found, Rad54 promotes the DNA strand exchange activity of Rad51, 
in which the invading strand base pairs with the homologous template (Cejka et al., 
2010). Here, RPA is required to bind and stabilise the displaced strand (Eggler et al., 
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2002). Rad54 may then promote dissociation of Rad51 from the nucleofilament, 
leaving a free 3` end for polymerase-mediated extension (Kiianitsa et al., 2006; Li 
and Heyer, 2009; Solinger et al., 2002). Synthesis seems to be achieved by DNA pol 
δ (Lydeard et al., 2007; Maloisel et al., 2008), in association with the replicative 
PCNA clamp (Li et al., 2009a). In addition, the Pif1 helicase has been found to 
promote recombination-coupled DNA synthesis, where it allows migration of the 
replication bubble (Wilson et al., 2013). The RECQ5 helicase may also act to protect 
the invading strand, where it prevents the formation of new Rad51 filaments (Paliwal 
et al., 2013). 
 
Second-end capture of the extended invading strand seems to be accomplished by 
Rad52, which facilitates annealing of this invading strand with the RPA-coated 
complementary sequence on the second end of the DSB (Nimonkar et al., 2009). The 
resulting structure, composed of two interlaced DNA strands, is known as a double 
Holliday junction (Bachrati and Hickson, 2009). The processing of these structures 
and the formation of two intact dsDNA strands may occur through two mechanisms 
‘dissolution’ and ‘resolution’ (Matos and West, 2014). Dissolution of the junction 
results from the ATP-driven convergent migration of the double Holliday junction by 
the BML RecQ-like helicase, resulting in the formation of a hemicatenane structure. 
The entangled strands are then cleaved, unwound, and rejoined by Topoiomerase 
IIIα, generating two non-crossover dsDNA molecules (Swuec and Costa, 2014). Due 
to restoration of the two original DNA strands, ‘dissolution’ is generally the favoured 
pathway of Holliday junction processing in eukaryotic somatic cells. By contrast, 
processing by ‘resolution’, which involves Yen1 and Mus81/Mms4-mediated 
nucleolytic cleavage at each junction branch point (Blanco et al., 2010; Chan and 
West, 2015; Ho et al., 2010), may generate either crossover and non-crossover 
products, depending on the direction in which the junction is cleaved (Lee et al., 
2015).  
 
hSSB1 has also been reported to rapidly localise to double-strand DNA breaks 
(Richard et al., 2008), where it may interact directly with exposed ssDNA (Richard 
et al., 2011b) and poly(ADP) ribose chains (Zhang et al., 2014). Here, hSSB1 seems 
to promote the resection of double-strand DNA breaks, most likely by interacting 
with and stimulating activity of the MRN complex (Richard et al., 2011a) and/or the 
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EXO1 endonuclease (Yang et al., 2012). hSSB1 also promotes activation of the 
ATM kinase, as well as subsequent downstream signalling and checkpoint activation 
(Richard et al., 2008). In addition to these early roles, the persistence of hSSB1 at 
double-strand DNA breaks for several hours post damage have suggested hSSB1 
may also be involved in subsequent steps of homologous recombination, however 
this remains to be tested (Zhang et al., 2009). 
 
1.5 Human single-stranded DNA-binding protein 1 (hSSB1)  
Human single-stranded DNA-binding protein 1 (hSSB1), also known as SOSS 
[sensor of single-stranded DNA] complex subunit B1 (SOSS-B1; recommended 
name given by the UniProt Consortium [uniprot.org]) or 
Oligonucleotide/oligosaccharide-binding fold-containing protein 2B (OBFC2B) is an 
~ 22 kDa single-stranded DNA binding protein encoded by the gene Nucleic acid 
binding protein 2 (NABP2, H. sapiens 12q13.3; approved name and symbol given by 
the HUGO Gene Nomenclature Committee [genenames.org]). hSSB1 is paralogous 
with hSSB2 (SOSS-B2/OBFC2A/NABP1; H, sapiens 2q32.2), a similarly sized 
protein with which it shares a common domain structure – a short N-teminus, an 
evolutionarily conserved oligonucleotide/oligosaccharide-binding (OB) fold and an 
unstructured, flexible C-terminus (Kang et al., 2006; Richard et al., 2008). The 
ssDNA-binding function of hSSB1 is facilitated by its OB-fold (Richard et al., 2008), 
a domain comprised of a cylindrical β-barrel (comprised of five antiparallel β-
strands), which is capped at one end by an α-helix originating from between the third 
and fourth β-strands (Murzin, 1993). In other proteins, these domains interact with 
ssDNA substrates both through electrostatic interactions with the phophodiester 
backbone, as well as by aromatic residue-mediated nucleotide base stacking 
(Bujalowski et al., 1988; Casas-Finet et al., 1987a; Casas-Finet et al., 1987b; Curth et 
al., 1993; Gamsjaeger et al., 2013; Khamis et al., 1987a; Khamis et al., 1987b; 
Lohman et al., 1988; Merrill et al., 1984; Overman and Lohman, 1994; Overman et 
al., 1988; Raghunathan et al., 2000; Savvides et al., 2004). Consistent with these 
observations, the recently solved crystal structure of hSSB1 (in complex with 
SOSSA) demonstrated an interaction with a poly(dT) oligonucleotide via numerous 
residues lining a groove on one side of the hSSB1-OB fold. This included the 
aromatic residues tryptophan 55 (W55), phenylalanine 78 (F78) and tyrosine 85 
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(Y85), each of which was involved in base stacking with various thymine bases (Ren 
et al., 2014). Furthermore, individual mutation of each of these residues to alanine 
reduced binding to a dT68 olignonucleotide as assessed by electrophorectic mobility 
shift assays (EMSA). Interestingly, the crystal structure did not identify tyrosine 74 
(Y74), another aromatic residue of the DNA-binding groove, as a likely contributor 
to DNA-binding. Mutation of this residue did however reduce interaction with the 
dT68 substrate to a level comparable with the W55A mutant, perhaps indicating its 
erroneous assignment within the proposed structure, or indirect involvement in DNA 
binding via another residue (Ren et al., 2014). These results were largely consistent 
with mutational analysis of murine SSB1 (mSSB1), which demonstrated 
substantially reduced binding of W55A, Y74A (most prominently) and Y85A 
mutants to a dT40 substrate (Gu et al., 2013). While these aromatic amino acids are 
likely to be the major residues involved in hSSB1 DNA-binding, other residues of 
the OB fold, as well of the N-terminal tail, likely have ancillary DNA-binding roles 
(Ren et al., 2014). DNA-binding may also be enhanced through an as yet unclear 
means by the hSSB1 C-terminal tail (Vidhyasagar et al., 2016). 
 
In addition to binding ssDNA, the hSSB1 OB-fold is also important for mediating an 
interaction with integrator complex subunit 3 (INTS3; also known as SOSS complex 
subunit A [SOSS-A]), a protein which, together with SOSS complex subunit C 
(SOSS-C; also known as INTS3- and NABP-interacting protein (INIP) or SSB-
interacting protein 1 (hSSBIP1)) constitutes the SOSS1 complex (Huang et al., 2009; 
Li et al., 2009b; Skaar et al., 2009; Zhang et al., 2009). By contrast, SOSS2 
complexes containing hSSB2 may similarly form to the mutual exclusion of hSSB1 
(Li et al., 2009b). In addition to mediating the interaction between hSSB1 and SOSS-
C, INTS3 may also directly bind integrator complex subunit 6 (INTS6) or its 
paralogue DDX2b as potential fourth components of SOSS complexes (Zhang et al., 
2013). Crystallography data (Ren et al., 2014), as well as earlier mutagenesis studies 
with mSSB1 (Gu et al., 2013), have demonstrated that hSSB1 may bind ssDNA and 
INTS3 simultaneously via separate OB-fold interfaces (Figure 1.1), suggesting 
hSSB1 may function as a scaffold through which the remainder of the complex may 
associate with DNA. As yet, however, the precise function of the SOSS1 (and 
SOSS2) complexes in DNA repair processes remains unclear. Indeed, whilst 
depletion or mutation of any component protein (Huang et al., 2009; Li et al., 2009b; 
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Ren et al., 2014) has been reported to sensitise cells to double-strand DNA break-
inducing compounds, it is unclear whether the complex itself is directly involved in 
DNA repair. Such studies have further been hampered by the apparent requirement 
of INTS3 for hSSB1 gene expression, a technical issue that has limited the 
investigation of INTS3 function by standard siRNA-based approaches, as this would 
similarly cause depletion of hSSB1 (Skaar et al., 2009). 
 
In addition to DNA repair, hSSB1 and hSSB2 have also recently been suggested to 
function with INTS3 and other components of the integrator complex to promote 
mRNA transcriptional termination at RNA polymerase II pause sites (Skaar, et al., 
2015). Here, hSSB1 may interact with RNA polymerase II as well as the 
transcription termination factors NELFB and SPT5, most likely via the association 
with INTS3. In addition, hSSB1 and hSSB2 were reported to bind the 3` ends of 
replication-dependent histone genes, as well as the promoter proximal regions of 
genes with polyadenylated transcripts and to promote proper transcript processing. 
These data therefore demonstrate additional roles of hSSB1 and hSSB2, suggesting 
the function of these proteins is not restricted to DNA repair. 
1.6 Post-translational regulation of hSSB1 
Previous reports have suggested that, in response to ionising radiation-induced 
double-strand DNA break formation, hSSB1 function may require phosphorylation 
of threonine residue 117 (T117) (Richard et al., 2008). T117 is a component of an 
SQ/TQ motif (serine/threonine – glutamine), numerous of which are phosphorylated 
in other DNA repair proteins by the PI3K-like kinases, ATM, ATR and DNA-PK 
(Traven and Heierhorst, 2005). Although phosphorylation of T117 remains to be 
confirmed, and has only been assessed indirectly, the expression of a T117A hSSB1 
mutant in cells has been shown to disrupt DNA repair signalling following ionising 
radiation exposure (Richard et al., 2008). Furthermore, while WT and T117A 
phosphomutant hSSB1 may associate with FBXL5, the E3 ubiquitin ligase 
responsible for hSSB1 poly-ubiquitination-mediated degradation, a T117E 
phosphomimetic hSSB1 reportedly does not (Chen et al., 2014). In addition, T117E 
hSSB1 may be less strongly ubiquitinated than the WT protein. Indeed, whilst WT 
hSSB1 protein levels have been suggested to accumulate in cells following double-
strand DNA break formation, this may be reduced for T117A hSSB1. These results 
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suggest that while hSSB1 is relatively labile in cells, T117 phosphorylation may 
promote protein stabilisation by disrupting association with FBXL5 (Chen et al., 
2014).  
 
Although not unambiguously demonstrated, numerous reports have concluded that 
hSSB1 T117 is most likely phosphorylated by the ATM kinase (Chen et al., 2014; 
Skaar et al., 2009; Wu et al., 2015; Yang et al., 2012). These conclusions have been 
drawn from two major observations: 1) Accumulation of hSSB1 protein levels in 
cells following double-strand DNA break formation is suppressed by inhibition of 
ATM or by use of ATM deficient cell lines (Chen et al., 2014; Richard et al., 2008). 
(Chen et al., 2014). 2) hSSB1 may associate with ATM in cells and WT, although 
not T117A hSSB1, is phosphorylated by immunoprecipitated ATM in vitro (Richard 
et al., 2008). These findings do not however rule out the possibility that hSSB1 T117 
may instead be phosphorylated by ATR or DNA-PK. Indeed, both of these kinases 
also function in response to double-strand DNA break formation and may associate 
with hSSB1 in cells ((Kar et al., 2015) and section 4.2.4 of this thesis).  
 
Acetylation of hSSB1 lysine 94 (K94) has also recently been reported and was 
detected both by mass spectrometry and antibody immunodetection (Wu et al., 
2015). Here, acetylation seems to be regulated by the opposing actions of the P300 
acetyltransferase and the SIRT4 and HDAC10 deacetylases. Similarly to 
phosphorylation of T117, K94 acetylation was suggested to also stabilise hSSB1 by 
impairing its ubiquitination and subsequent proteasomal degradation. Furthermore, a 
hSSB1 K94R mutant was unable to rescue clonogenic survival of hSSB1-depleted 
cells in response to ionising radiation exposure or treatment with camptothecin.   
Various mass spectrometry screens of immunoprecipitated cells have also detected a 
number of as yet un-validated instances of hSSB1 post-translational modifications 
and these have been curated on the online database, phosphositeplus (Hornbeck et 
al., 2015) (Figure 1.1). 
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Figure 1.1 hSSB1 post-translational modifications may occur at numerous 
residues 
 
A schematic of hSSB1 indicating potential sites of hSSB1 serine, threonine or 
tyrosine phosphorylation, as well as lysine acetylation. Modifications on the residues 
indicated above the schematic have been detected by mass spectrometry and are 
curated on the online database phosphositeplus (available at: www.phosphosite.org). 
Evidence of K94 and T117 acetylation and phosphorylation, respectively, have been 
published elsewhere and are listed below the hSSB1 schematic. 
 
1.7 Study aims 
The current study aims to further elucidate the mechanisms that regulate hSSB1 
function in cells.  
Specifically, this study aims to: 
1) Characterise the proteasome-targetting poly-ubiquitination of hSSB1 
2) Examine the regulation of hSSB1 in the response to replication stress 
 
Figure 1.1
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Chapter 2:  Materials and Methods 
2.1 E. coli strains and preparation of chemically competent cells 
One Shot Stbl3 E. coli were purchased from Life Technologies (now part of 
ThermoFisher Scientific, Scoresby, Vic), α-Select Gold E. coli were purchased from 
Bioline (Alexandria, NSW) and Shuffle T7 Express BL21 competent E. coli were 
purchased from New England BioLabs (distributed by Genesearch, Arundel, QLD). 
Stbl3 or α-Select Gold E. coli were used for general plasmid propagation, generation 
of glycerol stocks and for the transformation of site-directed mutagenesis reactions. 
Shuffle T7 Express E. coli were employed for expression of recombinant protein. E. 
coli were typically grown either in lysogeny broth (Bertani, 1951; Sezonov et al., 
2007) (10 g L-1 tryptone, 5 g L-1 yeast extract, 10 g L-1 sodium chloride) or 2XYT 
liquid medium (Siedler et al., 2014) (16 g L-1 tryptone, 10 g L-1 yeast extract, 10 g L-1 
sodium chloride), or on solid LB medium containing 18 g L-1 bacteriological agar. 
Where appropriate, media was supplemented with 100 µg mL-1 ampicillin or 50 µg 
mL-1 kanamycin. Cultures were typically incubated at 37 oC, or 30 oC for Shuffle T7 
Express E. coli. Liquid cultures were grown in a shaking incubator set to 220 rpm. 
Chemically competent E. coli were prepared from commercial cells using an 
adaptation of a previously published protocol (Hanahan et al., 1991). Here, 10 mL of 
LB media was inoculated with a single colony of commercially prepared E. coli and 
grown overnight in a shaking incubator (220 rpm) at 37 oC. The following day this 
culture was used to inoculate 500 mL of 2XYT media, which was further grown to ~ 
OD600 0.65. E. coli were then centrifuged at 5,000 x g for 10 minutes at 4 oC and re-
suspended in 40 mL of cold RF1 solution (100 mM RbCl, 50 mM MnCl2, 30 mM 
potassium acetate, 10 mM CaCl2, 15% w/v glycerol, pH 5.8). Cells were incubated 
on wet-ice in a 4 oC cold-room for 1 hour, centrifuged as per previously and re-
suspended in 7.5 mL cold RF2 (10 mM MOPS, 10 mM RbCl, 75 mM CaCl2, 15% 
w/v glycerol, pH 6.8). After 15 minutes incubation at 4 oC, 100 µL aliquots were 
snap-frozen in a dry-ice/ethanol bath. Competent cells were stored at -80 oC. Plasmid 
transformations were performed using a methodology based on standard ‘heat-shock’ 
protocols (Huff et al., 1990; Nakata et al., 1997). Briefly, an aliquot of chemically 
competent cells was thawed and 50 µL incubated on ice with 100-200 ng of plasmid 
DNA for 30 minutes. Cells were heat-shocked at 42 oC for 45 seconds, and incubated 
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on ice for a further 10 minutes. 500 µL of LB was then added to each reaction and E. 
coli placed in a shaking incubator at 30 or 37 oC for 1 hour (for ampicillin resistance 
plasmids) or 2 hours (for kanamycin resistance plasmids) prior to spreading or 
streaking onto LB agar.  
2.2 Plasmids and site-directed mutagenesis 
The N-terminal hexa-His-ubiquitin plasmid (pMT107) (Treier et al., 1994), was 
kindly provided by Ronald T. Hay (University of Dundee). The hexa-His-hSSB1 
bacterial expression plasmid has been described previously (Richard et al., 2008) and 
contains the coding sequence of hSSB1 cloned into the BamHI and SalI restriction 
sites of pet28A. Stocks of this construct were found to contain a G:C point mutation 
altering arginine 207 to a threonine residue (R207T). This mutation was restored to 
wild-type (WT) by site-directed mutagenesis. The 3x FLAG hSSB1 (pCMV6-AN-
3DDK) mammalian expression vector (Paquet et al., 2015) was purchased from 
Origene with the hSSB1 coding sequence cloned into the MluI and AsiSI restriction 
sites. The coding sequence for the N-terminal 3x FLAG tag was exchanged for that 
of Myc or HA by inverse PCR with 5` hybridised primers (Figure 2.1). 3x FLAG 
hSSB1 with a C-terminal HA tag was prepared similarly. A principally similar PCR-
based approach for such manipulations has been described previously (Liu and 
Naismith, 2008). PCR primers are listed in Table 2.1, as well as site-directed 
mutagenesis primers used to introduce point mutations in the 3x FLAG or hexa-His 
hSSB1 constructs. Primers were purchased from Sigma-Aldrich (Castle Hill, NSW) 
or Integrated DNA Technologies (Baulkham Hills, NSW). Site-directed mutagenesis 
was conducted as described previously (Paquet et al., 2014): AccuPrime Pfx 
polymerase (0.02 U µL1; Life Technologies), 1x AccuPrime Pfx polymerase reaction 
mix (Life Technologies), primers (0.3 µM) and template (0.8 ng µL -1), then PCR 
cycling 19x at: 94 oC (20 s), 57 oC (30 s), 68 oC (6 min 30 s). PCR was followed by 
Dpn1 (New England Biolabs) digestion (0.8 U µL-1, 2 h, 37 oC) and transformation 
into chemically competent Stbl3 E. coli. DNA sequencing (AGRF, St. Lucia, QLD) 
of the forward strand using the primers VP1.5 (for pCMV6 vectors) or T7 Universal 
(for PET28 vectors) was used to confirm successful mutagenesis. 
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Table 2.1 Oligonucleotide primers used for site-directed mutagenesis.  
Nucleotides in Bold represent mismatches with the target sequence. 
 
Primer Set Sequence (5`-3`) 
hS
SB
1 
Ph
os
ph
or
yl
at
io
n 
Si
te
 
Po
in
t M
ut
at
io
ns
 
S134A F: CAGCAACCCTTCAGCTGAGCAGCCTACCACTGGAC 
R: GTCCAGTGGTAGGCTGCTCAGCTGAAGGGTTGCTG 
S134E F: CAGCAACCCTTCAGCTGAGCAGCCTACCACTGGAC 
R: GTCCAGTGGTAGGCTGCTCAGCTGAAGGGTTGCTG 
T117A F: CCAGAGTACAGCGCCCAGCAGGCACC 
R: GGTGCCTGCTGGGCGCTGTACTCTGG 
T117E F: CAAACCCAGAGTACAGCGAACAGCAGGCACCCAACAAG 
R: CTTGTTGGGTGCCTGCTGTTCGCTGTACTCTGGGTTTG 
hS
SB
1 
L
ys
in
e 
Po
in
t M
ut
at
io
ns
 
K8R F: GGAGACCTTTGTGAGGGATATCAAGCCTGG 
R: CCAGGCTTGATATCCCTCACAAAGGTCTCC 
K11R F: CCTTTGTGAAGGATATCAGACCTGGGCTCAAGAATCTG 
R: CAGATTCTTGAGCCCAGGTCTGATATCCTTCACAAAGG 
K15R F: GATATCAAGCCTGGGCTCAGGAATCTGAACCTTATCTTC 
R: GAAGATAAGGTTCAGATTCCTGAGCCCAGGCTTGATATC 
K31R F: GCCGAGTGACCAGGACAAAGGACGGG 
R: CCCGTCCTTTGTCCTGGTCACTCGGC 
K33R F: GAGTGACCAAGACAAGAGACGGGCATGAGGTTC 
R: GAACCTCATGCCCGTCTCTTGTCTTGGTCACTC 
K42R F: GGTTCGGACCTGCAGAGTGGCGGACAAAAC 
R: GTTTTGTCCGCCACTCTGCAGGTCCGAACC 
K46R F: CAAAGTGGCGGACAGAACAGGCAGCATC 
R: GATGCTGCCTGTTCTGTCCGCCACTTTG 
K72R F: GACATTATCCGGCTCACCCGTGGGTACGCTTCAGTTTTC 
R: GAAAACTGAAGCGTACCCACGGGTGAGCCGGATAATGTC 
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hS
SB
1 
L
ys
in
e 
Po
in
t M
ut
at
io
ns
 
K79R F: GGGTACGCTTCAGTTTTCAGGGGTTGTCTGACACTATAT 
   AC 
R: GTATATAGTGTCAGACAACCCCTGAAAACTGAAGCGTAC 
   CC 
K94R F: GGGGTGATCTGCAGAGGATTGGAGAATTCTG 
R: CAGAATTCTCCAATCCTCTGCAGATCACCCC 
K123R F: CAGGCACCCAACAGGGCGGTGCAGAAC 
R: GTTCTGCACCGCCCTGTTGGGTGCCTG 
K203R F: CTGTTAGTAACGGCAGAGAAACCCGGAGGAG 
R: CTCCTCCGGGTTTCTCTGCCGTTACTAACAG 
K210R F: CGGAGGAGCAGCAGGAGAACGCGTTAAG 
R: CTTAACGCGTTCTCCTGCTGCTCCTCCG 
K11R 
(K8R) 
F: CTTTGTGAGGGATATCCGGCCTGGGCTCAAGAATC 
R: GATTCTTGAGCCCAGGCCGGATATCCCTCACAAAG 
K15R 
(K11R) 
F: GATATCAGACCTGGGCTCAGAAATCTGAACCTTATCTTC 
R: GAAGATAAGGTTCAGATTTCTGAGCCCAGGTCTGATATC 
K33R 
(K31R) 
F: GAGTGACCAGGACAAGAGACGGGCATGAGGTTC 
R: GAACCTCATGCCCGTCTCTTGTCCTGGTCACTC 
K46R 
(K42R) 
F: CAGAGTGGCGGACAGAACAGGCAGCATC 
R: GATGCTGCCTGTTCTGTCCGCCACTCTG 
IN
T
S3
-B
in
di
ng
 P
oi
nt
 
M
ut
at
io
ns
 
 
E97A F: GATCTGCAGAAGATTGGAGCATTCTGTATGGTTTATTCTG 
R: CAGAATAAACCATACAGAATGCTCCAATCTTCTGCAGATC 
F98A F: CTGCAGAAGATTGGAGAAGCCTGTATGGTTTATTCTGAG 
R: CTCAGAATAAACCATACAGGCTTCTCCAATCTTCTGCAG 
E104A F: CTGTATGGTTTATTCTGCGGTTCCTAACTTCAGTG 
R: CACTGAAGTTAGGAACCGCAGAATAAACCATACAG 
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R
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VL23AA F: CTGAACCTTATCTTCATTGCTGCGGAGACAGGCCGAGTGA 
CC 
R: GGTCACTCGGCCTGTCTCCGCAGCAATGAAGATAAGGTTC 
AG 
TG47AA F: CCTGCAAAGTGGCGGACAAAGCCGCCAGCATCAATATCTC 
TGTC 
R: GACAGAGATATTGATGCTGGCGGCTTTGTCCGCCACTTTG 
CAGG 
WD55AA F: GCAGCATCAATATCTCTGTCGCCGCCGATGTTGGCAATCT 
GATCC  
R: GGATCAGATTGCCAACATCGGCGGCGACAGAGATATTGAT 
GCTGC 
hS
SB
1 
D
N
A
-B
in
di
ng
 A
ro
m
at
ic
 P
oi
nt
 M
ut
at
io
ns
 W55A 
F: CAGCATCAATATCTCTGTCGCCGACGATGTTGGCAATCTG 
R: CAGATTGCCAACATCGTCGGCGACAGAGATATTGATGCTG 
Y74A F: CCGGCTCACCAAAGGGGCTGCTTCAGTTTTCAAAGG 
R: CCTTTGAAAACTGAAGCAGCCCCTTTGGTGAGCCGG 
F78A F: GGGTACGCTTCAGTTGCCAAAGGTTGTCTGAC 
R: GTCAGACAACCTTTGGCAACTGAAGCGTACCC 
Y85A F: CAGTTTTCAAAGGTTGTCTGACACTAGCTACTGGCCGTGG 
   GG 
R: CCCCACGGCCAGTAGCTAGTGTCAGACAACCTTTGAAAAC 
   TG 
Y74A_F78
A 
F: TCCGGCTCACCAAAGGGGCCGCTTCAGTTGCCAAAGGTTG 
   TCTGACAC 
R: GTGTCAGACAACCTTTGGCAACTGAAGCGGCCCCTTTGGT 
   GAGCCGGA 
hS
SB
1 
si
R
N
A
-
R
es
is
ta
nc
e hSSB1 
siRNA 
Resistance 
F: CAGGCCCGCCTGGCCCTTCTTCCAATCCCGTTAGTAACGG 
   CAAAGAAAC 
R: GTTTCTTTGCCGTTACTAACGGGATTGGAAGAAGGGCCAG 
   GCGGGCCTG 
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1 
T
ag
 M
an
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at
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N-term 
Myc 
F: GAACAAAAACTTATTTCTGAAGAAGATCTGGCGATCGCCA 
   TGACGACGGAGACC 
R: CAGATCTTCTTCAGAAATAAGTTTTTGTTCCATGGTGGCA 
   GATCTCCTCGGTACCGG  
N-term HA F: TACCCATACGATGTTCCAGATTACGCTGCGATCGCCATGA 
   CGACGGAGACC 
R: AGCGTAATCTGGAACATCGTATGGGTACATGGTGGCAGAT 
   CTCCTCGGTACCGG 
C-term HA F: GCATACCCATACGATGTTCCAGATTACGCATAAGCGGCCG 
   CACTCGAGGTTTAAACGGC 
R: TGCGTAATCTGGAACATCGTATGGGTATGCCGTTCTCTTG 
   CTGCTCCTCCGGGTTTCTTTGC 
O
th
er
 
M1A F: GATAAGGCGATCGCCGCCACGACGGAGACCTTTG 
R: CAAAGGTCTCCGTCGTGGCGGCGATCGCCTTATC 
pET28A 
repair 
F: GCAAAGAAACCCGGAGGAGCAGCAAGAGATAG 
R: CTATCTCTTGCTGCTCCTCCGGGTTTCTTTGC 
Se
qu
en
ci
ng
 VP1.5 F: GGACTTTCCAAAATGTCG 
T7 
Universal 
F: TAATACGACTCACTATAGGG 
 
 
 
Figure 2.1 Site directed mutagenesis (SDM) approaches described in section 2.2  
 
(A) Generation of Point Mutations e.g. hSSB1 siRNA resistance
CAGGCCCGCCTGGCCCTTCCAGCAACCCTGTTAGTAACGGCAAAGAAAC
GTCCGGGCGGACCGGGAAGGTCGTTGGGACAATCATTGCCGTTTCTTTG
CAGGCCCGCCTGGCCCTTCTTCCAATCCCGTTAGTAACGGCAAAGAAAC
...
... ...
...
GTCCGGGCGGACCGGGAAGAAGGTTAGGGCAATCATTGCCGTTTCTTTG
5` -
3` - - 5`
- 3`
5` -
3` -
- 3`
- 5`
CCGGTACCGAGGAGATCTGCCACCATG                           GCGATCGCCATGACGACGGAGACC
TACCCATACGATGTTCCAGATTACGCTGCGATCGCCATGACGACGGAGACC
GGCCATGGCTCCTCTAGACGGTGGTACATGGGTATGCTACAAGGTCTAATGCGA
 78 bp (3x FLAG Tag)... ...GGCCATGGCTCCTCTAGACGGTGGTAC
 27 bp (HA Tag)
CGCTAGCGGTACTGCTGCCTCTGG
5` -
5` -
...
...
5` -
3` -
- 3`
- 5`
...
... - 3`
- 5`
(B) Exchange of Epitope Tags e.g. 3x FLAG hSSB1 to HA hSSB1
... ...
Figure 2.1
|||||||||||||||||||||||||||||||||||||||||||||||||
||||||||||||||||||||||||||| ||||||||||||||||||||||||
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(A) Example of SDM primers used for the introduction of point mutations. 
Primer pairs were designed with 100% complementarity and containing central 
mismatches with the template sequence. Primers typically contained 25-45 
nucleotides, a G:C content of 30-70% and a melting temperature of ~78 oC. Primers 
were designed using primerX software (www.bioinformatics.org/primerx/).    
 
(B) Example of SDM primers used for protein epitope tag manipulation. 
Primer pairs contained 100% complementary 5` ends encoding the exogenous DNA 
sequence. Primer 3` ends were 100% complementary to the target sequence, 
contained 25-30 nt and had a calculated melting temperature of ~76 oC. Primers were 
visualised using SnapGene Viewer software (from GSL Biotech; available at 
snapgene.com). 
 
2.3 Cell culture reagents, cell lines and transfections 
HeLa, Human Embryonic Kidney (HEK) 293T and U-2 OS osteosarcoma cells were 
obtained from the American Type Culture Collection (ATCC) and maintained in 
Roswell Park Memorial Institute (RPMI) 1640 medium + L-glutamine (Sigma-
Aldrich) supplemented with 10% foetal bovine serum (FBS; Sigma-Aldrich). All cell 
cultures were grown at 37 oC, 5% CO2, in a humidified 2% or 21% O2 incubator. For 
clonogenic assays, cell media was further supplemented with 100 U mL-1 penicillin –
streptomycin (Life Technologies). Cell cultures were tested for mycoplasma 
contamination every 2-3 months at the TRI mycoplasma testing facility. 
Lipofectamine 2000 and Lipofectamine RNAiMAX (Life Technologies) were used 
for transfection of plasmids and RNAi, respectively, as per the manufacturer’s 
instructions. Typically 1 µg of plasmid and 2 µL of lipofectamine 2000 were used to 
transfect ~70% confluent cells grown in one well of a 6-well plate. The quantity of 
DNA and lipofectamine 2000 used was scaled proportionately for larger tissue 
culture vessels. Stealth or Silencer Select siRNA was purchased from Life 
Technologies. Lyophilised Stealth siRNA were resuspended to a concentration of 20 
µM in DEPC-treated H2O and transfected at a concentration of 50 nM. A stealth 
siRNA:lipofectamine RNAiMAX ratio of 0.75 µL:1 µL was typically used. Stealth 
siRNA negative control med GC (20 µM; Life Technologies) was used as a negative 
control siRNA. Silencer Select siRNA were resuspended to a concentration of 50 µM 
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and used at a concentration of 10 nM. A silencer select siRNA:lipofectamine 
RNAiMAX ratio of 0.9 µL:3 µL was typically used. Silencer select negative control 
no.1 was used as negative control siRNAs. All transfection solutions were prepared 
in Opti-MEM reduced serum media (Life Technologies). 
 
Table 2.2 siRNA oligonucleotides used for gene silencing. 
 
 
2.4 Induction of genotoxic stress and other cell treatments 
The genotoxic compounds hydroxyurea, aphidicolin and camptothecin, inhibitors of 
ribonucleotide reductase (Koç et al., 2004), DNA polymerase α (Krokan et al., 1981) 
and topoisomerase I (Staker et al., 2002), respectively, were purchased form Sigma-
Aldrich. Hydroxyurea was dissolved to 300 mM in RPMI and cells typically treated 
with a concentration of 3 mM unless otherwise indicated. Aphidicolin was purchased 
as a 1 mg mL-1 solution in DMSO and cells typically treated with 6 µg mL-1. Cells 
were treated with 2 µM Camptothecin, diluted from a 2 mM stock prepared in 
DMSO. Cycloheximide, an inhibitor of the 60S ribosomal subunit (Schneider-
Poetsch et al., 2010), was also purchased from Sigma-Aldrich. Cycloheximide was 
dissolved in DMSO to 10 mg mL-1 and cells treated by dissolving 1:200 in media to 
a final concentration of 50 µg mL-1. The 26S proteasome inhibitor MG-132 
(Goldberg, 2012) was purchased from Selleck Chemicals (distributed by Jomar Life 
Gene 
target 
Chemistry Sense Sequence (5`-3`) Usage 
concentration 
hSSB1 Stealth GCCCUUCCAGCAACCCUGU
UAGUAA 
30 – 50 nM 
ATM Stealth AGUCUAGUACUUAAUGAUC
UGCUUA 
30 – 50 nM 
ATR Stealth CAACCUCCGUGAUGUUGCU
UGAUUU 
30 – 50 nM 
DNA-PKcs Silencer 
Select 
CAAGCGACUUUAUAGCCUU
TT 
10 nM 
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Research, Scoresby, Victoria) and used in poly-ubiquitination assays as described in 
section 2.10. KU-60019, VE-821 and NU7441, inhibitors of ATM, ATR and DNA-
PK, respectively, were also purchased from Selleck Chemicals. Each drug was 
dissolved in DMSO at 5 mM for KU-60019 and NU7441 and 10 mM for VE-821. 
Cells were treated with each compound diluted 1:1000 in cell culture media. The 
PPP-family phosphatase inhibitors okadaic acid and calyculin A (Swingle et al., 
2007) were purchased from Cell Signaling Technology (distributed by Genesearch) 
and dissolved in DMSO to concentrations of 1 mM and 100 µM, respectively. 
Okadaic acid was added to cells at concentrations of 25 nM or 1 µM. Calyculin A 
was added to cells at a final concentration of 50 nM. Double-strand DNA breaks 
were induced in cells by exposure to ionising radation using a Gammacell 40 Exactor 
caesium-source irradiator. 
2.5 Clonogenic survival assays and statistical analysis 
Clonogenic assays were performed essentially as described previously (Paquet et al., 
2015). For these assays, hSSB1 was depleted from HeLa cells by transfection of 
siRNA targeting the hSSB1 CDS twice, separated by a 24-hour interval. WT or 
mutant siRNA-resistant 3x FLAG hSSB1 plasmids were then transiently expressed 
24 hours later, and after 6 hours, cells seeded at a density of 400 cells per well into 
wells of a 6-well plate. Wells for three technical repeats were prepared. For 
clonogenic assays where cells were to be exposed to ionising radiation, cells were 
seeded in media containing penicillin-streptomycin. Alternatively, cells were seeded 
in normal media, treated with hydroxurea or ampicillin as indicated, washed with 
PBS and then penicillin-streptomycin-containing media added. Cells were grown for 
10-days post-treatment and then fixed and stained with 4% methylene blue (Sigma-
Aldrich) dissolved in methanol. Colonies were manually counted and the surviving 
fraction at each dose calculated (average number of colonies counted/number of cell 
seeded) and expressed relative to un-treated cells for each data set. Each assay was 
performed 3 or 4 times as indicated and results presented as the mean ± 1 standard 
deviation (SD). Student’s t tests were performed to assess statistical significance 
between data sets using GraphPad Prism version 6 software (GraphPad Software, La 
Jolla California USA, available: www.graphpad.com). P < 0.05 was considered 
statistically significant. 
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2.6 Preparation of whole cell lysates, polyacrylamide gel electrophoresis (PAGE) 
and immunoblotting  
Whole cell lysates were prepared by incubation of cells on ice for 30 minutes in 
Radioimmunoprecipitation buffer (RIPA buffer; 50 mM Tris pH 8.0, 150 mM NaCl, 
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X100) supplemented with 1x 
phosphatase inhibitor cocktail (Cell Signaling Technology) and 1x protease inhibitor 
cocktail (Roche, distributed by Sigma-Aldrich; cOmplete, EDTA free). Samples 
were sonicated (Vibra-Cell, 3 mm probe; Sonics and Materials incBalcstone, QLD), 
with 3x 3 s bursts (10% output) and clarified by successive centrifugation at 5,000 x 
g and 21,000 x g, at 4 oC. Protein concentrations were estimated by bicinchoninic 
acid assay (BCA assay) (Sigma-Aldrich) and comparison to known concentrations of 
bovine serum albumin (BSA; Sigma-Aldrich). Samples were reduced and denatured 
by heating at 90 oC for 5 minutes in 1x SDS loading buffer (prepared by addition of 
6x SDS loading buffer: 375 mM Tris pH 6.8, 0.12 g mL-1 SDS, 0.03 g mL-1 
bromophenol blue, 60% (v/v) glycerol with 20 % (v/v) β-mercaptoethanol added 
immediately prior to use).  
Whole cell lysate (typically 15 µg) was separated by electrophoresis using a 4-12% 
Bis-Tris Plus Bolt precast gel (Life Technologies), 1x MOPS running buffer (Life-
Technologies) and run at 165 V for 75 minutes. For immunoblotting, proteins were 
transferred to nitrocellulose  (BioTrace NT, 0.2 µM pore size; Pall corporation) using 
the XCell II Blot Module (Life Technologies) system, typically in transfer buffer (3 g 
L-1 glycine, 6 g L-1 Tris, 20% methanol, 0.05% SDS) run at 35 V for 60 minutes. For 
immunoblotting of ATM, ATR and DNA-PKcs, the above buffer was modified to 
contain 10 % methanol and 0.01 % SDS and transfer run at 15 V for 16 hours. 
Membranes were blocked in 2 % v/v fish gelatin (Sigma-Aldrich) prepared in PBS-T 
and incubated for 2 hours at room temperature with gentle agitation. Membranes 
were incubated with antibody solutions prepared as indicated in Table 2.3. 
Incubations were typically performed overnight at 4 oC with agitation, with the 
exception of the FLAG and actin antibody solutions, which were incubated for 1 
hour at room temperature. Membranes were then washed with PBS-T and incubated 
with IRDye 680RD or 800CW-conjugated donkey anti- mouse, rabbit, goat or rat 
fluorescent secondary antibodies (Li-Cor, distributed by Millennium Science, 
Mulgrave, Vic) for 1 hour at room temperature. Membranes were then washed a 
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second time, and visualised using the Odyssey Imaging System (Li-Cor). Protein 
molecular weights were determined by comparison to the relative electrophoretic 
mobility of molecular weight standards (Precision Plus Protein Dual Colour; Bio-
Rad). When necessary, immunoblots were quantified using ImageJ software. 
Phosphorylation of hSSB1 S134 was expressed relative to total immunoprecipitated 
endogenous hSSB1, or to total 3x FLAG hSSB1, as appropriate. RPA32 
phosphorylation was calculated as the relative ratio of the 34 kDa to 32 kDa RPA32 
bands. 
Sheep-anti-hSSB1 was purified from anti-serum described previously (Richard et al., 
2008) using cyanogen bromide beads (Sigma-Aldrich) bound to recombinant His-
tagged hSSB1. Recombinant hSSB1 was expressed from T7 BL21 E. coli and 
purified as per below. Cyanogen bromide activated sepharose beads were prepared 
by swelling in 1 mM HCl for 30 minutes, prior to incubation with recombinant 
hSSB1 in coupling buffer (0.1 M NaHCO3, 0.5 M NaCl, pH 8.5). Unreacted 
cyanogen bromide groups were then blocked by 5 wash cycles of coupling buffer 
followed by 0.1 M acetate buffer. Beads were subsequently incubated with hSSB1-
anti-serum overnight at 4 oC, washed 5x with PBS and antibody eluted with pH 2.8 
200 mM glycine. 0.5 mL fractions were collected into tubes containing 13.5 µL 3M 
Tris-HCl pH 8 and 50 µL 3 M KCl. Antibody-containing fractions were identified by 
spectrometry at 280 nM, pooled, snap-frozen and stored at -80 oC. To detect pS134 
hSSB1, a rabbit polyclonal antibody was raised against the hSSB1 peptide 
PSA{pS}QPTTGPKC conjugated to the carrier protein keyhole limpet hemocyanin 
(KLH) by GenScript. 12 weeks after immunization, the antibody was affinity 
purified using the phosphorylated immunisation peptide. To prevent any non-specific 
binding of the antibody to non-phosphorylated hSSB1 on an immunoblot, a 200 x 
molar excess of a control peptide (PSAQPTTGPKC) was included in the antibody 
working solution. A 200 x molar excess of the phosphorylated immunisation 
peptides was used for antibody blocking in Figure 4.3. For validation of the antibody, 
whole cell lysates were dephosphorylated by addition of 200 U of lambda (λ) 
phosphatase (New England Biolabs) and incubation at 30 oC for 45 minutes. 
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Table 2.3 Primary antibody usage conditions 
 
Antigen Species / Clone/ Cat # Usage 
Concentration 
Diluent 
C
el
l S
ig
na
lin
g 
T
ec
hn
ol
og
y 
(C
ST
) 
p-S317 Chk1 Rabbit mAb D12H3  
Cat # 12302 
WB = 1:500  TBS-T 
p-S345 Chk1 Rabbit mAb 133D3 
Cat # 2348 
WB = 1:500 TBS-T 
Chk1 Mouse mAb 2G1D5 
Cat # 2360 
WB = 1:500 Fish Gelatin 
p-T68 Chk2  Rabbit mAb C13C1 
Cat # 2197 
WB = 1:500 TBS-T 
Chk2 Mouse mAb 1C12 
Cat # 3440 
WB = 1:500 Fish Gelatin 
RPA32 Rat mAb 4E4 
Cat # 2208 
WB = 1:500 Fish Gelatin 
DNA-PKcs Mouse mAb 3H6 
Cat # 12311 
WB = 1:500 Fish Gelatin 
ATR Rabbit mAb E1S3S 
Cat # 13934 
WB = 1:500 Fish Gelatin 
p-S1981 ATM Rabbit mAb D6H9 
Cat # 5883 
WB = 1:500 TBS-T 
ATM Rabbit mAb D2E2 
Cat # 2873 
WB = 1:500 Fish Gelatin 
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C
el
l S
ig
na
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g 
T
ec
hn
ol
og
y 
(C
ST
) 
HA Rabbit mAb C29F4 
Cat # 2348 
WB = 1:1000 Fish Gelatin 
Myc Mouse mAb 9B11 
Cat # 2276 
WB = 1:1000 
IP = 1:500 
Fish Gelatin 
IP Buffer 
Nucleolin Rabbit mAb D4C7O 
Cat # 14574 
WB = 1:1000 Fish Gelatin 
PARP1 Rabbit mAb 46D11 
Cat # 9532 
WB = 1:1000 Fish Gelatin 
PP2AC Rabbit pAb 
Cat # 2038 
WB = 1:500 Fish Gelatin 
 
β-actin Rabbit mAb 13E5 
Cat # 4970 
WB = 1:2,500 Fish Gelatin 
A
bc
am
 
SMARCA5/ 
SNF2H 
Rabbit pAb 
Cat # ab3749 
WB = 1:500 Fish Gelatin 
 
BAZ1B/ 
WSTF 
Rabbit mAb EP1704Y 
Cat # ab51256 
WB = 1:5000 Fish Gelatin 
MTA2 Rabbit pAb 
Cat # ab8106 
WB = 1:500 Fish Gelatin 
RbAp48/ 
RBBP4 
Rabbit pAb  
Cat # ab1765 
WB = 1:1000 Fish Gelatin 
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B
et
hy
l 
INTS3 Rabbit pAb 
Cat # A302-050 
WB = 1:2000 Fish Gelatin 
FANCI Rabbit pAb 
Cat # A300-212 
WB = 1:1000 Fish Gelatin 
p-S33 RPA32 Rabbit pAb 
Cat # A300-246A 
WB = 1:1000 TBS-T 
Si
gm
a FLAG epitope Mouse mAb (M2) 
Cat # F1804 
WB = 1:2000  
(1 hour) 
Fish Gelatin 
B
D
 Actin Mouse mAb C4 
Cat # 612656 
WB = 
1:10,000 
(1 hour) 
Fish Gelatin 
N
on
-c
om
m
er
ci
al
 hSSB1 Sheep pAb WB/IP = 
1:500 
Fish Gelatin 
pS134 hSSB1 Rabbit pAb WB = 1:444 TBS-T 
  
2.7 Immunoprecipitation 
Cells were resuspended in immunoprecipitation buffer (20 mM HEPES pH 7.5, 150 
mM KCl, 5% glycerol, 10 mM MgCl2, 0.5% Triton X-100) supplemented with 1x 
phosphatase inhibitor cocktail (Cell Signaling Technology) and 1x protease inhibitor 
cocktail (Roche, distributed by Sigma-Aldrich; cOmplete, EDTA free), sonicated and 
quantified as per section 2.6. Protein A or G magnetic dynabeads (Life 
Technologies) were prepared by incubation with antigen-specific antibodies as 
indicated in Table 2.3 or with equivalent quantities of mouse, rabbit, or sheep isotype 
control IgGs for 1 hour at 4 oC. Alternatively, for the precipitation of FLAG-tagged 
proteins, magnetic anti-FLAG M2 beads (Sigma-Aldrich) were resuspended and 
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prepared by washing in immunoprecipitation buffer. In either instance, whole cell 
lysates were incubated with antibody-bound beads from 2 hours to overnight at 4 oC, 
beads washed 5x with immunoprecipitation buffer and proteins eluted by heating to 
90 oC in 3x SDS loading buffer. Whole cell lysates (input) and eluted proteins were 
immunoblotted as described in section 2.6.  
2.8 Subcellular fractionation 
Subcellular fractionation was performed using an adaptation of a previously 
described methodology (Xia et al., 2006). Here, cells were resuspended in Buffer A 
(20 mM HEPES pH 7.9, 10 mM MgCl2, 10 nM KCl, 0.05 mM Dithiothreitol (DTT), 
0.05% Triton X-100, 1x protease inhibitors 1x phosphatase inhibitors) vortexed at 
maximum speed for 5 s, then incubated at 4 oC with agitation for 10 minutes before 
passing through a 26 gauge needle 6 times. Solutions were then centrifuged at 500 x 
g for 10 minutes at 4 oC and the supernatant (cytoplasmic fraction) discarded. Nuclei 
were washed once in Buffer A before resuspension in Buffer C (20 mM HEPES pH 
7.9, 10 mM MgCl2, 0.05 mM EDTA, 420 mM NaCl, 25% glycerol, 0.05% Triton X-
100, 1x protease inhibitors 1x phosphatase inhibitors). Solutions were vortexed at 
maximum speed for 15 s, then incubated at 4 oC with agitation for 30 minutes, before 
centrifugation at 2,000 x g for 10 minutes at 4 oC. Supernatant (soluble nuclear 
fraction) was collected, and the pellet washed once with Buffer C. The pellet was 
resuspended in Buffer C containing 4,000 units of micrococcal nuclease, vortexed for 
15 s and incubated for 30 minutes at room temperature with agitation. Solutions were 
centrifuged at 21,000 x g for 10 minutes and the supernatant (chromatin-bound 
fraction) collected. Fractions were quantified as per section 2.6. For 
immunoprecipitation from the chromatin-bound fraction, samples were diluted by 
addition of an equal volume of Buffer A and this sample incubated with antibody-
bound beads as per section 2.7. 
2.9 Mass spectrometry and data analysis 
For the detection of putative hSSB1 phosphorylation sites, 3x FLAG hSSB1 was 
transiently over-expressed in HEK293T cells for 24 hours and FLAG-tagged proteins 
immunoprecipitated from 12 mg of whole cell lysate by incubation with magnetic 
anti-FLAG M2 beads overnight at 4 oC as described in section 2.7. Protein eluent 
was separated by electrophoresis as described in section 2.6 and the gel stained 
overnight by gentle agitation in colloidal coomassie brilliant blue G-250 (fixative 
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solution prepared by dissolving 85 g (NH4)2SO4 and 15 mL H3PO4 in 330 mL H2O 
and then adding 165 mL methanol and shaking for 1 hour. 330 mg of coomassie 
brilliant blue G-250 was separately dissolved in 5 mL methanol to prepare the 
staining solution. Immediately prior to use, 500 µl of staining solution was added to 
24.5 mL of fixative solution). The gel was destained with multiple washes in H2O 
and gel bands excised and posted to the BRSC mass spectrometry facility at the 
University of St. Andrews. Here, gel bands were cut into 1 mm3 slices and subjected 
to in-gel digestion using a ProGest Investigator in-gel digestion robot (Digilab, 
Hannover, Germany). Briefly, the gel cubes were destained and washed with 
acetonitrile then reduced and alkylated before digestion with trypsin at 37 oC. The 
peptides were extracted with 5% formic acid and concentrated to a volume of 20 µL, 
using a Savant SpeedVac (Thermo Scientific, part of ThermoFisher Scientific, 
Paisley PA4 9RF, UK). Peptides were then separated on an Acclaim PepMap 100 
C18 trap and an Acclaim PepMap RSLC C18 column (ThermoFisher Scientific), 
using a nanoLC Ultra 2D plus loading pump and nanoLC AS-2 autosampler 
(Eksigent, Dublin, CA, USA). A quarter (5 uL) of the sample was loaded. Peptides 
were eluted with a gradient of increasing acetonitrile, containing 0.1 % formic acid 
(5-40% acetonitrile in 5 min, 40-95% in a further 1 min, followed by 95% 
acetonitrile to clean the column, before re-equilibration to 5% acetonitrile). The 
eluate was sprayed into a TripleTOF 5600 electrospray tandem mass spectrometer 
(ABSciex, Cheshire WA1 1RX, UK) and analysed in Information Dependent 
Acquisition (IDA) mode, performing 250 msec of MS followed by 150 msec MS/MS 
analyses on the 15 most intense peaks seen by MS. The MS/MS data file generated 
was analysed using the Mascot algorithm (Matrix Science) against the NCBI non-
redundant database July 2014 with no species restriction, trypsin as the cleavage 
enzyme, carbamidomethyl as a fixed modification of cysteines and methionine 
oxidation, deamidation of glutamines and asparagines and phosphorylation of serine, 
threonine and tyrosine as variable modifications. The raw mass spectrometry data 
and Mascot search files have been deposited to the ProteomeXchange Consortium 
via the PRIDE partner repository (Vizcaíno et al., 2016) with the dataset identifier 
PXD003964 
 
For the identification of proteins that associate with hSSB1, chromatin-bound 
proteins were isolated from HeLa cells as described in section 2.8 and hSSB1 
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immunoprecipitated by incubation with antibody-bound Dynabeads overnight at 4 oC 
as described in section 2.7. Eluent was then submitted to the TRI proteomics facility 
and was separated on a 10% acrylamide Mini-PROTEAN TGX precast SDS-PAGE 
Gel (Bio-Rad, Gladesville, NSW) to a depth of 8 mm. The gel was stained with 
colloidal coomassie brilliant blue G-250 as per above and the sample divided in eight 
1 mM gel bands. Here in-gel digestion was performed using an Agilent Bravo 
automated liquid handling platform (Agilent Technologies, Mulgrave, Victoria) to 
achieve the following: 90 minutes incubation in de-stain buffer (50% v/v acetonitrile, 
25 mM NH4HCO3), dehydration for 10 minutes using a SpeedVac, 20 minutes 
incubation in alkylation buffer (50 mM iodoacetamide), overnight trypsin digestion 
(0.4 µg trypsin, 10% acetonitrile, 25mM NH4HCO3), trypsin inactivation with 5% 
formic acid and peptide elution in extraction buffer (1% formic acid, 60% 
acetonitrile). Peptides were dried using a SpeedVac, resuspended in 5% formic acid 
and analysed using an Agilent HPLC CHIP QTOF 6530 system (Agilent 
Technologies). Peptides were loaded onto an Agilent (Agilent Technologies) G4240-
62010 large capacity chip in a solution containing 0.1% formic acid and 90% 
acetonitrile with a flow rate of 2.5 µl min-1. Peptides were separated with a gradient 
of 0.1% formic acid and 90% acetonitrile to 0.1% formic acid excluding acetonitrile. 
The MS1 analyzer acquired ions from 100m/z to 1700m/z at a rate of 10 spectra/s. 
The MS2 analyzer acquired ions from 50m/z to 1700m/z at a rate of 3spectra/s. A 
maximum of 10 precursors were selected per cycle and ions were excluded after 1 
spectra and released after 15 s. Data obtained in this way was processed using 
Spectrum Mill (Agilent technoliges, B.04.00.127) and extracted data searched 
against the Swiss-Prot Human (version 11/2014) database. Search parameters 
included tryspin digestion, carbamidomethyl as a fixed modification of cysteine 
residues and methionine oxidation. 
2.10 Poly-ubiquitination assay using hexa-His-tagged ubiquitin 
HEK293T cells were grown to ~70% confluence in 75 cm2 flasks before co-
transfection with equal quantities of a 3x FLAG hSSB1 expression vector and a 
plasmid encoding hexa-His tagged ubiquitin. Cells were grown for a further 24 hours 
and treated with 25 µM of the proteasome inhibitor MG132 for 4 hours. Cells were 
then harvested and lysed in 500 µL urea buffer (8 M urea, 20 mM sodium phosphate 
pH 7.8, 500 mM NaCl, 20 mM imidazole). Whole cell lysates were then sonicated 
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and quantified as per section 2.6. 20 µL of HIS-select HF nickel agarose beads (40 
µL slurry; Sigma-Aldrich) were prepared by washing 2x in denaturing binding buffer 
and added to 1000 µg of total cell lysates and incubated at room temperature with 
gentle agitation for 1-2 h. Beads were then washed 5x with urea buffer and protein 
eluted by heating to 90 oC in 3x SDS loading buffer. Whole cell lysates (input) and 
eluted proteins were immunoblotted as described in section 2.6. 
2.11 Protein purification 
Shuffle T7 E. coli were transformed with plasmids encoding hexa-His tagged hSSB1 
and grown in 1 L of LB media at 30 oC. Cultures were grown to OD600 0.6-0.8 and 
protein expression induced overnight at 16 oC by addition of 0.3 mM IPTG. E. coli 
were harvested by centrifugation at 5,000 x g for 10 minutes and cell pellets 
resuspended in 1x breaking buffer (50 mM Tris pH 7.5, 10 % sucrose, 10 mM 
EDTA, 600 mM KCl, 1 mM DTT, 1mM phenylmethylsulfonyl fluoride (PMSF) + 
1x protease inhibitor cocktail) and lysed by sonication (10 x 20 s). IGEPAL was then 
added to a final concentration of 0.01% and the lysate clarified by centrifugation at 
17,000 x g for 25 minutes at 4 oC, following by 100,000 x g for 1 h at 4 oC. During 
this time, 500 µL of HIS-Select Nickel Affinity Gel (Sigma-Aldrich) was prepared 
by washing 3x in PBS. Beads were then incubated with the lysate at 4 oC for 2 h. 
Slurry was poured onto a gravity chromatography column (Bio-Rad), and washed 2x 
with 10 packed bead volumes of buffer K (1 M KCl, 0.01% IGEPAL, 20 mM 
Imidazole). Protein was then eluted with 5x 1000 µl additions of buffer K + 250 mM 
Imidazole) and concentrated to a volume of 250 µl using a 10 kDa cut-off Vivaspin 
column (GE Healthcare; Silverwaterm NSW). This volume was loaded onto a 
Superdex 200 size exclusion chromatography column (GE healthcare) and run in 
buffer K containing 300 mM KCl, using an AKTA FPLC (GE healthcare). 0.5 mL 
fractions were collected and those containing the target protein identified by 
separating 10 µL of sample on a PAGE gel as described in section 2.6 and staining 
with coomassie blue (1 g L-1 coomassie brilliant blue G-250, 50% v/v methanol, 10% 
v/v glacial acetic acid, 40% H2O; the solution was stirred for 3-4 hours and then 
filtered through Whatman filter paper) for 2 hours with agitation at room 
temperature. Gel was then de-stained overnight in de-stain buffer (50% v/v methanol, 
10% v/v glacial acetic acid, 40% H2O). Fractions containing hSSB1 with little 
contamination were pooled, concentrated as per above, aliquoted, snap frozen in dry-
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ice/ethanol and stored at -80 oC. The concentration of fully reduced hSSB1 was 
initially determined by spectrometry at 280 nM and then relative to other samples by 
electrophoresis and staining with coomassie blue.  
2.12 In vitro DNA-PK kinase assays 
10 U of DNA-PK (DNA-PKcs/Ku70/Ku80) purified from HeLa cells (Promega, 
Alexandria, NSW) was incubated with 500 ng of hexa-His hSSB1 in 50 µl of kinase 
buffer (20 mM HEPES, 50 mM NaCl, 10 mM MgCl2, 10 mM MnCl, 1 mM DTT) 
containing 100 µM ATP (Sigma-Aldrich) and 10 µg mL-1 sonicated salmon sperm 
DNA (Life Technologies). Reactions were incubated for 30 minutes at 30 oC and 
then stopped by addition of 1x SDS loading buffer containing 20% β-
mercaptoethanol. Reactions were heated to 90 oC for 10 minutes and eluent analysed 
by immunoblotting as per section 2.6. 
2.13 One dimensional nuclear magnetic resonance spectroscopy (1D-NMR)  
Approximately 100-200 µM of WT, S134A or S134E hexa-His hSSB1 was 
resuspended in NMR buffer (20 mM Tris pH 6.9, 100 mM NaCl, 1 mM EDTA, 1 
mM TCEP) with 10% 2H2O and analysed at 298 K on a Bruker 600 Mhz 
spectrometer (Bruker Avance III; Bruker, Preston, VIC) equipped with a 5-mm TCI 
cryoprobe. Proton chemical shifts are references to 4,4-dimethyl-4-
silapentanesulfonic acid (DSS) at 0 ppm. Data were processed using Topspin 
software (Bruker). These experiments were performed by Dr Roland Gamsjaeger at 
the University of Western Sydney 
2.14 Electrophoretic mobility shift assays (EMSA) 
FAM (6-Carboxyfluorescein)-labelled oligonucleotides were purchased from 
Integrated DNA Technologies (IDT). The fork substrate has been described 
previously (Marini and Krejci, 2012). The FAM-labelled ssDNA strand of this 
substrate was used as the ssDNA oligonucleotide in the EMSA assays. Substrates 
were annealed and purified as previously described (Prakash et al., 2009). Briefly, 
oligonucleotides were firstly purified on 12 % polyacrylamide, 8 M urea gels. 
Following electroelution, equimolar quantities of oligonucleotides were mixed in 
hybridization buffer (50 mM Tris pH 7.5, 100 mM NaCl, 10 mM MgCl2), heated at 
99 oC for 10 minutes and slowly cooled down to room temperature. Annealed 
structures were purified on a 10% polyacrylamide gel, electroeluted and concentrated 
 52 
Characterisation of Human Single-Stranded DNA-Binding Protein 1 (hSSB1) Regulation by Post-Translational 
Modifications 
using EMD Millipore Amicon Ultra-4 centrifugal filter units with a 3 kDa cut-off. 
Concentrations were determined using absorbance at 260 nm and the oligonucleotide 
molar extinction coefficients (ɛfluorescein,260 = 13,700 L mol-1 cm-1). For EMSA assays, 
increasing concentrations of hSSB1 (0, 0.05, 0.1, 0.25, 0.5, 0.75, 1.0, 2.0 µM) were 
incubated with 10 µmol of FAM-labelled synthetic substrates, in 10 µL of binding 
buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 100 µg mL-1 BSA, 1 mM DTT) for 
15 minutes at 37 oC. Samples were electrophoresed on 10% polyacrylamide gels and 
visualized using a Starion FLA-9000 image scanner (GE Healthcare). Non-linear 
regression analysis was performed using the GraphPad Prism version 6 software and 
the equation ‘one site: specific binding with Hill slope’. 
 
2.15 pS/T-Reader protein domain array 
Proteins microarrays were prepared and utilised as previously described (Espejo et 
al., 2002) by the “protein array and analysis core” at the University of Texas MD 
Anderson Cancer Center. Briefly, glutathione S-transferase (GST)-tagged proteins 
were arrayed onto a glass slide pre-coated with nitrocellulose (FAST Slide; 
Schleicher and Schuell Bioscience; NH, USA) using an Aushon 2470 Arrayer 
(Aushon BioSystems, MA, USA) with a 24 pinhead. GST-tagged proteins are given 
in Figure 4.10. The protein chips contained 20 grids allowing up to 9 GST-tagged 
proteins to be spotted onto each chip in duplicate, as well as GST alone that was 
spotted in the middle of each chip. N-terminal biotinylated peptides were synthesised 
by Sigma-Aldrich of sequence Biotin-KAVQNDSNPSASQPTTGPS and Biotin- 
KAVQNDSNPSA{pSer}QPTTGPS, representing hSSB1 amino acids K123 to S141. 
10 µg of each peptide was pre-bound with 5 µL of Cy3-streptavidin (Amersham, GE 
Life Sciences, PA, USA) in PBS containing 0.1% Tween 20. The solution was then 
incubated with 20 µL of biotin agarose beads (Sigma-Aldrich) to capture any free 
Cy3-strepavidin label. Arrayed slides were blocked in PBS-T containing 3% 
powdered milk (w/v) then incubated with the Cy3-labbeled peptide for 1 hour at 
room temperature. Alternatively, the array was probed with an anti-GST primary 
antibody, which was then detected with a Flourescein isothiocyanate (FITC)-
conjugated secondary antibody. Slides were washed three times with PBS-T, air 
dried and scanned with a GenePix 4400A microarray scanner using a 550 nm long 
pass filter (Molecular Devices; CA, USA). 
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Chapter 3:  Identification of hSSB1 Post-Translational 
Modifications 
3.1 Introduction 
Ubiquitination is a post-translational modification whereby a ubiquitin peptide 
protein is covalently conjugated to (predominantly) lysine residues of a target 
substrate protein (Li and Ye, 2008). This process occurs through the concerted 
function of three types of enzymes, generically referred to as E1, E2 and E3 
(Komander, 2009). Here, the E1 ubiquitin-activating enzyme initially binds the 
ubiquitin peptide via an ATP-dependent reaction, forming a thioester bond with the 
ubiquitin c-terminal carboxyl group. Ubiquitin is then transferred from the E1 to an 
E2 conjugating enzyme via a trans-thiolation reaction. In the final step, the ubiquitin 
peptide c-terminal carboxyl group is covalently attached to the ε-amino group of a 
substrate lysine residue, in a reaction mediated by an E3 ubiquitin ligase (Metzger et 
al., 2012). The E3 enzyme is responsible for substrate specificity, which it ensures by 
binding and aligning both the E2-ubiquitin thioester and the correct protein substrate 
(Berndsen and Wolberger, 2014). To enable this high specificity, human cells encode 
~600 E3 enzymes (1-2% of all human genes), which work in concert with fewer than 
40 E2 and only 2 E1 enzymes (Li et al., 2008). Of the ~600 E3 ligases, 95% belong 
to the really interesting new gene (RING) domain family, which function to direct 
the transfer of ubiquitin from the E2 to the substrate protein. By contrast, the 
remaining ~30 E3 ligases predominantly belong to the homologous to the E6AP 
carboxyl terminus (HECT) domain family, which mediate ubiquitin transfer through 
a two-step mechanism. Here, ubiquitin is covalently bound to a ligase active site 
cysteine, prior to subsequent transfer to the substrate protein (Metzger et al., 2012).  
 
Proteins may be modified by mono-ubiquitination, the attachment of a single 
ubiquitin peptide on one or more residues, however many are also poly-ubiquitinated 
(Sadowski and Sarcevic, 2010). In this process, the ubiquitin molecule covalently 
attached to a substrate is further ubiquitinated at one of seven lysine residues, 
forming a di-ubiquitin chain. Longer, linear polymers can also form by successive 
ubiquitination of the terminal ubiquitin molecule, as can branched chains, formed at 
multiple ubiquitin lysine residues (Sadowski and Sarcevic, 2010). A poly-ubiquitin 
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chain topology that has been thoroughly studied results from the successive linkage 
of ubiquitin lysine residue 48 (K48). Here, the generation of K48-linked chains of 4 
or more ubiquitin molecules in length appears to be the primary signal for 
proteasomal degradation (Thrower et al., 2000). The eukaryotic 26S proteasome is a 
large protein structure composed of a cylindrical 20S core particle, which is capped 
at either end by 19S regulatory particles (Husnjak et al., 2008). Detection of K48-
linked ubiquitin chains is mediated by the 19S components, which contains the 
receptor proteins RPN10 and RPN13 (Husnjak et al., 2008; Schreiner et al., 2008). 
Binding to the 19S cap stimulates ATP-dependent conformational changes in the 20S 
particle, allowing accessibility of the substrate protein to the inner catalytic cavity 
(Bech-Otschir et al., 2009). Entry however first requires removal of the poly-
ubiquitin chain, catalysed by the 19S de-ubiquitinating enzymes (DUBs), Usp14, 
Uch37 and Rpn11 (Finley, 2009). This thereby allows recycling of the ubiquitin 
peptides, whilst exposing the target protein to the proteolytic enzymes of the 20S 
inner chamber. Proteolysis is here provided by the 20S β1, β2 and β5 subunits, 
which possess chymotrypsin-like, trypsin-like and caspase-like activities, 
respectively (Xie, 2010).  
 
Unlike K48 chains linkages, other poly-ubiquitination topologies, as well as mono-
ubiquitination, do not seem to similarly mark proteins for proteasomal degradation. 
Instead, these modifications facilitate a wide range of other processes, including 
intracellular signalling, the mediation of protein-protein interactions and endosomal 
trafficking to the lysosome (Nathan et al., 2013). Indeed, whilst the RPN10 and 
RPN13 proteasome ubiquitin receptors can also detect K63-linked ubiquitin chains in 
vitro (Peth et al., 2010), these chains may be more rapidly bound by proteins of the 
endosomal sorting complex required for transport (ESCRT) pathway (Nathan et al., 
2013; Williams and Urbé, 2007). In addition, whilst K48–linked ubiquitinated 
protein are ‘shuttled’ to the proteasome by Rad23, this protein seems to have little 
affinity for other chain types (Nathan et al., 2013). 
 
A potential role for K48-linked poly-ubiquitination in the regulation of hSSB1 was 
initially suggested based on the observation that hSSB1 protein levels are elevated 
following treatment of cells with the proteasome inhibitor, MG132 (Richard et al., 
2008). This compound, a small hydrophobic peptide (carbobenzyl-Leu-Leu-Leu-
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aldehyde), is able to penetrate cell membranes and by virtue of its aldehyde group, 
inhibit the chymotrypsin-like active sites of the 20S proteasome (Goldberg, 2012). 
hSSB1 protein levels were also seen to increase in cells following exposure to 
ionising radiation, which was not further enhanced by proteasomal inhibition. It was 
therefore interpreted that hSSB1 is most likely maintained at low-levels in 
undamaged cells by proteasomal degradation, presumably as a consequence of K48-
linked poly-ubiquitination (Richard et al., 2008). Poly-ubiquitination of hSSB1 was 
later directly demonstrated through nickel agarose pull-down assays, performed from 
cells transiently expressing hexa-histidine tagged ubiquitin (Chen et al., 2014). Here, 
ubiquitination of hSSB1 seems to be mediated by Skp1-Cul1-F-box (SCF) 
complexes containing the F-box protein, FBXL5 (Chen et al., 2014).  
 
Despite progress in the characterisation of hSSB1 ubiquitination, the residues of 
hSSB1 modified in this way have remained elusive. In this chapter, site-directed 
mutagenesis was employed to prepare single and combination hSSB1 lysine-to-
arginine mutant proteins and ubiquitination of these assessed using hexa-His-
ubiquitin pull-down assays. In the final section of the chapter, mass spectrometry 
was employed and while not providing further information regarding sites of hSSB1 
ubiquitination, identified numerous potentially phosphorylated serine and threonine 
residues that are of relevance to the following chapter.  
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3.2 Results 
3.2.1 Poly-ubiquitinated hSSB1 may be detected following nickel agarose pull-
down of hexa-histidine tagged ubiquitin 
Regulation of hSSB1 by poly-ubiquitination-mediated targeting to the proteosome 
was initially suggested based on the protein accumulation observed in cells treated 
with the proteasome inhibitor MG132 (Richard et al., 2008). It was therefore of 
initial interest to directly demonstrate the ubiquitination of hSSB1 in cells. His-
ubiquitin pull-down assays are one of the most commonly employed techniques for 
such purposes and involve the capture of ubiquitinated proteins on nickel agarose 
beads (Ehrlund et al., 2009). To employ this technique, HEK293T cells were co-
transfected with plasmids encoding 3x FLAG hSSB1 and N-terminal hexa-His-
tagged ubiquitin. These constructs were expressed for 24 hours prior to the treatment 
of cells with 25 µM MG132 for 4 hours. Cells were then harvested and resuspended 
in a buffer containing 8 M urea, which functioned both to lyse cells, as well as to 
denature cellular de-ubiquitinating enzymes (DUBs). Whole cell lysates were then 
incubated with Ni-NTA agarose beads for 2 hours to capture hexa-His-tagged 
ubiquitinated proteins, prior to elution in SDS loading buffer. Proteins were then 
immunoblotted and probed with antibodies against hSSB1 and the FLAG epitope 
(Figure 3.1A). Using either antibody, a number of distinct hSSB1 bands were 
detected that were specific to those lanes in which cells had been transfected with 
hexa-His tagged ubiquitin. It should be noted that, consistent with prior findings 
(Chen et al. 2014), non-ubiquitinated hSSB1 was also found to bind Ni-NTA 
agarose, most likely due to non-specific electrostatic interaction.   
 
As the assay above suggested that hSSB1 was most likely poly-ubiquitinated, it was 
of interest to consider on which lysine residue this may occur. As a preliminary 
assessment of the likelihood of each residue being modified, the amino acid sequence 
of a number of hSSB1 homologues from a variety of animal species were retrieved 
and aligned (Figure 3.1B). A high level of conservation was however observed for 
each lysine residue (at least 8 of 9 sequences) and indeed only in the Danio rerio 
(Zebrafish) SSB1 protein was any variation in terms of number and position of lysine 
residues observed in relation to the Homo sapiens sequence.  
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Homo.sapiens           -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Papio.anubis           -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Mus.musculus           -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Sus.scrofa             -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Canis.lupus            -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Python.bivittatus      -----MTTETLVKDIKPGMKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Chrysemys.picta        -----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVW 55
Xenopus.laevis         -----MTTETFVKDVKPGLKNLSVLFIVLETGRVTKTKDGHEVRTCKVADKTGTINISVW 55
Danio.rerio            MSNISNEAVILIKDVKPGSKNLNIVFIVLEIGRVTKTKDGHEVRSCRVADKSGSIAISVW 60
                              :  ::**:*** ***.::***** *************:*:****:*:* ****
Homo.sapiens           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Papio.anubis           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Mus.musculus           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Sus.scrofa             DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Canis.lupus            DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Python.bivittatus      DDVGNLIQPGDIIRLTKGYSSIFKGCLTLYTGRGGDLQKVGEFCMVYSEVPNFSEPNPEY 115
Chrysemys.picta        DDVGNLIQPGDIIRLTKGYASIFKGCLTLYTGRGGDLQKIGEFCMIYSEVPNFSEPNPEY 115
Xenopus.laevis         DEVGNFIQPGDIIRLTKGYASLFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Danio.rerio            DELGSLIQPGDIIRLTRGYASIWKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEL 120
                       *::*.:**********:**:*::****************:*****:************* 
Homo.sapiens           STQQAPNKAVQN-DSNPSASQPTTGPSAASPASENQNGNGLSAPPGPGGGPHPPHTPSHP 174
Papio.anubis           STQQTPNKAVQN-DSNPSASQPTTGPSAASPASESQNGNGLSAPTGPGGGSHPPHTPSHP 174
Mus.musculus           NTQQAPNKSVQNNDNSPTAPQATTGPPAASPASENQNGNGLSTQLGPVGGPHPSHTPSHP 175
Sus.scrofa             SAQQAPNKTVQN-DSSPTAPQPATGPPAASPASESQNGNGLSAPPGPGGGPHPPHTPSHP 174
Canis.lupus            SAQQAPNKTVQN-DSSPTAPQPATGPPAVSPASENQNGNGLSAPPGPGGGPHPPHVPSHP 174
Python.bivittatus      VAQQSQNKNTPNDNAAPAASQTTPGPSTS-AAAENQNGNGLIP-SGSGGSLHPPSIPTHP 173
Chrysemys.picta        VTQQSQTKAAQNDNATPAASQTTPGPAASSPAAESQNGNGLSA-PGPGAPPHPPNVPSHP 174
Xenopus.laevis         TAQQSQNKQAQAESGTGTNNHNSSSPAPP--APDLDNGNGSNS---SGPSTNQSTAPAHS 170
Danio.rerio            LAQANQQNKTSKEQRGNSPP-------------NQNAGNGTVPVFSNNNAAPVPRDPNFG 167
                        :*    : .   .   :               : : ***                * . 
Homo.sapiens           PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Papio.anubis           PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Mus.musculus           PSTRITRS-----QPNHTPSGPPG--PSSNPVSNGKETRRSSKR 212
Sus.scrofa             PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Canis.lupus            PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Python.bivittatus      TSGRITRS-----QPNHQGGSSSGIGSSSNPVSNGKETRRSSKR 212
Chrysemys.picta        TSGRITRS-----QPNHQGAGSAGSSSSSSPISNGKETRRSSKR 213
Xenopus.laevis         TSGRITRS-----QPNHSLPGAP------NSVSNGKEPRRTGKR 203
Danio.rerio            ASGRPNGRAPGNGPPPVTAGGTPAPPKPTVSISNGRDPRRASKR 211
                        * * .        *     .          :***:: **:.**
OB Fold
OB Fold
8 11 15 3133 42 46
72 79 94
123
203 210
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Figure 3.1 hSSB1 is poly-ubiquitinated at an unidentified residue 
 
(A) Detection of poly-ubiquitinated hSSB1. HEK293T cells were co-transfected 
with plasmids encoding 3x FLAG hSSB1 and hexa-His tagged ubiquitin and 
expressed for 24 h. Cells were treated with 25 µM MG132 for 4 hours, harvested, 
and lysed in a buffer containing 8 M urea. 1000 µg of whole cell lysate was 
incubated with 20 µL of Ni-NTA agarose beads for 2 hours at room temperature, 
washed 3x with 8 M urea and eluted by heating to 90 oC for 10 minutes in SDS 
loading buffer. Eluent was immunoblotted and probed with antibodies against the 
FLAG tag and hSSB1. 15 µg of whole cell lysate (input) was immunoblotted and 
probed with antibodies against the FLAG tag and actin. These results are 
representative of three independent experiments. 
 
(B) hSSB1 lysine residues are conserved amongst animal species. Amino acid 
sequences of proteins homologous to hSSB1 from the indicated species were 
retrieved and aligned using Clustal Omega software (ebi.ac.uk /Tools/msa/clustalo/). 
Lysine residues are outlined by rectangles with numbers corresponding to the hSSB1 
protein sequence. Amino acids of the OB-fold are underlined. Consensus symbols 
given below each row should be interpreted as: * = a fully conserved residue, : = 
conservation between groups of strongly similar properties, . = conservation between 
groups of weakly similar properties. 
 
(C and D) hSSB1 lysine residues are surface-exposed. hSSB1 X-ray diffraction 
crystal structure PDB file 4OOW (Ren et al., 2014) (downloaded from RCSB PDB; 
rcsb.org) was modelled and visualised using Swiss-PdbViewer software (spdv.vital-
it.ich). This file comprises hSSB1 residues T5 to P111 (primarily the N-terminus and 
OB-fold shown), as well as INTS3 residues R35 to C497, SOSS-C residues G62 to 
R100 and 6 nucleotides of ssDNA (not shown). The hSSB1 protein structure is 
shown as a ribbon diagram and is coloured by secondary structure (red = helices, 
yellow = beta-sheet, grey = unstructured). Lysine residues are shown as three-
dimensional wireframe models including the backbone oxygen and are labelled and 
CPK coloured (white = hydrogen, blue = nitrogen, red = oxygen). Two views are 
given (C vs D) where the model was rotated 180o around the Y-axis. 
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As the essentially complete conservation of SSB1 lysine residue prevented the 
exclusion of poorly conserved and therefore unlikely sites of ubiquitination, the 
hSSB1 crystal (containing amino acids 5-111) was instead visualised with the 
prospect that certain amino acids could instead be excluded based on their lack of 
apparent accessibility (Figure 3.1C and D). This modelling however indicated that 
each hSSB1 lysine side-chain is likely to be surface exposed and therefore may be 
available for modification. 
 
3.2.2 The disruption of hSSB1 poly-ubiquitination requires the complete 
removal of lysine residues 
As the ubiquitination of exogenously expressed 3x FLAG hSSB1 could be readily 
detected from cells, a mutagenesis approach was therefore employed to disrupt each 
putative ubiquitination site. Here, lysine residues were individually mutated to 
arginine and co-expressed with hexa-His-ubiquitin in HEK293T cells. Hexa-His-
ubiquitin pull-down assays were then performed as previously, and eluent 
immunoblotted with antibodies against the 3x FLAG tag (Figure 3.2A and B). The 
mutation of single lysine residues was however unable to disrupt or reduce the 
detection of ubiquitinated hSSB1. 
 
The ubiquitination of multiple lysine residues has been detected in numerous other 
proteins and is often localised to a group of residues within a particular region. 
Indeed, poly-ubiquitination of the tumour suppressor p53 most likely involves six 
lysine residues located within a sixteen amino acid region of its C-terminus 
(Rodriguez et al., 2000b). hSSB1 contains three distinct regions, the N-terminus, the 
OB-fold and the C-terminus and so it was interesting to consider that ubiquitination 
may be restricted to one of these regions.  
 
To assess this, hSSB1 combination mutants were prepared where lysine residues on 
the N-terminus, OB-fold and C-terminus were mutated to arginine (K-N-R, K-OB-R 
and K-C-R, respectively) (Figure 3.2C). Hexa-His-ubiquitin pull-down assays were 
then performed and eluent immunoblotted for 3x FLAG hSSB1 as above (Figure 
3.2D). Ubiquitination of each combination mutant was however observed to a similar 
degree as of the WT protein. 
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Figure 3.2 The disruption of hSSB1 poly-ubiquitination requires the complete 
removal of lysine residues 
 
(A and B) Individual mutation of lysine residues to arginine does not prevent 
poly-ubiquitination of  3x FLAG hSSB1. hSSB1 lysine residues were individually 
mutated to arginine by site-directed mutagenesis of the WT 3x FLAG hSSB1 
construct. Each construct was co-transfected into HEK293T cells with a plasmid 
encoding hexa-His tagged ubiquitin and expressed for 24 hours. Cells were treated 
with 25 µM MG132 for 4 hours, harvested, and lysed in a buffer containing 8 M 
urea. 1000 µg of whole cell lysate was incubated with 20 µl of Ni-NTA agarose 
beads for 2 hours at room temperature, washed 3x with 8 M urea and eluted by 
heating to 90 oC for 10 minutes in SDS loading buffer. Eluent was immunoblotted 
and probed with antibodies against the FLAG tag. 15 µg of whole cell lysate (input) 
was immunoblotted and probed with antibodies against the 3x FLAG tag, hSSB1 and 
actin. These results are representative of three independent experiments. 
 
(C) hSSB1 lysine residues are found on the N-terminus, OB-fold and C-terminal 
tail. A schematic of hSSB1 indicating the location of each lysine residue. 
 
(D) The mutation of every lysine residue in the hSSB1 protein sequence of the 
3x FLAG construct is insufficient to disrupt poly-ubiquitination. 3x FLAG 
hSSB1 constructs were prepared where lysine residues of the N-terminus (K-N-R), 
OB-fold (K-OB-R) or C-terminus (K-C-R) were mutated in combination. A 3x 
FLAG hSSB1 construct where all thirteen endogenous lysine residues were mutated 
to arginine (K0) was prepared from the OB fold lysine hSSB1 mutant. Constructs 
were co-expressed with hexa-His-tagged ubiquitin in HEK293T cells and poly-
ubiquitination experiments performed as per (A and B). These results are 
representative of three independent experiments. 
 
(E) The disruption of hSSB1 poly-ubiquitination requires the complete removal 
of lysine residues. HA-tagged WT, K-N-R, K-OB-R, K-C-R and K0 constructs were 
prepared by inverse PCR with 5` hybridised primers (see section 2.2) using the 3x 
FLAG-tagged hSSB1 constructs. Constructs were co-expressed with hexa-His-
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tagged ubiquitin in HEK293T cells and poly-ubiquitination experiments performed 
as per (A and B). These results are representative of three independent experiments. 
 
The data above indicates that in addition to no single residue of hSSB1 functioning 
as the sole available site of modification, potentially ubiquitinated residues may be 
located in multiple regions of the protein. Indeed, it is tempting to consider that the 
mutation of an endogenously ubiquitinated lysine residue may promote the 
ubiquitination of other sites. As misfolded proteins may also be non-specifically 
poly-ubiquitinated for degradation (Eisele and Wolf, 2008; Heck et al., 2010), this 
may represent an explanation for the poly-ubiquitination of the lysine combination 
hSSB1 mutants. At this stage it was interesting to note that the 3x FLAG epitope tag 
of hSSB1 also contained six lysine residues (two on each repeat). As these residues 
could also represent sites of ubiquitination that are not found on endogenous hSSB1, 
it was reasoned that the ubiquitination of these may be informative as to the 
specificity of 3x FLAG hSSB1 ubiquitination in this assay. To test whether the 3x 
FLAG tag may be ubiquitinated, the remainder of the lysine residues from the K-OB-
R hSSB1 amino acid sequence were mutated to arginine (K0 hSSB1), such that only 
those lysine residues of the 3x FLAG tag were still present. This construct was then 
used in a poly-ubiquitination assay as per above and the eluted protein 
immunoblotted for the 3x FLAG tag (Figure 3.2D). As similar levels of 
ubiquitination were detected for both WT and K0 3x FLAG hSSB1, this suggests 
that the 3x FLAG tag may indeed also be ubiquitinated in cells. These data indicate 
that ubiquitination of endogenous hSSB1 lysine residues and of those within the 3x 
FLAG tag cannot be distinguished in this assay. 
 
Although the above conclusions seem likely, one other possible explanation could be 
that hSSB1 is ubiquitinated on non-lysine residues. Indeed, whilst only observed in a 
limited number of instances, ubiquitination of cysteine, serine and threonine residues 
(Ishikura et al., 2010; Okumoto et al., 2011; Tokarev et al., 2011; Williams et al., 
2007), as well as the N-terminal NH2 group of the polypeptide backbone 
(Breitschopf et al., 1998; Fajerman et al., 2004) has been described previously. To 
determine whether hSSB1 may be modified at non-lysine amino acids, an inverse 
PCR strategy (Figure 2.1) was used to exchange the coding sequence for the 3x 
FLAG epitope tag of the WT, K-N-R, K-OB-R, K-C-R and K0 3x FLAG hSSB1 
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constructs with that of HA, an epitope tag which lacks lysine residues. This construct 
was then used in a poly-ubiquitination assay and eluent immunoblotted with an anti-
HA antibody (Figure 3.2E). Whilst ubiquitination of WT, K-N-R, K-OB-R, and K-
C-R HA-hSSB1 was readily detected at equal levels, ubiquitination of K0 HA-
hSSB1 was not. These results indicate that poly-ubiquitination of transiently 
expressed hSSB1 occurs at lysine residues, although is not restricted to a single site. 
 
3.2.3 The N-terminal 3x FLAG tag of hSSB1 may be modified 
An interesting observation from the above section was that while 3x FLAG hSSB1 
migrated with an observed molecular weight of ~ 35 kDa (theoretical molecular 
weight = 26.1 kDa), HA hSSB1 migrated at ~ 28 kDa (theoretical molecular weight 
= 24.1 kDa). Although a small difference in observed molecular weight may be 
expected due to the difference in size the 3x FLAG and HA epitope tags, as well in 
the isoelectric point of the resulting hSSB1 proteins (3x FLAG hSSB1 = 5.97, HA 
hSSB1 = 8.94), this may not be a sufficient explanation for the differences observed. 
As plasmids encoding Myc hSSB1 or 3x FLAG hSSB1 with an additional C-terminal 
HA tag had also recently been prepared, each of these four constructs was expressed 
in cells and proteins immunoblotted with antibodies against each epitope tag (Figure 
3.3A). Whilst an observed molecular weight of ~28-30 kDa was observed for both 
Myc and HA tagged hSSB1, 3x FLAG hSSB1 was consistently detected at ~35 kDa 
with an anti-FLAG antibody. Unexpectedly, however, a lower molecular weight 3x 
FLAG hSSB1 band of similar size to Myc hSSB1 (~30 kDa) was also detected using 
the hSSB1 antibody. One explanation that was considered for the differences in 
bands detected for 3x FLAG hSSB1 with the FLAG or hSSB1 antibodies was the 
presence of the endogenous methionine codon downstream of the N-terminal 3x 
FLAG tag. Here it was envisaged that this might act as an internal start codon that 
would allow for expression of an hSSB1 transcript lacking the 3x FLAG tag. As this 
might explain the difference in detected bands, the endogenous methionine codon 
(M1) was mutated to alanine and this mutant expressed in cells. Whole cell lysates 
were then prepared and immunoblotted with antibodies against hSSB1 and the 3x 
FLAG tag (Figure 3.3B). 
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Figure 3.3 The N-terminal FLAG tag may be modified 
 
(A) The ~35 kDa hSSB1 band may be specific to 3x FLAG hSSB1. The coding 
sequence for the N-terminal tag of the 3x FLAG hSSB1 construct was exchanged 
with the CDS sequence of the HA or Myc epitopes using inverse PCR with 5` 
hybridised primers. The coding sequence of the HA epitope was separately added to 
the C-terminus of the 3x FLAG hSSB1 construct by the same method. Each 
construct, or a control vector, were expressed in HEK293T cells for 24 hours before 
cells were lysed and 15 µg of whole cell lysate immunoblotted with antibodies 
against FLAG, HA, Myc, hSSB1 and actin (loading control). These results are 
representative of two independent experiments. 
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 (B) The ~30 kDa 3x FLAG hSSB1 band is not caused by the endogenous hSSB1 
ATG functioning as an internal initiator codon. Site-directed mutagenesis was 
employed to mutate hSSB1 residue M1 of the N-terminal 3x FLAG hSSB1 construct. 
This construct, or a control vector, was expressed in HEK293T cells for 24 hours 
before cells were lysed and 15 µg of whole cell lysate immunoblotted with 
antibodies against FLAG, hSSB1 and actin (loading control). These results are 
representative of two independent experiments. 
 
(C) The ~35 kDa 3x FLAG hSSB1 band may be ubiquitinated. 3x FLAG hSSB1 
was transiently expressed in HEK293T cells for 24 hours. Cells were then harvested 
and lysed before incubation of 500 µg whole cell lysate with M2 FLAG magnetic 
beads overnight at 4 oC. Beads were washed the following day and protein eluted by 
heating to 90 oC for 10 min in SDS loading buffer. Eluent was immunoblotted and 
probed with antibodies against FLAG (green) and ubiquitin (red). These results are 
representative of two independent experiments. 
  
(D) A single predominant 3x FLAG hSSB1 band is observed in cells grown at 2 
% O2. HeLa cells grown at 2 % O2 were transfected with the 3x FLAG and MYC 
hSSB1 constructs, separately or together, and then harvested after 24 hours. Whole 
cell lysates were prepared and 15 µg immunoblotted with antibodies against FLAG, 
Myc, hSSB1 and actin (loading control). These results are representative of three 
independent experiments. 
 
Two hSSB1 bands were however similarly detected for WT and M1A hSSB1, 
suggesting the observed banding pattern was not due to translational initiation at the 
endogenous ATG codon. These observations also indirectly suggest both bands may 
contain the FLAG tag. Indeed, this is consistent with the ~ 2 kDa difference in the 
observed molecular weight of endogenous hSSB1 (~ 28 kDa) and the lower 3x 
FLAG hSSB1 band (~ 30 kDa), corresponding to the approximate molecular mass of 
the 3x FLAG tag (2.7 kDa).  
 
From the above data it can be observed that while 3x FLAG hSSB1 migrates at two 
predominant molecular weights, the lower band does so most similarly to 
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endogenous hSSB1. In addition, in Figure 3.3A, both bands of the 3x FLAG hSSB1 
HA construct were detected with the HA antibody, suggesting the lower band is not 
formed due to a C-terminal cleavage event. Although formation of ~30 kDa hSSB1 
due to an N-terminal cleavage event could not be excluded based on this data, it 
seemed more likely that the upper 3x FLAG hSSB1 band may instead be modified.  
 
As previous observations suggested 3x FLAG hSSB1 may be non-specifically poly-
ubiquitinated, it was tempting to consider that the ~35 kDa 3x FLAG hSSB1 band 
observed may also reflect this event. To test this, 3x FLAG hSSB1 was transiently 
expressed in cells prior to immunoprecipitation of FLAG tagged proteins. These 
were then immunoblotted and probed with antibodies against the FLAG tag and 
ubiquitin (Figure 3.3C). In doing so, an ubiquitin band corresponding to ~35 kDa 3x 
FLAG hSSB1 was detected, supporting that the ~35 kDa 3x FLAG hSSB1 band may 
be ubiquitinated. Unexpectedly, in this assay, both ~30 and 35 kDa bands were also 
detected using the FLAG antibody (the ~30 kDa band was not detected by 
immunoblotting of whole cell lysates with the FLAG antibody previously). An 
explanation for this may involve the greater antigenicity ~30 kDa 3x FLAG hSSB1 
in its native state, allowing for its enrichment by immunoprecipitation. These 
observations nevertheless support that both 3x FLAG hSSB1 bands are FLAG tagged 
and full-length, as well as that ~35 kDa hSSB1 may be ubiquitinated.  
 
One explanation for the ubiquitination of ~35 kDa hSSB1 may be that this 
modification is the first step of poly-ubiquitin chain formation. It was therefore 
interesting to notice that while both 3x FLAG hSSB1 bands are present when cells 
are grown at 21 % O2, only ~35 kDa hSSB1 was observed in cells grown at 2% O2 
(Figure 3.3D). In this experiment, cells were grown at 2% O2 for 2 weeks and then 
transfected with plasmids encoding 3x FLAG hSSB1, Myc hSSB1 or co-transfected 
with both. Whole cell lystates were then immunoblotted and probed with antibodies 
against the Myc and 3x FLAG epitope tags. While initially performed as part of a 
separate study, the absence of the lower 3x FLAG hSSB1 band was particularly 
striking. Although yet to be demonstrated, it is tempting to speculate that this may 
represent a greater turnover of hSSB1 protein at low oxygen conditions in the 
absence of oxidative DNA damage. It should be noted that while this experiment was 
performed in HeLa cells, unlike other experiments here which were performed in 
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HEK293T cells, this observation is unlikely to represent a cell line difference, as ~30 
and ~35 kDa hSSB1 bands are observed from HeLa cells grown at 21% O2 in chapter 
4 (e.g. Figure 4.2A). 
 
3.2.4 Mass spectrometric analysis of immunoprecipitated 3x FLAG hSSB1 
The data reported above suggests that site-directed mutagenesis studies may not be 
an effective approach to detect residues of hSSB1 that may be ubiquitinated. Indeed, 
it seems likely that transiently expressed hSSB1 is highly ubiquitinated and that 
mutation of those lysine residues that are ubiquitinated in the endogenous protein 
may go undetected in the over-expressed protein. This may be due to non-residue-
specific ubiquitination of the protein in general, or due to ubiquitination of additional 
residues on mutant hSSB1. These observations nevertheless indicate that an alternate 
approach to assess hSSB1 ubiquitination may be required. 
 
The use of mass spectrometry to identify ubiquitinated lysine residues has been 
frequently reported, most often subsequent to trypsin digestion of the target protein 
(Udeshi et al., 2012). Here, trypsin cleaves the ubiquitin peptide, leaving only the 
two C-terminal ubiquitin glycine residues attached to the ε-amino group of the 
ubiquitinated substrate lysine residue. Although trypsin characteristically cleaves 
proteins C-terminal to acidic residues (lysine and arginine) (Olsen et al., 2004), the 
di-glycyl moiety remaining on the modified lysine residues prevents this activity 
(Udeshi et al., 2013a), resulting in an internal modified lysine residue that may be 
detected with an additional mass of 114.04 Da (Fiedler and Cotter, 2013; Xu and 
Peng, 2006). Enrichment of the target protein, or of ubiquitinated proteins in general, 
is however essential for this approach due to the low stoichiometric presence of 
ubiquitinated proteins, as well as their rapid degradation in cells. For this purpose, 
isolation of ubiquitinated proteins has been reported by the capture of hexa-histidine 
tagged ubiquitin on Ni-NTA beads (Peng et al., 2003), or by immunoprecipitation of 
the di-glycyl group from trypsin digested proteins (Kim et al., 2011; Udeshi et al., 
2013b; Xu et al., 2010b). As yet, however, the detection of ubiquitinated hSSB1 by 
mass spectrometry has not been reported using these approaches. 
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It was therefore envisaged that hSSB1 ubiquitination might be assessed more 
successfully following immunoprecipitation of hSSB1 directly. To assess this, 
HEK293T cells were firstly treated with 25 µM MG132 for 4 hours. Cells were then 
lysed and 6000 µg of whole cell lysate incubated with protein G magnetic beads 
bound either to an IgG isotype control, or the hSSB1 antibody, overnight at 4 oC. The 
following day, beads were washed and protein eluted by heating in SDS-loading 
buffer at 80 oC for 10 minutes. Proteins were then separated by electrophoresis and 
stained with colloidal coomassie brilliant blue G-250. Although bands were 
specifically detected in the hSSB1:IP lane, these were however considered too faint 
to justify their extraction and subsequent mass spectral analysis.  
 
As it is seemed unlikely that enough endogenous hSSB1 could be isolated to assess 
hSSB1 ubiquitination by mass spectrometry, it was therefore conceded that over-
expressed protein would need to be employed. Indeed, while such protein is likely 
highly-ubiquitinated, regardless of the epitope tag used, it was reasoned that a certain 
level of specificity may still exist when using the WT protein. For these studies, it 
was therefore concluded that 3x FLAG hSSB1 would be used, both as the plasmid 
has previously been published by our group (Paquet et al., 2015), as well as due to 
the higher running molecular weight of the protein, which would allow greatest 
separation from the FLAG antibody IgG light chain. As our group (Bolderson et al., 
2014) and others (Kar et al., 2015) recently identified a novel role for hSSB1 in the 
response to replication stress, a response during which the regulation of hSSB1 is 
unclear, it was further considered that this experiment would be conducted in the 
presence or absence of treatment with the replication inhibitor hydroxyurea.  
 
For this experiment, WT 3x FLAG hSSB1 was transiently expressed in HEK293T 
cells for 24 hours. Cells were then treated with 3 mM hydroxurea for 4 hours, or 
mock treated, prior to collection of cells and preparation of whole cell lysates. 
Exogenously expressed hSSB1 was then immunoprecipitated from 12 mg of whole 
cell lysate overnight at 4 oC using anti-FLAG M2 magnetic beads and separated on a 
BOLT precast PAGE gel. This gel was stained overnight with colloidal coomassie 
blue as per above and the following day de-stained in H2O (Figure 3.4A). Here, 3x 
FLAG hSSB1 bands were detected at ~30 and 35 kDa.  
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Homo.sapiens           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Papio.anubis           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Mus.musculus           DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Sus.scrofa             DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Canis.lupus            DDVGNLIQPGDIIRLTKGYASVFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Python.bivittatus      DDVGNLIQPGDIIRLTKGYSSIFKGCLTLYTGRGGDLQKVGEFCMVYSEVPNFSEPNPEY 115
Chrysemys.picta        DDVGNLIQPGDIIRLTKGYASIFKGCLTLYTGRGGDLQKIGEFCMIYSEVPNFSEPNPEY 115
Xenopus.laevis         DEVGNFIQPGDIIRLTKGYASLFKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEY 115
Danio.rerio            DELGSLIQPGDIIRLTRGYASIWKGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEL 120
                       *::*.:**********:**:*::****************:*****:************* 
Homo.sapiens           STQQAPNKAVQN-DSNPSASQPTTGPSAASPASENQNGNGLSAPPGPGGGPHPPHTPSHP 174
Papio.anubis           STQQTPNKAVQN-DSNPSASQPTTGPSAASPASESQNGNGLSAPTGPGGGSHPPHTPSHP 174
Mus.musculus           NTQQAPNKSVQNNDNSPTAPQATTGPPAASPASENQNGNGLSTQLGPVGGPHPSHTPSHP 175
Sus.scrofa             SAQQAPNKTVQN-DSSPTAPQPATGPPAASPASESQNGNGLSAPPGPGGGPHPPHTPSHP 174
Canis.lupus            SAQQAPNKTVQN-DSSPTAPQPATGPPAVSPASENQNGNGLSAPPGPGGGPHPPHVPSHP 174
Python.bivittatus      VAQQSQNKNTPNDNAAPAASQTTPGPSTS-AAAENQNGNGLIP-SGSGGSLHPPSIPTHP 173
Chrysemys.picta        VTQQSQTKAAQNDNATPAASQTTPGPAASSPAAESQNGNGLSA-PGPGAPPHPPNVPSHP 174
Xenopus.laevis         TAQQSQNKQAQAESGTGTNNHNSSSPAPP--APDLDNGNGSNS---SGPSTNQSTAPAHS 170
Danio.rerio            LAQANQQNKTSKEQRGNSPP-------------NQNAGNGTVPVFSNNNAAPVPRDPNFG 167
                        :*    : .   .   :               : : ***                * . 
Homo.sapiens           PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Papio.anubis           PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Mus.musculus           PSTRITRS-----QPNHTPSGPPG--PSSNPVSNGKETRRSSKR 212
Sus.scrofa             PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Canis.lupus            PSTRITRS-----QPNHTPAGPPG--PSSNPVSNGKETRRSSKR 211
Python.bivittatus      TSGRITRS-----QPNHQGGSSSGIGSSSNPVSNGKETRRSSKR 212
Chrysemys.picta        TSGRITRS-----QPNHQGAGSAGSSSSSSPISNGKETRRSSKR 213
Xenopus.laevis         TSGRITRS-----QPNHSLPGAP------NSVSNGKEPRRTGKR 203
Danio.rerio            ASGRPNGRAPGNGPPPVTAGGTPAPPKPTVSISNGRDPRRASKR 211
                        * * .        *     .          :***:: **:.**
OB Fold
OB Fold
2 3 5 53
76 83 103 109
132 134 137/8 147
180 182 187 196
144141129
195
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Figure 3.4 Mass spectrometric analysis of immunoprecipitated 3x FLAG hSSB1 
 
(A) Immunoprecipitation of 3x FLAG hSSB1 from cells treated with 
hydroxyurea. 3x FLAG hSSB1 was transiently expressed in HEK293T cells for 24 
hours, prior to treatment with 3 mM hydroxyurea (HU) for 4 hours. Whole cell 
lysates were then prepared from these cells and 12 mg incubated with 40 µl of 
magnetic M2 FLAG beads overnight at 4 oC. Beads were then washed and protein 
eluted by heating to 90 oC in SDS loading buffer for 10 min. Two-thirds of the eluent 
was separated by PAGE and stained with colloidal coomassie brilliant blue G-250. 
The remaining eluent was immunoblotted with antibodies against the FLAG tag. The 
upper ~30 and ~35 kDa hSSB1 bands are indicated, as well as bands of ~65 kDa. * = 
IgG proteins 
 
(B) Peptides spanning the N- and C- terminus of hSSB1 were identified for the 
~30 and ~35 kDa bands in (A). The ~30 and 35 kDa bands indicated for both 3x 
FLAG hSSB1 lanes were excised from the colloidal coomassie blue-stained gel and 
transported to the BSRC mass spectrometry facility at the University of St Andrews. 
Gel slices were excised and digested with trypsin. Peptides were detected by ESI-
MS/MS and data analysed using the Mascot algorithm against the NCBI non 
redundant database with carbamidomethyl as a fixed modification of cysteines and 
methionine oxidation, deamidation of glutamines and asparagines and 
phosphorylation of serine, threonine and tyrosine as variable modifications. Red bold 
font indicates hSSB1 residues that were detected from each band. 
 
(C and D) Numerous phosphorylated hSSB1 residues were detected for each 
band excised in (B). The mascot algorithm detected numerous potentially 
phosphorylated serine and threonine residues. (C) A schematic of hSSB1 indicating 
putative phosphorylation sites detected prior to (above) and following (below) HU 
treatment. (D) A table of detected putative phosphorylation sites, indicating the band 
from which they were detected. 
 
(E) Putative phosphorylation residues on the hSSB1 N-terminus, OB-fold and 
far C-terminus are strongly conserved. Amino acid sequences of proteins 
homologous to hSSB1 from the indicated species were compiled and aligned using 
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Clustal Omega software (ebi.ac.uk). Putative residues of phosphorylation are 
outlined by rectangles with numbers corresponding to the hSSB1 protein sequence. 
Amino acids of the OB-fold are underlined. Consensus symbols given below each 
row should be interpreted: * = a fully conserved residue, : = conservation between 
groups of strongly similar properties, . = conservation between groups of weakly 
similar properties 
 
These bands were also detected by immunoblotting the same eluent with an antibody 
against the FLAG epitope (Figure 3.4A), further confirming that these were 
transiently expressed hSSB1. Interestingly, when separated in this way, the ‘~35 kDa 
hSSB1’ was actually found to be composed of multiple similar molecular weight 
species, potentially signifying different forms of modified hSSB1. Whilst mono-
ubiquitination may represent the difference between ~30 and 35 kDa hSSB1 
(ubiquitin is a 8.5 kDa protein which migrates with an apparent molecular weight on 
5.5 kDa (Beers and Callis, 1993)), it is unclear whether the differences between the 
bands at ~35 kDa hSSB1 represent an additional ubiquitination event, or one or more 
other modifications. With the exception of faint bands at ~65 kDa, few other specific 
high-molecular weight bands were identified, suggesting that poly-ubiquitinated 
hSSB1 had not been efficiently isolated. Despite this, it was considered that 
identification of ~30 and ~35 kDa hSSB1 bands may still be useful, especially 
considering cells were treated +/- hydroxyurea. These bands were therefore excised 
for analysis at the BRSC mass spectrometry and proteomics facility at the University 
of St Andrews. Here, bands were cut into 1 mm slices and subjected to in-gel trypsin 
digestion. Peptides were then extracted with formic acid and separated on a reverse 
phase chromatography column prior to detection by electrospray ionisation 
quadrupole time-of-flight mass spectrometry (ESI-Q-TOF-MS).  
 
Error tolerant searches using the Mascot algorithm were then performed against the 
St. Andrews Mascot database with carbamidomethyl as a fixed modification of 
cysteines and methionine oxidation, deamidation of glutamines and asparagines and 
phosphorylation of serine, threonine and tyrosine as variable modifications. In doing 
so, peptides from each sample were detected that corresponded to the hSSB1 protein 
sequence (Figure 3.4B). Consistent with Figures 3.3 A and B, peptides representing 
the N - and C-terminus of hSSB1 were detected in all samples, suggesting that both 
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the ~30 and 35 kDa bands contain full-length hSSB1. Furthermore, in bands where a 
peptide containing the N-terminal methionine was detected, this was with an 
additional 271.1487 Da at the N-terminus. This is consistent with the additional mass 
expected from the cleaved 3x FLAG tag (K.AIA-MTTETFVK) and further 
demonstrates that the lower full-length hSSB1 band is not caused by translation 
initiation at the internal methionine codon C-terminal to the 3x FLAG protein tag 
 
Interestingly, while none of the hSSB1 lysine residues were detected with an 
additional mass of 114.04 Da, as would be expected of an ubiquitinated lysine 
residue, numerous putative phosphorylated serine and threonine residues were 
identified from each hSSB1 band (Figure 3.4 C and D). Of the phosphorylation sites 
detected, two (S134 and T187) have previously been reported by other mass 
spectrometry screens and have been curated on the PhosphoSitePlus database 
(Hornbeck et al., 2015), potentially supporting them as likely phosphorylation sites. 
By contrast, phosphorylation of S116, T117 and S200, phosphorylation events 
reported by PhosphoSitePlus, were not detected in this data set.  
 
It should be noted that certain ambiguities do exist in the assignment of 
phosphorylation to specific residues, especially in peptides that contain multiple 
serine or threonine residues (Dephoure et al., 2013). This is an issue further 
discussed in chapter 4. To indirectly assess the likelihood of each phosphorylation 
site, the protein alignment in Figure 3.1 was further examined (Figure 3.4 E). 
Interestingly, each of the putative phosphorylated residues residing on the N-
terminus, as well as the OB fold, were highly conserved amongst the examined 
species, whilst these were less so on the C-terminus tail. These findings may 
however represent the high conservation of the DNA-binding region of hSSB1, 
rather than of particular phosphorylation sites. Further validation of these residues 
will therefore be required.  
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3.4 Discussion 
In this chapter, site-directed mutagenesis was employed to determine hSSB1 lysine 
residues that may be ubiquitinated in cells (Figure 3.2). The mutation of single lysine 
residues, or each lysine residue in a particular region, was however unable to prevent 
or suppress hSSB1 ubiquitination, suggesting this modification may occur at multiple 
sites. Indeed, examination of the hSSB1 crystal structure revealed that each hSSB1 
lysine residue is surface exposed and likely accessible for modification (Figure 3.1).  
 
Although the data obtained here indicate that transiently expressed hSSB1 may be 
ubiquitinated at multiple lysine residues, it is unclear whether endogenous hSSB1 is 
also modified in this way. One interpretation may be that while hSSB1 could be 
normally ubiquitinated only at specific sites, the ubiquitination of other lysine 
residues may be promoted by high-level hSSB1 transient over-expression. This could 
be explained by a detrimental effect of hSSB1 over-expression, such that a certain 
pressure exists to remove excess hSSB1 in the cell. Another possibility is that while 
FBXL5, the endogenous hSSB1 E3 ligase (Chen et al., 2014), may specifically 
ubiquitinate certain residues, non-specific ubiquitination of hSSB1 by other enzymes 
may be increasingly favourable at higher hSSB1 concentrations.  
 
One method that could be useful for the identification of specific hSSB1 
ubiquitination events is similar to that which has been employed for the 
characterisation of MDM2-mediated p53 ubiquitination (Kubbutat et al., 1998; 
Rodriguez et al., 2000b). In these studies, co-expressed MDM2 caused the rapid 
degradation of WT p53, although not of a p53 mutant truncated of its c-terminal 30 
amino acids (Kubbutat et al., 1998), or where the six c-terminal residues within this 
region were mutated to arginine (Rodriguez et al., 2000a). While these data suggest 
that MDM2 catalyses the poly-ubiquitination of these six p53 lysine residues, 
eventuating in p53 degradation, similar poly-ubiquitination of WT and lysine mutant 
p53 was observed in an in vitro MDM2 ubiquitination assay. These data thereby 
suggest multiple other p53 lysine residues may also be modified in an artificial 
setting (Rodriguez et al., 2000a), reminiscent of the observations for hSSB1 
ubiquitination observed in this chapter. It is therefore interesting to consider that, 
similarly to MDM2 and p53, the co-over-expression of FBXL5 with hSSB1 lysine 
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mutants may be one method of identifying specific residues of FBXL5-catalysed 
hSSB1 ubiquitination.  
 
Another potentially confounding issue is that while it seems likely that hSSB1 is 
modified by K48-linked poly-ubiquitination, as hSSB1 does seem to be 
proteasomally degraded (Richard et al., 2008), it is possible that hSSB1 may also be 
modified (specifically or non-specifically) by other ubiquitin chain types. One 
method through which different poly-ubiquitin topologies have been discriminated 
previously has included the mutation of certain ubiquitin peptide lysine residues, to 
prevent the formation of certain chain types (such as by mutating K48), or limit chain 
formation to a certain lysine residue (for instance if every lysine expect K48 is 
mutated). Such methods would allow further investigation into the nature of the 
hSSB1 poly-ubiquitination chains reported here. 
 
In addition to the non-specific ubiquitination of transiently expressed hSSB1 
described above, the data provided here suggests that the 3x FLAG epitope tag may 
also be poly-ubiquitinated, further supporting the non-specific nature of transiently 
expressed hSSB1 poly-ubiquitination in cells (Figure 3.2). Interestingly, 3x FLAG 
hSSB1 was found to form two prominent bands on an immunoblot at ~30 and 35 
kDa when probed with an hSSB1 antibody (Figure 3.3). Whilst the FLAG antibody 
poorly detected the lower band, both bands nevertheless do seem to contain this 
epitope tag and to represent full-length hSSB1. Immunoblotting of 
immunoprecipitated 3x FLAG hSSB1 then suggested that the ~35 kDa band might 
be ubiquitinated. Although it remains possible that hSSB1 may be modified by 
mono-ubiquitination at an endogenous lysine residue, based on the non-specific 
ubiquitination of the 3x FLAG epitope tag suggested above, it is tempting to consider 
the difference between ~30 and ~35 kDa 3x FLAG hSSB1 may result from similar 
mono-ubiquitination of the 3x FLAG tag. Indeed, a higher molecular weight species 
was not detected for HA or Myc tagged hSSB1 (which contain 0 and 1 lysine 
residue, respectively, compared to 6 on the 3x FLAG tag). It is curious however that 
although potentially ubiquitination, the epitope tag of ~35 kDa 3x FLAG hSSB1 
appears to be more antigenic when using the FLAG antibody than the band at ~30 
kDa, which is presumably unmodified. It is also important to note that while the 3x 
FLAG tag may be modified, this does not appear to affect hSSB1 function, as 
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transiently expressed 3x FLAG hSSB1 is able to recapitulate siRNA-depleted 
endogenous hSSB1 in cells (Paquet et al., 2015) (and Chapter 4 of this thesis).  
 
Given that non-specific hSSB1 poly-ubiquitination is likely to be stimulated by 
transient over-expression, it is interesting to consider that the ubiquitination observed 
for ~35 kDa 3x FLAG hSSB1 may occur as an intermediate in this process. This may 
be supported by the observation that 3x FLAG hSSB1 expressed in cells grown at 
2% O2, unlike those grown at 21 % O2, migrates solely at ~35 kDa on a PAGE gel, 
rather than also at ~30 kDa. Here, it may be interpreted that while hSSB1 is rapidly 
poly-ubiquitinated in cells grown at 2% O2, leading to the predominant formation of 
the ~35 kDa band, ubiquitination may be partially suppressed at 21 % O2. This 
potentially may occur due to increased oxidative stress resulting in the stabilisation 
of hSSB1, causing a relative increase in hSSB1 of ~30 kDa. Conversely, non-specific 
ubiquitination of ~35 kDa hSSB1 may occur not as an intermediate, although rather 
as a separate mono-ubiquitination event. This indeed may be more consistent with 
prior conceptions of poly-ubiquitin chain formation, where initial ubiquitination of 
the substrate is rate limiting, while subsequent chain extension occurs more rapidly 
(Petroski and Deshaies, 2005). Under this circumstance, the formation of a stable 
mono-ubiquitinated intermediate may be unexpected to form. Alternatively, although 
initial ubiquitination and subsequent poly-ubiquitin chain extension is often mediated 
by the same E3 ligase, in some instances, chain extension is catalysed by a distinct 
class of specific ligases, referred to as E4 (Kuhlbrodt et al., 2005). A discrepancy in 
the enzymatic constituents of each stage of hSSB1 poly-ubiquitination, which may 
be differentially affected by hSSB1 over-expression, such as by free components of 
one or the other becoming ‘saturated’, may therefore explain the stable formation of 
the mono-ubiquitinated form of hSSB1.  
 
In view of the likely ubiquitination of the ~35 kDa hSSB1 band, it may be 
unexpected that lysine residues containing an additional di-glycyl group, remnants 
from ubiquitin trypsinisation, were not detected by mass spectrometry. If 
ubiquitination does predominantly occur on FLAG tag lysine residues, these however 
would not be detected in the analysis, which was performed using the NCB1 non-
redundant database of endogenous proteins (and therefore does not contain epiptope-
tagged proteins). Indeed, whilst a fragment of the FLAG tag (K.AIA) can be detected 
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as an additional mass fused to the hSSB1 N-terminus, other tryptic peptides of the 
tag have not been analysed.  
 
The mass spectrometric-detection of numerous putative phosphorylation sites on 
immunoprecipitated hSSB1 does however provide valuable new insight into the 
regulation of hSSB1. It should be noted however that while specific residues of 
phosphorylation were represented in Figure 3.4, these represent only the ‘most-
likely’ sites of modification for each phosphorylated tryptic peptide detected. Indeed, 
whilst these were identified based on ‘confidence scores’ generated by the Mascot 
algorithm, a complete array of high confidence fragment ions was not obtained for 
each tryptic fragment. Definitive site assignment of phosphorylation within each 
typtic peptide is therefore unachievable. Such issues are further elaborated in Section 
4.2.1. Nevertheless, these data may provide a useful guide for the further 
investigation of hSSB1 regulation by phosphorylation.  
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Chapter 4:  Regulation of hSSB1 in the Response to Replication 
Stress   
 
4.1 Introduction 
DNA replication constitutes one of the most important processes within the cell and 
allows for the accurate duplication of genomic information prior to cell division. 
While this process occurs rapidly in unperturbed cells, numerous endogenous and 
exogenous sources may either slow or stall replication fork progression (Branzei and 
Foiani, 2005). Such disruption results in the exposure of single-stranded DNA 
(ssDNA) that must be protected and stabilised to prevent replication fork collapse 
and double-strand DNA break formation (Toledo et al., 2013). This process includes 
the coating of exposed ssDNA by replication protein A (RPA), as well as the 
subsequent accumulation and activation of the ataxia telangiectasia and Rad3-related 
(ATR) kinase (Ball et al., 2005). ATR may then phosphorylate Chk1, which 
promotes intra-S cell cycle checkpoint activation (Zhao and Piwnica-Worms, 2001), 
as well as other proteins involved in stabilising and remodelling the replication fork 
(Couch et al., 2013). In addition to ATR, numerous additional regulatory enzymes 
are also activated by replication stress, including the related P13K-like kinases, 
ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase (DNA-PK) 
(Lin et al., 2014; Liu et al., 2012; Ying et al., 2015). Activation of these enzymes 
results in the coordinated regulation of numerous DNA repair proteins. Such 
regulation is exemplified by phosphorylation of the RPA 32 kDa subunit (RPA32) 
and is mediated by ATM, ATR and DNA-PK, as well as by cyclin-CDK (Anantha et 
al., 2007; Liu et al., 2012; Shao et al., 1999). Here, RPA32 phosphorylation is 
required for efficient restart of stalled replication forks following their disruption 
(Ashley et al., 2014), potentially due to an association with the BRCA2-interacting 
protein, PALB2 (Murphy et al., 2014).  
 
Recently our group and others provided evidence that the restart of stalled replication 
forks is also promoted by human single-stranded DNA-binding protein 1 (hSSB1) 
(Bolderson et al., 2014; Kar et al., 2015). Following the disruption of replication, 
hSSB1 was found to localise to stalled replication forks, where it promotes the 
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activation of the ATR kinase and the subsequent phosphorylation of Chk1. The 
importance of hSSB1 in these processes is highlighted by the inefficiency of hSSB1-
depleted cells to activate checkpoint signalling following replication stress, as well as 
to restart stalled replication forks. These deficiencies are manifested by 
hypersensitivity to multiple replication inhibitors (Bolderson et al., 2014).  
 
While the precise function of hSSB1 following fork disruption remains unclear, one 
explanation may be that hSSB1 functions in a similar way to RPA. Following 
replication disruption, RPA is known to sequester exposed ssDNA and recruit the 
ATR kinase through a direct interaction with the ATR-interacting protein, ATRIP 
(Ball et al., 2005). Indeed, hSSB1 also associates with the ATR-ATRIP heterodimer 
in cells and is required for the recruitment of these proteins to chromatin (Bolderson 
et al., 2014; Kar et al., 2015). In addition, hSSB1 is able to promote the interaction of 
ATR-ATRIP with a ssDNA substrate in vitro (Kar et al., 2015). The coordination of 
hSSB1 and RPA in cells, however, remains unclear. The considerably lower affinity 
of hSSB1 than RPA for ssDNA (Yang et al., 2012) indeed does suggest these 
proteins are more likely to function by separate means, rather than by competing for 
the same substrate. An alternative explanation for the involvement of hSSB1 in ATR 
activation may therefore reflect a functional interplay with other proteins known to 
promote ATR activity following fork stalling. This may include components of the 
MRN complex, with which hSSB1 has been suggested to interact previously 
(Richard et al., 2011a) and which also inefficiently localise to replication forks 
following hSSB1 depletion (Bolderson et al., 2014). Although the function of this 
complex at sites of replication disruption remains a subject of debate, a role in the 
activation of ATR has been suggested (Duursma et al., 2013). Here, MRN was 
suggested to promote the association of TopBP1 with the 9-1-1 complex at 
replication fork junctions, where it may interact with and subsequently activate the 
ATR kinase (Delacroix et al., 2007). An involvement of hSSB1 in these processes 
may therefore offer some explanation for its role in stimulating ATR-mediated Chk1 
phosphorylation.  
 
Whilst the precise mechanism through which hSSB1 functions at sites of stalled 
forks remains unclear, it is tempting to draw and infer parallels with its described 
roles in the repair of double-strand DNA breaks by homologous recombination 
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(Richard et al., 2008). In this process, hSSB1 is thought to bind exposed ssDNA 
(Richard et al., 2011b), as well as poly-(ADP) ribose (PAR) (Zhang et al., 2014) and 
to promote resection of the break by either the MRN (Richard et al., 2011a) or Exo1 
nucleases (Yang et al., 2012). In addition, hSSB1 is required for efficient activation 
of the ATM kinase (Richard et al., 2008). ATM has then been inferred to 
phosphorylate hSSB1 at threonine residue 117 (T117), initiating a positive feedback 
loop to further promote ATM signalling (Richard et al., 2008). It is therefore 
interesting to hypothesise that hSSB1 may be regulated through a similar means in 
the stabilisation of stalled replication forks, especially given the role of hSSB1 in the 
stimulation of ATR (a kinase related to ATM).  
 
In Chapter 3, numerous putative phosphorylation events were detected by mass 
spectrometric analysis of hSSB1 that had been immunoprecipitated from HEK293T 
cells. In this chapter, the phosphorylation of one of these, serine residue 134 (S134) 
is further characterised and found to be required for hSSB1-dependent cell survival 
following replication fork inhibition. Evidence is also provided for the necessity of 
an interaction between hSSB1 and the INTS3 complex in the response to replicative 
stress, although this is likely to modulate hSSB1 through a means that is independent 
of S134 phosphorylation. Chromatin-bound hSSB1 is also found to associate with 
numerous complexes that have been implicated in nucleosome remodelling following 
fork disruption, potentially suggesting a novel process in which hSSB1 may be 
involved. 
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4.2 Results 
4.2.1 Detection of phosphorylated hSSB1 by mass spectrometry  
In response to ionising radiation-induced double-strand DNA break formation, 
hSSB1 function may require phosphorylation of threonine residue 117 (T117) 
(Richard et al., 2008). T117 is a component of a SQ/TQ motif (serine/threonine – 
glutamine), numerous of which are phosphorylated in other DNA repair proteins by 
the PI3K-like kinases, ATM, ATR and DNA-PK (Traven and Heierhorst, 2005). 
Although phosphorylation of T117 remains to be confirmed and has only been 
assessed indirectly, the expression of a T117A hSSB1 mutant in cells has been 
shown to disrupt DNA repair signalling following ionising radiation exposure 
(Richard et al., 2008). The mass spectrometry data reported in Figure 3.4 indicated 
the potential presence of two other phosphorylated hSSB1 SQ/TQ residues at S134 
and S182, both of which may represent PI3K-like kinase-mediated regulatory sites. 
Of these, the putative phosphorylation of S134 was of particular interest due to its 
proximity to T117, suggesting that this region might represent a DNA damage-
responsive “regulatory region”.  
 
In addition to S134, the putative phosphorylation of S132 was also reported in 
section 3.4. Although these may represent separate phosphorylation events and 
indeed both were listed on the Mascot database user interphase, the unambiguous 
site-assignment of phosphorylation to either of these residues could not be achieved. 
Indeed, whilst the tryptic peptide (amino acids 124-178; Figure 4.1A) containing 
S132 and S134 was detected twice from HU-treated cells with a neutral loss of ~98 
Da (5351.389 da vs 5271.4227 da), most likely resulting from gas-phase β-
elimination of phosphoserine to dehydroaminobutyric acid (Palumbo et al., 2011), 
this may be due to phosphorylation of one of several serine residues (S129, S132, 
S134, S141, S144, S147, S156, S172, S176). The detection of numerous high-
confidence non-phosphorylated y-fragment ions generated at the c-terminus of these 
peptides however does suggest that phosphorylation is unlikely to occur C-terminal 
to A157, at S172 or S176 (Figure 4.1B).  
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Figure 4.1 Detection of phosphorylated hSSB1 by mass spectrometry 
 
(A) Detection of a singularly phosphorylated peptide corresponding to hSSB1 
amino acids 124-178. The fragment ion spectrum of a tryptic peptide corresponding 
to hSSB1 amino acids 124-178 with neutral loss of ~98 Da (5351.389 da vs 
5271.4227 da) was interrogated and major peaks correlated with various y- ions. The 
intensity of each peak is given in arbitrary units of intensity. The hSSB1 schematic 
and amino acid sequence at the top of the spectrum indicate the region and sequence 
of hSSB1 represented by the peptide, as well as the detected b- and y- ions.  
 
(B) The residue of hSSB1 phosphorylation is ambiguous. The expected b- and y- 
ions for hSSB1 phosphorylated at S129, S132, S134 or a c-terminal residue are given 
in the indicated columns. b- or y- ions are listed in mass/charge units. Values in 
green are confident matches to peaks in the spectra, whilst peaks in amber are 
observed but of low signal to noise ratio and are thus less confident.  
 
 
In addition, the presence of numerous (albeit low confidence) b- fragment ions N-
terminal to Q135, including b11-98, suggests that phosphorylation might occur at 
S129, S132 or S134. Although these data do indicate that b ions C-terminal to S134 
should also contain neutral losses of ~ 98 Da, b- fragment ions containing Q135 or 
any subsequence residues of these peptides were not detected. Furthermore, although 
a signal corresponding to a b6-98 ion was detected (with low confidence), suggesting 
phosphorylation may occur at S129, the presence of contradictory high confidence 
b6 and b7 ions instead indicate that phosphorylation of S132 or S134 is more 
probable. Indeed, the Mascot algorithm designated phosphorylation of S132 or S134 
an identical probability score for either peptide that was greater than that of 
phosphorylation at other serine residues. Moreover, whilst peaks were detected 
corresponding to b9 and b10, which support that phosphorylation occurs C-terminal 
to S132 at S134, a contradictory signal was also observed of similar m/z to b9-98, 
consistent with phosphorylation of S132.  
 
It is worth noting that hSSB1 S134 phosphorylation has also recently been detected 
in another study and was listed on the curation website, phosphositeplus (Hornbeck 
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et al., 2012). Here, a phospho-serine 14-3-3 binding motif antibody was used to 
immunoprecipitate phosphorylated proteins from the chronic myelogenous leukemia 
cell line K562 and these analysed by tandem mass spectrometry. Although hSSB1 
does not actually contain a 14-3-3 binding motif, this most likely reflects cross-
reactivity of the antibody (Cell Signaling Technology cat # 9606) with other serine-
phosphorylated motifs.  
 
4.2.2 S134A hSSB1 is unable to rescue cells from the hydroxyurea and 
aphidicolin-sensitivity caused by hSSB1 depletion  
The data above suggests that hSSB1 may be phosphorylated at S132 or S134, 
although that these events cannot be distinguished based on the mass spectrometry 
data. As the putative phosphorylation of S134 was of particular interest due to its 
presence within an SQ motif, which may suggest a role in the regulation of hSSB1 
during DNA repair, it was of interest to test this directly. hSSB1 has previously been 
demonstrated to promote clonogenic survival following hydroxyurea treatment 
(Bolderson et al., 2014) and so it was reasoned that S134 phosphorylation may be 
required for this response. In order to assess this, a rescue experiment was planned in 
which endogenous hSSB1 would be firstly depleted and cells transiently 
reconstituted with siRNA-resistant WT hSSB1, or with a mutant where the putative 
S134 phosphorylation site was disrupted.  
 
To achieve this, the preparation of siRNA-resistant hSSB1 constructs was firstly 
required. To this end, 5 silent point mutations were introduced into the hSSB1 CDS 
to disrupt the binding region of a previously optimised hSSB1 siRNA. Resistance of 
transiently expressed hSSB1 was then assessed by successive transfection of HeLa 
cells with hSSB1 siRNA over 48 hours, followed by transient over-expression of WT 
or siRNA-resistant 3x FLAG hSSB1 (5Δ). Cells were then harvested and 
immunoblotted using an M2 FLAG antibody (Fig 4.2A). While WT 3x FLAG 
hSSB1 was almost entirely depleted in hSSB1 siRNA transfected cells, siRNA-
resistant hSSB1 protein levels were only partially reduced and were indeed 
maintained at a level greater than that of endogenous hSSB1 in non-siRNA 
transfected cells. This level of resistance was reasoned as sufficient for the purpose 
of restoring hSSB1 levels in previously depleted cells.  
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Figure 4.2 Cells expressing S134A hSSB1 are hypersensitive to hydroxyurea and 
aphidicolin 
 
(A) Preparation of siRNA-resistant 3x FLAG hSSB1. Five silent point mutations 
were introduced into the coding sequence of the WT and S134A 3x FLAG hSSB1 
pCMV6 vectors by site-directed mutagenesis in the region targeted by the hSSB1 
siRNA. HeLa cells were then transfected with 50 nM stealth siRNA targeting the 
hSSB1 coding sequence, or with a negative control siRNA, twice, separated by 24 
hours. The original plasmid, or the siRNA-resistant WT 3x FLAG hSSB1 construct, 
was then transiently expressed 24 hours later. Cells were harvested after 24 hours 
and lysed in RIPA buffer. 15 µg of whole cell lysate was immunoblotted and probed 
with antibodies against hSSB1, FLAG and actin. 
 
(B) Expression of WT and S134A siRNA-resistant 3x FLAG hSSB1 in HeLa 
cells depleted of endogenous hSSB1. HeLa cells were depleted of endogenous 
hSSB1 as per (A). Cells were then transfected with WT or S134A siRNA-resistant 
3x FLAG hSSB1, or an empty plasmid, 6 hours prior to seeding into wells of a 6-
well plate at a density of 400 cells per well. Remaining cells were grown for an 
additional 24 hours and lysed in RIPA buffer. 15 µg of whole cell lysate was 
immunoblotted and probed with antibodies against hSSB1, FLAG and actin. 
 
(C, D E) Cells expressing S134A hSSB1 are hypersensitive to hydroxyurea and 
aphidicolin. The cells plated in (B) were incubated for 24 hours and treated with 3 
mM hydroxyurea  (HU) (C) or 6 µg µL-1 aphidicolin (Aph) (D) for 4, 8, 12, 16 or 20 
hours, or left untreated, prior to exchange with fresh media. Alternatively, cells were 
treated with 20, 40, 60 or 80 mM hydroxyurea (HU), or mock-treated, for 4 hours 
(E). Three technical repeats were performed per dose. Cells were then grown for 10 
days prior to staining of colonies with methylene blue. Colonies were manually 
counted and normalised to untreated cells. Data is graphed as the mean ± 1 standard 
deviation from 4 independent experiments. t tests were used to compare the ‘sihSSB1 
+ WT hSSB1’ and “sihSSB1 + S134A hSSB1’ datasets at each dose. ns = P > 0.05,  
* = P < 0.05, ** = P < 0.01, *** = P < 0.001 
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(F) A similar plating efficiency was observed regardless of hSSB1 
depletion/expression in clonogenic assays. The plating efficiency for the untreated 
cells of each data set in (C) was calculated as the average colony count between 
technical replicates divided by the number of cells seeded (400). Data is graphed as 
the mean ± 1 standard deviation from 12 independent experiments. No statistically 
significant difference was observed between data sets. 
 
(G) WT and S134A hexa-His-tagged hSSB1 is similarly folded in vitro. WT and 
S134A hexa-His-tagged hSSB1 was expressed in SHuffle T7 E. coli and purified by 
Ni-NTA affinity capture, followed by size exclusion chromatography. 100-200 µM 
of WT or S134A hSSB1 was analysed by one-dimensional NMR and proton 
chemical shifts measured relative to 4,4-dimethyl-4-silapentanesulfonic acid (DSS) 
at 0 ppm. The 1D NMR spectra of amide protons for WT and S134A hSSB1 are 
depicted. 
 
To determine the requirement of S134 for hSSB1 function following hydroxyurea 
treatment, HeLa cells were depleted of endogenous hSSB1 over 48 hours using 
siRNA and WT or S134A siRNA-resistant 3x FLAG hSSB1 transiently re-
introduced (Fig 4.2B). Cells were then seeded into wells of a 6-well plate and after 
24 hours treated with 3 mM HU for 4, 8, 12, 16 or 20 hours. Cells were then released 
into fresh media and grown for 10 days before the surviving fraction of cells at each 
dose calculated relative to untreated cells (Fig 4.2C). Consistent with previously 
published data (Bolderson et al., 2014), hSSB1-depleted cells were hypersensitive to 
hydroxyurea treatment and a statistically significant numerical difference in the 
relative surviving fraction of cells transfected with control siRNA (siControl) or 
hSSB1 siRNA (sihSSB1) was observed between those treated with 3 mM HU for 4, 
8, 12 and 16 hours. Interestingly however, a similar surviving fraction was observed 
for cells treated with 3 mM hydroxyurea for 20 hours regardless of hSSB1 status. 
Transient expression of WT siRNA resistant 3x FLAG hSSB1 was found to rescue 
cells from the hydroxyurea-sensitivity observed for hSSB1 depleted cells and no 
statistically significant difference in surviving fraction was observed at any time-
point when compared with control siRNA transfected cells. By contrast, a 
statistically significant difference in surviving fraction was observed between cells 
depleted of endogenous hSSB1 and those reconstituted with WT siRNA resistant 3x 
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FLAG hSSB1. The transient expression of siRNA resistant S134A 3x FLAG hSSB1 
was however unable to rescue cells from depletion of endogenous hSSB1 and no 
statistically significant difference in cell survival was observed between cells 
depleted of hSSB1 and those re-constituted with 3x FLAG S134A hSSB1. In 
addition, when compared to control siRNA transfected cells, or those cells 
expressing WT 3x FLAG hSSB1, HeLa cells reconstituted with S134A hSSB1 
showed a statically significant difference in cell survival following hydroxyurea 
treatment for 4, 8, 12, and 16 hours. These data suggest that phosphorylation of 
residue S134 may be required for the function of hSSB1 following hydroxyurea 
treatment. 
 
Hydroxyurea stalls replication forks through the depletion of dNTPs within the cells, 
which thereby disrupts new DNA synthesis (Koç et al., 2004). To confirm that our 
findings were due to fork disruption and not other effects of hydroxurea treatment, 
cells were also treated with 6 µg µL-1 of the DNA polymerase α inhibitor aphidicolin 
(Aph) as per above. Similarly to hydroxyurea treatment, hSSB1-depleted cells were 
hypersensitive to treatment with Aph, which could be rescued by re-introduction 
with WT, although not S134A, siRNA resistant 3x FLAG hSSB1 (Fig 4.2D). 
Interestingly, while these trends are similar to those observed following HU 
treatment, the reduction in surviving fraction observed at any time-point was 
markedly milder. 
 
In the above two experiments, cells were treated with either 3 mM hydroxyurea or 6 
µg µL-1 aphidicolin for 4, 8, 12, 16, or 20 hours. Under either of these treatments, a 
significant decrease in cell survival was observed for cells depleted of hSSB1 
relative to control siRNA transfected cells, which could be rescued by over-
expression of WT although not S134A siRNA resistant 3x FLAG hSSB1. These 
findings suggest that hSSB1 S134 is functionally important in the response to 
replicative stress. To confirm this further, an alternative treatment regime was 
employed where HeLa cells were treated with 20, 40, 60 or 80 mM hydroxyurea for 
a constant time of 4 hours prior to release into fresh media (Fig 4.2E). Similarly to 
above, hSSB1-depleted cells were hypersensitive to this treatment, which could be 
rescued by transient expression of siRNA resistant WT, although not S134A, 3x 
FLAG hSSB1. It should be noted that while hSSB1 depleted cells, as well as those 
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expressing S134A hSSB1, were hypersensitive to replication stress, a statistically 
significant difference in the colony count of untreated cells between datasets was not 
observed (Fig 4.2F). These data suggest that hSSB1 S134, or indeed hSSB1 in 
general, may not affect cell survival in the absence of exogenous DNA damage.  
 
The data presented here indicate that phosphorylation of hSSB1 S134 may promote 
clonogenic survival following replication stress. A similar inability to rescue hSSB1 
depletion may however also result from incorrect folding of the S134A hSSB1 
phosphomutant. To assess whether S134A hSSB1 is folded similarly to the WT 
protein, site-directed mutagenesis was used to prepare a S134A hexa-His hSSB1 
bacterial expression plasmid. This construct was then transported to Dr Roland 
Gamsjaeger at the University of Western Sydney who performed 1D NMR analysis 
using recombinant protein. Here, WT and S134A hexa-His hSSB1 were expressed 
and purified from BL21 E. coli using Ni-NTA beads and size exclusion 
chromatography. WT or S134A hexa-His-hSSB1 were then analysed by one-
dimensional NMR and proton chemical shifts measured relative to 4,4-dimethyl-4-
silapentanesulfonic acid (DSS) at 0 ppm (Fig 4.2G) As a similar spectrum was 
observed for WT and S134 hSSB1, these data demonstrate that S134A does not 
affect the folding of hSSB1. This indicates that the lack of complementation in 
HU/Aph survival assays is not merely due to general protein destabilisation but to a 
specific biological function normally carried out by S134 
 
4.2.3 hSSB1 is phosphorylated at serine residue 134 (S134) 
The data obtained in sections 4.2.1 and 4.2.2 suggests that hSSB1 may be 
phosphorylated at residue S134 following hydroxyurea treatment of cells and that 
this modification may promote clonogenic survival of cells following such treatment. 
These findings thereby warranted further investigation into the potential 
phosphorylation of this residue. To do so, a rabbit polyclonal antibody was raised 
against a peptide representing residues 131-140 of hSSB1 and containing 
phosphoserine at residue 134 (PSA{pS}QPTTGPKC). The peptide also contained a 
lysine – cysteine (KC) motif at the 3` termini. While, the lysine residue afforded the 
peptide a net positive charge, the cysteine was added to facilitate conjugation to 
keyhole limpet hemocyanin (KLH), the carrier protein used during immunisation. 
Approximately 12 weeks later, the antibody was then affinity purified from serum 
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using the phosphorylated immunisation peptide. This work was conducted by the 
contract research organisation, GenScript. 
Upon receipt of the S134 phospho-antibody, whole cell lysates were prepared from 
HeLa cells treated with 3 mM hydroxyurea for a range of time periods. Under all 
conditions tested, a band corresponding to the approximate size of hSSB1 could 
however not be detected by immunoblotting. As this may be due to the low 
abundance of endogenous phosphorylated hSSB1 in these samples, hSSB1 was 
instead immunoprecipitated from similar samples using a sheep polyclonal hSSB1 
antibody bound to protein G magnetic dynabeads. Immunoprecipitated protein was 
then immunoblotted and probed with the pS134 hSSB1 antibody. In doing so, a 
hSSB1-specific band was detected, which was enhanced following hydroxyurea 
treatment (Fig 4.3A). These results suggest that hSSB1 may be phosphorylated at 
S134 following hydroxyurea treatment. 
Although hSSB1 S134 phosphorylation could be detected as above, only a relatively 
indistinct band could ever be observed from immunoprecipitated endogenous 
protein. In an attempt to amplify this signal, WT 3x FLAG hSSB1 was instead 
transiently over-expressed in cells. In this way, immunoblotting of whole cell lysates 
revealed a distinct band that was specific to the over-expressed protein and which 
was enhanced following hydroxyurea treatment. The antibody did however also 
detect a non-phosphorylatable hSSB1 mutant where serine 134 was converted to 
alanine (S134A); this suggested that the antibody might also detect non-
phosphorylated hSSB1. To overcome the non-specificity of the hSSB1 phospho-
antibody, a non-phosphorylated peptide was included in the antibody working 
solution (Fig 4.3B; + control peptide). This peptide was of the same sequence as the 
immunisation peptide, although contained a serine residue in place of phosphoserine. 
The peptide was included at a 200 x molar excess to the antibody to prevent non-
specific binding by competing with non-phosphorylated hSSB1 in the whole cell 
lysate. Specificity of the pS134 antibody was further demonstrated by incubation of 
whole cell lysates from HeLa cells expressing WT or S134A 3x FLAG hSSB1 and 
treated with or without 3 mM hydroxyurea for 4 hours with lambda phosphatase 
(λPPase) for 45 minutes at 30 oC. 
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Figure 4.3 hSSB1 serine residue 134 (S134) phosphorylation is enhanced in 
response to replication stress 
 
(A) Phosphorylation of immunoprecipitated hSSB1. HeLa cells were treated with 
3 mM hydroxyurea for 2, 4, or 6 hours, or mock treated, prior to harvesting. Cells 
were lysed in IP buffer and 1 mg of whole cell lysate incubated with protein G 
dynabeads bound to a hSSB1 antibody, or an isotype control IgG. Beads were 
incubated with sample overnight at 4 oC with rotation, washed 5x with IP buffer and 
protein eluted by heating to 80 oC for 10 minutes. Eluent was then immmunoblotted 
and probed with antibodies against total and S134 phosphorylated hSSB1. 
Densitometry of pS134 hSSB1 bands was performed using ImageJ, normalised to 
total hSSB1, and expressed relative to the untreated sample. These results are 
representative of three independent experiments. 
 
(B) The S134 phospho-antibody is specific for transiently expressed S134 
phosphorylated hSSB1 when incubated with a non-phosphorylated S134 hSSB1 
peptide. HeLa cells were transiently transfected with WT or S134A 3x FLAG 
hSSB1, or a pCMV6 empty vector, 24 hours prior to treatment with or without 3 mM 
hydroxyurea (HU). Cells were then harvested, lysed in RIPA buffer and incubated 
either with or without addition of lambda (λ) phosphatase at 30 oC for 45 minutes. 
Each sample (15 µg) was then immunoblotted and probed with a novel polyclonal 
antibody raised against the hSSB1 peptide PSA{pS}QPTTGPKC, representing 
hSSB1 phosphorylated at S134. The antibody was pre-incubated either for 30 
minutes with a control non-phosphorylated peptide (+ control peptide), which 
functioned to prevent binding of the antibody to non-phosphorylated hSSB1, or with 
E
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the phosphorylated immunisation peptide (+ phosphopeptide), which functioned to 
block the binding to phosphorylated hSSB1. The immunoblot was also probed for 
S345 phosphorylated and total Chk1, which functioned as a positive control for HU 
treatment, as well as for lambda phosphatase activity. Actin served as a loading 
control. Densitometry of pS134 hSSB1 bands was performed using ImageJ, 
normalised to FLAG, and expressed relative to untreated WT 3x FLAG hSSB1-
expressing cells. * = non-specific band. These results are representative of three 
independent experiments. 
 
(C) hSSB1 phosphorylation increases with up to 20 hours HU treatment. HeLa 
cells were transfected as per (A) and treated with 3 mM hydroxyurea (HU) for 4, 8, 
12, 16 or 20 hours, or left untreated and harvested. Whole cell lysates were prepared 
in RIPA buffer and 15 µg immunoblotted with antibodies against S134 
phosphorylated hSSB1, FLAG and actin. Blots were also probed for total and serine 
33 phosphorylated RPA32, which was used as a positive control. Densitometry of 
pS134 hSSB1 bands was performed as per (B). Phosphorylation of RPA32 is 
expressed as the relative ratio of the 34 kDa to 32 kDa RPA32 bands. These results 
are representative of three independent experiments 
 
(D and E) hSSB1 S134 phosphorylation is enhanced following treatment with 
aphidicolin or camptothecin. HeLa cells were transfected with WT or S134A 3x 
FLAG hSSB1, or a vector control, 24 hours prior to treatment of cells with 6 µg µl-1 
Aph for 4, 8, or 12 hours (E), or with 2 µM CPT for 4 hours (F). Whole cell lysates 
prepared from these cells were immunoblotted for S134 phosphorylated hSSB1, 
FLAG, S345 phosphorylated and total Chk1 (positive control) and actin (loading 
control). Densitometry of pS134 hSSB1 bands was performed as per (B). These 
results are representative of three independent experiments 
 
λPPase is a serine/threonine/tyrosine protein phosphatase and under such incubation 
conditions may remove phosphate groups from other proteins. These samples were 
then immunoblotted and probed with the pS134 hSSB1 antibody (Fig 4.3B). As 
depicted in Figure 4.3B, phosphorylated hSSB1 could not be detected in λPPase-
treated whole cell lysates from WT 3x FLAG hSSB1-expressing cells. As a third 
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specificity control, a pS134 antibody working solution was also prepared containing 
the phosphorylated immunisation peptide (Fig 4.3B; + phospho peptide). Inclusion 
of this peptide entirely blocked detection of WT 3x FLAG hSSB1 and further 
confirms specificity of this antibody for S134 phosphorylated hSSB1. By confirming 
specificity of the pS134 antibody for S134 phosphorylated hSSB1, these data also 
confirm the phosphorylation of this residue in cells.  
 
To further characterise the phosphorylation of hSSB1 S134 following replicative 
fork disruption, HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1 
were treated with 3 mM hydroxyurea for increasing time periods over 20 hours 
(treatments were staggered and cells harvested at the same time). Immunoblotting of 
whole cell lysates demonstrated a gradual increase in hSSB1 S134 phosphorylation 
over this time, increasing in intensity by over 3-fold (Fig 4.3C). Phosphorylation of 
serine 33 of the RPA 32 kDa subunit (pS33 RPA32) was also seen to increase over 
this time and functioned as a positive control for this assay. Interestingly, 
densitometry of hSSB1 S134 and RPA32 S33 demonstrated a comparable relative 
increase in phosphorylation over this time, indicating that these residues may be 
phosphorylated with similar kinetics.  
 
To further confirm that hSSB1 is phosphorylated at S134 in response to replication 
fork disruption, HeLa cells expressing 3x FLAG hSSB1 were treated with 6 µg µL-1 
of the polymerase α inhibitor aphidicolin (Aph) for 4, 8, and 12 hours. This 
treatment also resulted in a significant increase in hSSB1 S134 phosphorylation that 
continued for at least 12 hours (Fig 4.3D).  
 
Hydroxyurea and aphidicolin cause disruption to replication by inhibiting 
polymerase progression. In both instances, affected replication forks are rapidly 
stabilised by numerous DNA repair proteins whilst the cell attempts to re-initiate 
replication. Stalled replication forks are typically stable for at least 12-18 hours, 
before collapsing to form double-strand DNA breaks (Saintigny et al., 2001). In 
contrast to the fork disruption caused by hydroxyurea and aphidicolin, compounds 
that directly inhibit separation of the DNA strands ahead of the replisome cause the 
essentially immediate formation of double-strand DNA breaks (Saleh-Gohari et al., 
2005). To determine if hSSB1 is also phosphorylated following such stress, HeLa 
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cells transiently expressing 3x FLAG hSSB1 were treated with 2 µM of the DNA 
topoisomerase II inhibitor camptothecin for 4 hours. Whole cell lysates were then 
prepared and immunoblotted. In doing so, a marked increase in hSSB1 S134 
phosphorylation was observed that was comparable to 8 hours treatment with 3 mM 
hydroxyurea (Fig 4.3E). Together, these data support that hSSB1 is phosphorylated 
in response to genotoxic stress during replication. 
 
4.2.4 hSSB1 S134 phosphorylation is mediated by the DNA-dependent protein 
kinase 
As mentioned in previous sections, residue S134 of hSSB1 is a component of an SQ 
(serine-glutamine) motif. As these motifs frequently function as phosphorylation 
substrates of the PI3K-like kinases, ATM, ATR and DNA-PK (Liu et al., 2012), it 
was interesting to consider that one of these enzymes may be responsible for hSSB1 
S134 phosphorylation. Indeed, each of these kinases is known to function in the 
response to replication disruption (Liu et al., 2012). To determine if one of these 
kinases is responsible for hSSB1 S134 phosphorylation, HeLa cells transiently 
expressing 3x FLAG hSSB1 were pre-treated with chemical inhibitors against each 
of these kinases 30 min prior to addition of 3 mM hydroxyurea for 4 hours. Inhibitors 
were used at concentrations described in previous publications (Couch et al., 2013; 
Farber-Katz et al., 2014; Fujisawa et al., 2015; Gautam and Bridge, 2013). While a 
small decrease in hSSB1 phosphorylation was consistently observed following 
addition of KU-60019 and VE-821, inhibitors of ATM and ATR, respectively, an ~ 
90% reduction in both basal and HU-induced hSSB1 phosphorylation was observed 
by treatment of cells with the DNA-PK inhibitor NU7441 (Fig 4.4A and B).  
 
To further explore the role of ATM, ATR and DNA-PK in the phosphorylation of 
hSSB1 S134, each kinase was depleted from HeLa cells by double transfection with 
single-sequence siRNA. 3x FLAG hSSB1 was then transiently over-expressed in 
these cells for 24 hours prior to 4 h treatment with 3 mM HU. While Stealth siRNA 
was used for ATM and ATR depletion, Silencer Select siRNA was employed for 
depletion of the DNA-PK catalytic subunit (DNA-PKcs).  
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Figure 4.4 Phosphorylation of hSSB1 S134 is mediated by DNA-PK 
 
(A and B) hSSB1 S134 phosphorylation is suppressed by inhibition of ATM, 
ATR and DNA-PKcs. HeLa cells transiently expressing WT or S134A 3x FLAG 
hSSB1, or an empty vector, for 24 hours were pre-treated with 5 µM KU-60019 
(ATMi), 10 µM VE-821 (ATRi) or 5 µM NU7441 (DNA-PKi) for 30 min, or with 
DMSO, prior to treatment with 3 mM HU for 4 hours. (A) Whole cell lysates were 
then prepared and immunoblotted for phosphorylation of hSSB1 S134, FLAG, 
pS345 and total Chk1, and actin (loading control). Densitometry of pS134 hSSB1 
bands was performed using ImageJ, normalised to FLAG, and expressed relative to 
untreated WT 3x FLAG hSSB1-expressing cells. (B) Bar graph illustrating relative 
hSSB1 S134 phosphorylation from 3 independent repeats of (A). Data is graphed as 
the mean ± 1 standard deviation. t tests were used to compare phosphorylation of 
hSSB1 S134 for each inhibitor data set relative to DMSO lanes for each dose. ns = P 
> 0.05, * = P < 0.05, ** = P < 0.01, *** = P < 0.001, **** = P<0.0001. 
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(C) hSSB1 S134 phosphorylation is not suppressed by siRNA-depletion of ATM 
or ATR. HeLa cells were depleted of ATM or ATR by transfection of 50 nM siRNA 
twice, separated by 24 hours. The following day, cells were transiently transfected 
with plasmids encoding WT or S134A 3x FLAG hSSB1 for 24 hours. Cells were 
then treated with 3 mM HU for 4 hours, lysed and immunoblotted with antibodies 
against ATM, ATR, pS134 hSSB1, FLAG, pS345 and total Chk1, and actin (loading 
control). Densitometry of pS134 hSSB1 bands was performed using ImageJ, 
normalised to FLAG, and expressed relative to untreated control siRNA WT 3x 
FLAG hSSB1-expressing cells. These results are representative of three independent 
experiments. 
 
(D) hSSB1 S134 phosphorylation is strongly suppressed by siRNA-depletion of 
DNA-PKcs. DNA-PKcs was depleted from HeLa cells by double transfection with 
10 nM silencer select siRNA, prior to transient expression of WT or S134A 3x 
FLAG hSSB1, or an empty control, for 24 hours. Cells were then treated with 3 mM 
HU for 4 hours and whole cell lysates immunoblotted for phosphorylation of S134 
hSSB1, FLAG, pS345 and total Chk1, and actin (loading control). Densitometry of 
pS134 hSSB1 bands was performed as per (C). These results are representative of 
three independent experiments. 
 
(E) hSSB1 S134 is phosphorylated by DNA-PK in vitro. 500 ng of recombinant 
WT or S134A hexa-His-hSSB1 was incubated with 10 U of DNA-PKcs/Ku for 30 
mins at 30 oC with or without 100 µM ATP and 10 µg mL-1 sonicated salmon sperm 
DNA. Reactions were separated on a SDS-PAGE gel and either immunoblotted for 
hSSB1 S134 phosphorylation or stained with colloidal coomassie blue (shown in 
greyscale). These results are representative of three independent experiments. 
 
(F) hSSB1 associates with DNA-PKcs in cells before and after HU treatment. 
HeLa cells were treated with 3 mM HU, or mock treated, for 4 h. Whole cell lysates 
were then prepared and 500 µg incubated with protein G magnetic dynabeads bound 
to antibodies against hSSB1, or a sheep isotype control IgG, for 2 hours at 4 oC. 
Beads were washed and protein eluted by heating to 90 oC in SDS loading buffer for 
10 min. Eluent was immunoblotted for hSSB1 and DNA-PKcs. Whole cell lysates 
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were immunblotted with antibodies against hSSB1, DNA-PKcs, pS345 and total 
Chk1 and actin (loading control). These results are representative of three 
independent experiments. 
 
Immunoblotting of whole cell lysates from these experiments demonstrated that 
while ATM and ATR depletion did not suppress phosphorylation of hSSB1 S134 
(Fig 4.4C), basal and HU-induced phosphorylation was largely reduced in cell 
depleted of DNA-PKcs (Fig 4.4D). These data support that while ATM and ATR 
may have a role in the regulation of hSSB1 S134 phosphorylation, DNA-PK is most 
likely the major kinase involved in cells and may function both prior to and 
following replication fork disruption. 
 
To further determine whether DNA-PK may directly phosphorylate hSSB1 S134, an 
in vitro kinase assay using purified DNA-PK and recombinant hexa-His-hSSB1 was 
employed. For this assay, WT and S134A hexa-His hSSB1 was expressed and 
purified from Shuffle T7 Express E. coli. Recombinant hSSB1 was purified similarly 
to in Figure 4.2G and concentrations estimated on coomassie blue-stained SDS-
PAGE gels. Kinase assays were performed by incubating 500 ng of recombinant WT 
or S134A hexa-His hSSB1 with 10 U of DNA-PK for 30 mins at 30 oC +/- 100 µM 
ATP and 10 µg mL-1 sheared salmon sperm DNA. Immunoblotting of the reaction 
with the pS134 hSSB1 antibody demonstrated robust phosphorylation of WT, 
although not of S134A hexa-His hSSB1, which was substantially increased following 
stimulation of DNA-PK activity by the addition of ssDNA (Figure 4.4E).  
 
Although the data above suggests that DNA-PK may phosphorylate hSSB1 S134 in 
vitro, it remained important to ensure that DNA-PK may be spatially available to act 
on hSSB1 in cells. To test this, hSSB1 was immunoprecipitated from whole cell 
lysates of HeLa cells treated with +/- 3 mM hydroxyurea for 4 hours and 
immunoblotted for DNA-PKcs. In doing so, hSSB1 was found to associate with 
DNA-PKcs both before and following hydroxyurea treatment, suggesting that hSSB1 
and DNA-PK may form a complex independently of exogenous DNA damage. 
Indeed, these observations are consistent with the finding that DNA-PKcs depletion 
or inhibition reduces both hydoxyurea-induced and basal hSSB1 S134 
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phosphorylation. These findings provide evidence that hSSB1 is regulated by direct 
DNA-PK phosphorylation of S134, which is enhanced following replication fork 
disruption.  
 
4.2.5 hSSB1 S134 may not be phosphorylated in response to double-strand DNA 
break formation 
Previous work on hSSB1 has largely focussed on its potential role in the repair of 
double-strand DNA breaks by homologous recombination. Here, hSSB1 may be 
involved in the detection of ssDNA exposed as a result of break formation (Richard 
et al., 2008), as well as the subsequent recruitment and stimulation of the MRN 
nuclease complex (Richard et al., 2011b; Richard et al., 2011a). In addition, hSSB1 
may promote Exo1-mediated end-resection of the break (Yang et al., 2012), as well 
as the activation of cell cycle checkpoints (Richard et al., 2008). It was therefore of 
interest to determine whether hSSB1 S134 may also be phosphorylated in response 
to the formation of double-strand DNA breaks. To assess this, HeLa cells transiently 
expressing 3x FLAG hSSB1 were exposed to 6 Gy of ionising radiation to cause 
such breaks and then harvested 0.5, 1, 2, or 4 hours later. 4 h treatment with 3 mM 
hydroxyurea was used as an antibody control. Whole cell lysates were then prepared 
and immunoblotted for hSSB1 phosphorylation, as well as auto-phosphorylation of 
ATM 1981, a marker of double-strand DNA break formation (Figure 4.5A). While 
phosphorylation of ATM was observed following DNA damage, an increase in the 
phosphorylation of hSSB1 S134 comparable to that observed following 4h HU 
treatment was not detected at any time-point post-irradiation. These data indicate that 
hSSB1 S134 may not be phosphorylated during the homology-directed repair of 
double-strand DNA breaks.  
 
In addition to homologous recombination, a relatively rare pathway that occurs 
exclusively during S and G2 of the cell cycle, double-strand DNA breaks may also 
be repaired via the more frequently employed and cell cycle-wide process of non-
homologous end-joining (NHEJ) (Shrivastav et al., 2008). 
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Figure 4.5 hSSB1 S134 may not be phosphorylated in response to double-strand 
DNA-break formation 
 
(A) hSSB1 S134 may not be phosphorylated in response to double-strand DNA-
break formation. HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1 
for 24 hours were exposed to 6 Gy ionising radiation (IR) and harvested after 0.5, 1, 
2, or 4 hours. Alternatively, cells were treated with hydroxyurea (HU) for 4 hours 
and then harvested. Whole cell lysates were then prepared and 15 µg immunoblotted 
with antibodies against pS134 hSSB1 and FLAG, as well as pS1981 and total ATM 
(IR and HU positive control) and actin (loading control). Densitometry of pS134 
hSSB1 bands was performed using ImageJ, normalised to FLAG, and expressed 
relative to untreated WT 3x FLAG hSSB1-expressing cells. These results are 
representative of three independent experiments 
 
(B) hSSB1 S134 phosphorylation is not enhanced at short time-points after 
ionising radiation exposure. HeLa cells were transfected with WT or S134A 3x 
FLAG hSSB1 as per (A) and exposed to 6 Gy ionising radiation for 5, 15 or 30 
minutes. Cells were then harvested, lysed, and 15 µg of whole cell lysate 
immunoblotted with antibodies against pS134 hSSB1 and FLAG, as well as pT68 
and total Chk2 (positive control) and actin (loading control). Densitometry of pS134 
hSSB1 bands was performed as per (A). These results are representative of two 
independent experiments. 
 
(C) Expression of WT, S134A and T117A siRNA-resistant 3x FLAG hSSB1 in 
HeLa cells depleted of endogenous hSSB1. HeLa cells were depleted of 
endogenous hSSB1 by double transfection with siRNA. Cells were then transfected 
with WT or S134A siRNA-resistant 3x FLAG hSSB1, or an empty plasmid, 6 hours 
prior to seeding into wells of a 6-well plate at a density of 400 cells per well. 
Remaining cells were grown for an additional 24 hours and lysed in RIPA buffer. 15 
µg of whole cell lysate was immunoblotted and probed with antibodies against 
hSSB1, FLAG and actin. This figure is representative of each repeat shown in (D). 
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(D and E) Cells expressing S134A or T117A hSSB1 are hypersensitive to 
ionising radiation (IR). The cells plated in (C) were incubated for 24 hours and 
treated with 1, 2, 4 or 6 Gy ionising radiation (IR). Three technical repeats were 
performed for each. Cells were grown for 10 days prior to staining of colonies with 
methylene blue. Colonies were manually counted and counts normalised to untreated 
cells. Data is graphed as the mean ± 1 standard deviation from 3 independent 
experiments (D). t tests were used to compare the ‘sihSSB1 + WT hSSB1’ and 
“sihSSB1 + mutant hSSB1’ datasets at each dose. ns = P > 0.05, * = P < 0.05, ** = P 
< 0.01, *** = P < 0.001 (E). 
 
Furthermore, whilst DNA-PK may have roles in the negative regulation of 
homologous recombination (Zhou & Paull, 2013), it is mostly associated with repair 
by NHEJ (Bekker-Jensen and Mailand, 2010; Zhou and Paull, 2013). Although a role 
for hSSB1 in this process has not been directly assessed, numerous data have 
indirectly implied its involvement. These include: 1) hSSB1 forms distinct nuclear 
foci in 95% of cells within 30 minutes of exposure to ionising radiation, presumably 
at sites of double-strand DNA breaks (Richard et al., 2008). This percentage is 
considerably higher than would be expected if foci formation were restricted to S and 
G2 phase cells. 2) hSSB1 is required for the fast repair of double-strand DNA breaks 
in cells synchronised in G1 by a double thymidine block (Zhang et al., 2014). It is 
therefore interesting to consider that while hSSB1 S134 may not be phosphorylated 
during homologous recombination, it may be during non-homologous end joining.  
 
Whilst the time-points assessed in Figure 4.5A are appropriate for homologous 
recombination repair, which requires ~ 7 hours, non-homologous end joining will 
typically conclude within 10-30 minutes of double-strand DNA break formation 
(Mao et al., 2008b). It is therefore possible that hSSB1 is phosphorylated and 
dephosphorylated within the time-points assessed. To determine whether S134 may 
be phosphorylated at earlier time-points post ionising radiation exposure, HeLa cells 
transiently expressing 3x FLAG hSSB1 were irradiated and harvested after 5, 15 or 
30 minutes. Whole cell lysates prepared from these cells were then immunoblotted 
for S134 phosphorylation (Figure 4.5B). In this instance, phosphorylation of Chk2 
T68 was used as a DNA damage positive control (Ward et al., 2001). While Chk2 
phosphorylation was detected within 5 minutes of ionising radiation exposure, a 
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change in hSSB1 S134 phosphorylation was not observed. These data suggest that 
phosphorylation of hSSB1 S134 may not be enhanced following double-strand DNA 
break exposure. 
 
Based on these observations it seemed reasonable that while phosphorylation of 
hSSB1 S134 may be required for the response to replication inhibition, it may be 
dispensable following double-strand DNA break formation. Furthermore, it is 
tempting to speculate that S134 and T117 phosphorylation may be differentially 
required - S134 phosphorylation during S phase disruption and T117 
phosphorylation in the response to double-strand DNA breaks. To confirm that S134 
is not required following ionising radiation exposure, cells were depleted of 
endogenous hSSB1 as described previously (Section 4.2.2) and then transiently 
expressed with WT, S134A or T117A siRNA-resistant 3x FLAG hSSB1 (Figure 
4.5C). Cells were then seeded into wells of a 6-well plate and after 24 hours exposed 
to 1, 2, 4 or 6 Gy of ionising radiation. After 10 days, cells were stained with 
methylene blue and the surviving fraction of cells at each dose calculated relative to 
the survival of untreated cells (Figure 4.5D and E). Consistent with previous data, a 
statistically significant decrease in cell survival was observed at all doses for hSSB1-
depleted cells relative to control cells (Ren et al., 2014; Richard et al., 2008). 
Surprisingly, while WT 3x FLAG hSSB1 was able to rescue the sensitivity 
associated with hSSB1 depletion, cells expressing S134A or T117A 3x FLAG 
hSSB1 phenocopied the hSSB1 knock down cells. Indeed, a statistically significant 
reduction in the relative surviving fraction of cells was observed at multiple doses 
when compared to WT. These data may suggest that hSSB1 S134 phosphorylation is 
required for the response to double-strand DNA breaks, despite the lack of additional 
S134 phosphorylation observed under such conditions.  
 
4.2.6 S134 hSSB1 is suppressed by PPP-family protein phosphatases 
In undamaged cells, several DNA repair proteins, including Chk1 and ATM are 
maintained in a hypo-phosphorylated state through the function of PPP-family 
serine/threonine phosphatases (protein phosphatases (PP) 1, 2A, 4, 5, 6) (Goodarzi et 
al., 2004; Leung-Pineda et al., 2006). As data presented in earlier sections suggests 
that hSSB1 S134 may be partially phosphorylated in undamaged cells and then 
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enhanced following replication stress, we reasoned that steady-state hSSB1 
phosphorylation might also be subject to enzymatic suppression. To determine 
whether hSSB1 S134 may be de-phosphorylated by one of these phosphatases, HeLa 
cells were transiently transfected with WT or S134A 3x FLAG hSSB1 24 hours prior 
to treatment with 3 mM hydroxyurea for 4 hours. Thirty minutes before harvesting, 
cells were additionally treated with the PPP-family phosphatase inhibitors okadaic 
acid and calycurin A (Figure 4.6A). Whole cells lysates were then prepared and 
immunoblotted for hSSB1 S134 phosphorylation (Figure 4.6B).  
 
Okadaic acid (OA) was used either at 25 nM or 1 µM. 25 nM was chosen to cause 
‘low-level’ of inhibition of PP2A (~10%) (Goodarzi et al., 2004), as well as, by 
similarity, of PP4 and PP6 (Prickett and Brautigan, 2006; Swingle et al., 2007). 1 µM 
of okadaic acid was then chosen as a dose that has been reported to inhibit PP2A, as 
well as presumably PP4 and PP6, by close to 100% (Goodarzi et al., 2004; Swingle 
et al., 2007). Such assumptions are based on the high sequence similarity of PP2A, 
PP4 and PP6 which together constitute the type 2 family of PPP-family phosphatases 
(Andreeva and Kutuzov, 2001). Indeed, whilst okadaic acid inhibition of PP6 has not 
been reported to date, almost identical IC50 values have been reported for inhibition 
of PP2A and PP4 by okadaic acid in vitro (Honkanen and Golden, 2002). As PP1 is 
much less sensitive to okadaic acid inhibition than PP2A (PP1 IC50 = ~ 10 nM, PP2A 
IC50 = ~ 0.1 nM (Obara and Yabu, 1993)), a concentration of 25 nM is unlikely to 
cause any substantial inhibition in cells, while 1 µM is expected to inhibit PP1 by ~ 
15% (Resjö et al., 2002). Although relatively uncharacterised, the intermediate 
sensitivity of PP5 to okadaic acid (IC50 = 3.5 nM) (Swingle et al., 2007) indicates 
this enzyme is likely to be less efficiently inhibited by okadaic acid in cells than 
PP2A, PP4 or PP6, although more so than PP1. By contrast, 50 nM of calyculin A 
(CA) was chosen as a concentration that should inhibit PP1, PP2A, PP4, PP5 and 
PP6 by at least 70% (Favre et al., 1997; Swingle et al., 2007). At the concentrations 
used, neither okadaic acid nor calcylculin A are known to inhibit PP2B, PP2C, PP7 
or any other protein phosphatases to a detectable degree (Swingle et al., 2007). 
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Figure 4.6 hSSB1 is dephosphorylated by PPP-family protein phosphatases 
 
(A) Okadaic acid and calyculin A are inhibitors of PPP-family protein 
phosphatases. A table illustrating the previously reported inhibition of PP1, PP2A, 
PP4, PP5 and PP6 by the doses of okadaic acid and calyculin A used in Figure 4.6B 
(Goodarzi et al., 2004; Honkanen and Golden, 2002; Prickett and Brautigan, 2006; 
Swingle et al., 2007). 
 
(B) hSSB1 S134 phosphorylation is enhanced by inhibition of PPP-family 
protein phosphatases. HeLa cells transiently expressing WT or S134A 3x FLAG 
hSSB1, or an empty vector, for 24 hours, were treated with 3 mM HU for 3.5 hours 
prior to addition of 25 nM okadaic acid (OA), 1 µM OA, or 50 nM calyculin A (CA) 
for 30 minutes. Whole cell lysates were prepared and 15 µg immunoblotted for 
phosphorylation of S134 hSSB1, FLAG, pS345 and total Chk1 (HU positive control) 
and actin (loading control). Densitometry of pS134 hSSB1 bands was performed 
using ImageJ, normalised to FLAG, and expressed relative to untreated WT 3x 
FLAG hSSB1-expressing cells. These results are representative of three independent 
experiments. 
 
(C) hSSB1 S134 is phosphorylated within 5 minutes of phosphatase inhibition. 
HeLa cells transiently expressing WT or S134A 3x FLAG hSSB1, or an empty 
vector, for 24 hours were treated with 50 nM calyculin A (CA) for 5, 10, 20 or 30 
minutes. Cells were then harvested and 15 µg of whole cell lysate immunoblotted 
with antibodies against pS134 hSSB1, FLAG and actin (loading control). 
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Densitometry of pS134 hSSB1 bands was performed as per (B). These results are 
representative of three independent experiments. 
 
(D) DNA-PKi suppresses CA-enhanced hSSB1 S134 phosphorylation. HeLa cells 
transiently expressing WT or S134A 3x FLAG hSSB1, or an empty vector, for 24 
hours, were treated 5 µM of NU7441 (DNA-PKi) for 10 minutes and then with 50 
nM calyculin A (CA) for an additional 30 minutes. Cells were then harvested and 15 
µg of whole cell lysate immunoblotted with antibodies against pS134 hSSB1, FLAG 
and actin (loading control). Densitometry of pS134 hSSB1 bands was performed as 
per (B). These results are representative of three independent experiments. 
 
(E) hSSB1 associates with the catalytic subunit of PP2A in cells. HeLa cells were 
treated with 3 mM HU, or mock treated, for 4 h. Whole cell lysates were then 
prepared and 500 µg incubated with protein G magnetic dynabeads bound to 
antibodies against hSSB1, or a sheep isotype control IgG, for 2 hours at 4 oC. Beads 
were washed and protein eluted by heating to 90 oC in SDS loading buffer for 10 
min. Eluent was immunoblotted for hSSB1 and PP2A-C. 15 µg whole cell lysate 
(input) was immunoblotted with antibodies against hSSB1, PP2A-C, pS345 and total 
Chk1 and actin (loading control). These results are representative of three 
independent experiments. 
 
Strikingly, the treatment of undamaged cells with 1 µM OA or 50 nM CA led to an 
increase in hSSB1 S134 phosphorylation of greater than 5- and 8-fold, respectively, 
which was further increased in cells treated with hydroxyurea (Figure 4.6B). Indeed, 
a comparably small although consistent increase in S134 phosphorylation was 
observed even following 10% inhibition of PP2A, PP4 and PP6 with 25 nM of 
okadaic acid. Consistent with previous data, the treatment of cells with 1 µM okadaic 
acid or 50 nM calcyulin A, compounds that inhibit PP1, caused a substantial increase 
in Chk1 S345 phosphorylation even in non-hydroxyurea treated cells (Leung-Pineda 
et al., 2006). To further investigate the rapidity by which the phosphatase inhibitors 
increase hSSB1 S134 phosphorylation, cells transiently expressing WT or S134A 3x 
FLAG hSSB1 were treated with 50 nM calyculin A for 5, 10, 20 or 30 minutes prior 
to preparation of whole cell lysates and immunoblotting for hSSB1 S134 
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phosphorylation. In doing so, an increase in hSSB1 S134 phosphorylation of ~ 5 fold 
was observed within 5 minutes of 50 nM calyculin treatment (Figure 4.6C). These 
finding are particularly striking when it is considered that an increase of only 3.3 fold 
was observed even after 20 hour of hydroxyurea treatment (Figure 4.3D). Together, 
these data suggest that hSSB1 S134 phosphorylation may be dynamically 
phosphorylated although largely supressed in undamaged cells, most likely by PPP-
family protein phosphatases. 
 
The inhibition of DNA-PK for 4.5 hours (Figure 4.4 A and B) or the depletion of the 
DNA-PK catalytic subunit (Figure 4.4 D), was found in section 4.2.4 to reduce 
hSSB1 S134 phosphorylation by 80-90%, suggesting that this kinase may 
phosphorylate hSSB1 even in undamaged cells. Indeed, hSSB1 was found to 
immunoprecipitate DNA-PKcs even prior to hydroxyurea treatment (Figure 4.4F). It 
is therefore tempting to speculate that DNA-PK may mediate the increase in S134 
phosphorylation observed following PPP-family phosphatase inhibition. By means of 
assessing this, cells transiently expressing WT or S134A 3x FLAG hSSB1 were 
treated with 5 µM of the DNA-PK inhibitor NU7441 for 15 minutes prior to addition 
of 50 nM calyculin A for 30 minutes. Whole cell lysates were then immunoblotted 
for hSSB1 S134 phosphorylation (Figure 4.6D). Consistent with the observations of 
section 4.2.4, the co-inhibition of DNA-PK and PPP-family phosphatases markedly 
reduced calyculin A-induced S134 phosphorylation by ~ 50% (10.2-fold increase vs. 
3-fold). These results do however suggest that while DNA-PK is likely the major 
hSSB1 S134 kinase in cells, other kinases may have additional ancillary roles.  
 
Although the increase in hSSB1 S134 phosphorylation observed following treatment 
with okadaic acid or calyculin A suggests the involvement of PPP-family protein 
phosphatases in the dephosphorylation of hSSB1, it remains unclear which member 
is directly involved. The availability of an antibody against the catalytic subunit of 
PP2A (PP2A-C) however enabled the enquiry of whether hSSB1 may associate with 
this enzyme in cells. Indeed, PP2A has also been suggested to dephosphorylate the 
DNA repair proteins RPA32 (Feng et al., 2009) and H2A.X (Chowdhury et al., 
2005), suggesting this enzyme is a reasonable candidate. To assess this, hSSB1 was 
immunoprecipitated from HeLa whole cell lysates treated +/- 3 mM HU for 4 hours 
and immunoblotted for PP2A-C and hSSB1 (Figure 4.6E). In doing so, PP2A-C was 
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found to co-immunoprecipitate with hSSB1, although not with a control isotype IgG. 
These findings provide evidence that hSSB1 may associate with PP2A in cells, 
potentially suggesting the involvement of this enzyme in hSSB1 S134 
dephosphorylation. 
 
4.2.7 Enzymatic regulation of hSSB1 phosphorylation is mediated similarly in 
HeLa and U-2 OS cells 
In the preceding chapter, 3x FLAG hSSB1 was transiently expressed in HEK293T 
cells for 24 hours, immunoprecipitated using anti-FLAG beads, and analysed by LC-
MS/MS. By doing so, numerous peptides were detected which may correspond to 
hSSB1 phosphorylated at various residues. This included the detection of peptides 
that may be phosphorylated at hSSB1 S134 and prompted the preparation of the 
S134 phospho-specific antibody that has been used in this chapter. Although 
HEK293T cells had been utilised for the isolation of hSSB1 for mass spectrometry, 
largely due to the high protein yield obtainable from these cells, HeLa cells were 
used for immunodetection experiments. These cells were employed due to their 
status as a major model cell line for DNA repair research. HeLa cells do however 
exhibit substantial genomic and transcriptomic differences when compared to normal 
human tissues, including high levels of aneuploidy and genomic rearrangements, as 
well as gene expression profiles differences in pathways including DNA repair and 
cell cycle maintenance (Landry et al., 2013). It was therefore possible that hSSB1 
may be uniquely regulated in this cell line. Due to these concerns, it was deemed 
appropriate that a second cell line should be used to reassess the enzymatic 
regulation of hSSB1 S134 phosphorylation.  
 
U-2 OS are an additional cell line model that has been extensively employed for the 
characterisation of DNA repair mechanisms. Indeed, whilst these cells are also 
aneuploid and contain numerous chromosomal rearrangements, deletions and 
duplications, they are not known to contain mutations in the core DNA repair 
pathways (Akan et al., 2012; Conery and Harlow, 2010). These cells were therefore 
chosen for the further assessment of hSSB1 S134 phosphorylation.   
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To test the occurrence and HU-stimulation of hSSB1 S134 phosphorylation in U-2 
OS cells, as well as the involvement of DNA-PK, U-2 OS cells were initially 
depleted of DNA-PKcs using siRNA. WT or S134A 3x FLAG hSSB1 was then over-
expressed and cells treated with 3 mM HU for 4 hours. Whole cell lysates were then 
prepared and immunoblotted (Figure 4.7A). Here, an increase in hSSB1 S134 
phosphorylation was observed following HU treatment, albeit to a milder degree than 
observed in HeLa cells (~ 20 – 30 % in U-2 OS cells vs. 40 – 50% in HeLa cells after 
4h treatment). The depletion of DNA-PKcs was also found to reduce hSSB1 
phosphorylation by ~ 80 - 90% prior to and following HU treatment. These data 
support a major role for DNA-PK in the phosphorylation of hSSB1 S134 
phosphorylation and suggest this modification is not limited to the HeLa cell line. It 
was interesting to note that, similarly to phosphorylation of hSSB1, a less striking 
increase in Chk1 S345 phosphorylation was also observed in U-2 OS cells, in 
comparison to in HeLa cells (e.g. Figure 4.3), following HU treatment. Although an 
explanation for these discrepancies is not immediately apparent, U-2 OS cells were 
observed to proliferate at a lower rate than HeLa cells in culture. It therefore seems 
reasonable to consider that a less robust response to replication inhibition may occur 
in U-2 OS cells, simply due to a lower proliferative rate.  
 
Another interesting observation from Figure 4.7A was the reduction in Chk1 protein 
levels, as well as HU-induced Chk1 S345 phosphorylation, observed in U-2 OS cells 
depleted of DNA-PKcs. Indeed, whilst DNA-PK has previously been reported to 
promote Chk1 stability and HU-induced phosphorylation (Lin et al., 2014), a 
comparably striking effect on Chk1 was not observed following depletion of DNA-
PKcs from HeLa cells in Figure 4.4D. These findings may represent variations in the 
regulation of Chk1 in U-2 OS cells compared to HeLa cells.  
 
An increase in S134 phosphorylation was also observed in HeLa cells treated with 
the PPP-family phosphatase inhibitor, calyculin A, which was suppressed by co-
treatment with the DNA-PK inhibitor NU7441. It was therefore of interest to 
determine whether these inhibitors would also affect hSSB1 S134 phosphorylation in 
U-2 OS cells. 
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Figure 4.7 Enzymatic regulation of hSSB1 phosphorylation is mediated 
similarly in HeLa and U-2 OS cells 
 
(A) DNA-PK depletion suppresses phosphorylation of hSSB1 S134 in U-2 OS 
cells. U-2 OS cells were transfected with 10 nM of siRNA targeting the DNA-PKcs 
transcript, or with a control siRNA sequence, twice, separated by 24 hours. WT or 
S134A 3x FLAG hSSB1 was then expressed for 24 hours, prior to treatment of cells 
with 3 mM HU for 4 hours. Whole cell lysates prepared from these cells were then 
immunoblotted with antibodies against DNA-PKcs pS134 hSSB1, FLAG, pS345 or 
total CHK1, or actin (loading control). Densitometry of pS134 hSSB1 bands was 
performed using ImageJ, normalised to FLAG, and expressed relative to untreated 
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WT 3x FLAG hSSB1-expressing cells. Data is representative of two independent 
repeats. 
 
(B) hSSB1 S134 phosphorylation is enhanced by HU treatment or inhibition of 
PPP-family protein phosphatases, and suppressed by DNA-PK inhibition, in   
U-2 OS cells. WT or S134A 3x FLAG hSSB1, or an empty vector control, was 
transiently expressed in U-2 OS cells for 24 hours. Cells then treated either with 5 
µM NU7441, or DMSO, for 30 minutes, prior to addition of 3 mM HU, or mock-
treatment, for 3.5 hours. Cells were then treated with 50 nM calyculin A, or DMSO, 
for 30 minutes. Whole cell lysates were then prepared and immunoblotted with 
antibodies against pS134 hSSB1, FLAG, pS345 or total CHK1, or actin (loading 
control). Densitometry of pS134 hSSB1 bands was performed as per (A). Data is 
representative of three independent repeats. 
 
To test this, plasmids encoding WT or S134A 3x FLAG hSSB1 were transfected into 
U-2 OS cells, and then 24 hours later, cells treated either with 5 µM of the DNA-PK 
inhibitor NU7441 or with DMSO, 30 minutes prior to treatment with 3 mM 
hydroxyurea or mock-treatment. In the final 30 minutes of the HU treatment, cells 
were also treated with 50 nM calyculin A, or DMSO. Whole cell lysates were then 
prepared from these cells and immunoblotted for hSSB1 S134 phosphorylation, as 
well as for phosphorylation of CHK1 S345 (Figure 4.7B). As per HeLa cells, the 
inhibition of DNA-PK substantially reduced phosphorylation of hSSB1 S134 in both 
damaged and undamaged cells. This was, however, to a smaller degree than observed 
in HeLa cells. The treatment of U-2 OS cells with calyculin A (CA) also caused an 
increase in S134 phosphorylation of ~ 6-fold, (compared to ~ 10-fold in HeLa cells), 
which was enhanced following HU treatment. CA-induced hSSB1 S134 
phosphorylation was also detectably suppressed by addition of the DNA-PK inhibitor 
by ~ 20% (compared to ~ 50% in HeLa cells). These data support that hSSB1 S134 
phosphorylation is suppressed in U2-OS cells by PPP-family phosphatases. Although 
the DNA-PK inhibitor was not as efficacious in preventing hSSB1 phosphorylation 
in U-2 OS, compared to in HeLa cells, these discrepancies most likely represent 
pharmacogenetic differences between these cell lines. For instance, while 5 µM of 
NU7441 may be sufficient to inhibit DNA-PK in HeLa cells, higher doses may be 
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required in the U-2 OS cell line. This explanation is supported by the almost 
complete suppression of S134 phosphorylation in U-2 OS cells depleted of DNA-
PKcs (and which therefore largely lacked active DNA-PK) (Figure 4.7A). 
 
The data above therefore support that in U-2 OS cells, as in HeLa cells, hSSB1 is 
phosphorylated at S134, predominantly by DNA-PK and that this modification is 
enhanced following replication inhibition. Phosphorylation of hSSB1 in U-2 OS is 
also stimulated by the inhibition of PPP-family protein phosphatases. Together, these 
data suggest that this mechanism of hSSB1 regulation is likely broadly employed 
amongst cell lines. 
 
4.2.8 hSSB1 may be phosphorylated at S134 independently of PAR- or DNA-
binding 
The observation that hSSB1 S134 is phosphorylated in response to replication 
inhibition by DNA-PK may indicate that phosphorylation occurs directly at sites of 
fork disruption. Indeed, as hSSB1 has been suggested to associate with such lesions 
in cells (Bolderson et al., 2014), it is interesting to consider that phosphorylation may 
occur subsequently to hSSB1-fork binding. Recently, hSSB1 was found to bind 
poly(ADP-ribose) (PAR) in vitro, an action which may be required for the efficient 
recruitment of hSSB1 to sites of double-strand DNA breaks (Zhang et al., 2014). 
Although it remains unclear whether hSSB1 also binds to PAR substrates at sites of 
stalled replication forks, PAR binding is known to stimulate the recruitment of other 
proteins that facilitate DNA repair, including Chk1 (Min et al., 2013). As numerous 
hSSB1 PAR-binding mutants have recently been described (WD55AA that does not 
bind PAR, as well as VL23AA and TG47AA which do not bind PAR and INTS3) 
(Zhang et al., 2014) it was therefore envisaged that these mutants could be used to 
assess the requirement of PAR-binding for hSSB1 phosphorylation. VL23AA, 
TG47AA and WD55AA 3x FLAG hSSB1 were therefore prepared by site-directed 
mutagenesis and transiently expressed in HeLa cells alongside WT or S134A hSSB1. 
Cells were then treated with 3 mM hydroxyurea for 4 hours and whole cell lysates 
immunoblotted for hSSB1 S134 phosphorylation (Figure 4.8A). Only minimal 
differences in hSSB1 S134 phosphorylation were however observed for any of the 
PAR-binding mutants when compared to phosphorylation of the WT protein. These 
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data suggest that PAR-binding may not be essential for hSSB1 S134 phosphorylation 
in response to replication inhibition. 
 
Despite the above observations, it is likely that hSSB1 may also bind to single-
stranded DNA exposed by replication inhibition and that this binding may instead be 
required for hSSB1 S134 phosphorylation. The recently solved crystal structure of 
hSSB1 in complex with INTS3 illustrates that numerous aromatic residues in the 
OB-fold (W55, Y74, F78, Y85) may be predominantly responsible for hSSB1-DNA 
binding (Ren et al., 2014). Indeed, individual mutation of each of these residues was 
demonstrated to largely reduce binding to a dT48 oligonucleotide in vitro. The 
requirement of these residues for DNA-binding has also been supported by similar 
assays performed using murine SSB1 (mSSB1) (Gu et al., 2013). Here, mSSB1 
aromatic mutants were additionally unable to recapitulate ionising radiation-induced 
DNA repair signalling following mSSB1 depletion. Given that a similar requirement 
for these residues could be demonstrated with hSSB1, it therefore seemed reasonable 
that such constructs could be used to assess the importance of DNA-binding for 
hSSB1 S134 phosphorylation.  
 
Firstly, to determine the requirement of the hSSB1 OB-fold aromatic residues for 
hSSB1 function, siRNA resistant 3x FLAG hSSB1 constructs were prepared where 
W55, Y74, F78 or Y85 were individually mutated to alanine. Clonogenic assays 
were then performed by depletion of endogenous hSSB1 as in Section 4.2.2, 
followed by transient expression of each mutant construct (Figure 4.8B). Cells were 
then seeded into wells of a 6-well plate and after 24 hours exposed to 1, 2, 4 or 6 Gy 
of ionising radiation. After 10 days, cells were stained with methylene blue and the 
surviving fraction of cells at each dose calculated relative to the survival of untreated 
cells (Figure 4.8C and D). Ionising radiation was used as the DNA damaging agent 
as this is most relevant to existing hSSB1 literature and is most comparable to 
previous work with mSSB1. As per figure 4.5D, cells depleted of hSSB1 were 
hypersensitive to ionising radiation, which could be rescued by transient expression 
of the WT protein. Cells expressing any of the OB-fold aromatic residue mutants 
were however comparably sensitive to hSSB1-depleted cells. Indeed, a statistically 
significant difference in surviving fraction was calculated between each mutant and 
the WT protein at multiple doses.  
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Figure 4.8 hSSB1 may be phosphorylated independently of PAR- or DNA-
binding 
 
(A) hSSB1 S134 phosphorylation may not require PAR- binding. VL23AA, 
TG47AA and WD55AA hSSB1 mutations were introduced into the 3x FLAG hSSB1 
construct by site-directed mutagenesis. Each mutant has previously been described to 
diminish PAR-binding, while VL23AA and TG47AA have also been demonstrated 
not to bind INTS3 (Zhang et al., 2014). HeLa cells expressing each mutant, WT 
hSSB1 or an empty control vector for 24 hours were treated with 3 mM HU for 4 
hours. Whole cell lysates were then prepared and immunoblotted for pS134 hSSB1, 
FLAG, pS345 and total Chk1 and actin (loading control). Densitometry of pS134 
hSSB1 bands was performed using ImageJ, normalised to FLAG, and expressed 
relative to untreated WT 3x FLAG hSSB1-expressing cells. These results are 
representative of two independent experiments. 
 
(B) Expression of hSSB1 DNA-binding mutants in HeLa cells depleted of 
endogenous hSSB1. HeLa cells were depleted of endogenous hSSB1 by double 
transfection with siRNA. Cells were then transfected with WT, W55A, Y74A, F78A 
or Y85A siRNA-resistant 3x FLAG hSSB1, or an empty plasmid, 6 hours prior to 
seeding into wells of a 6-well plate at a density of 400 cells per well. Remaining cells 
were grown for an additional 24 hours and lysed in RIPA buffer. Whole cell lysate 
(15 µg) was immunoblotted and probed with antibodies against hSSB1, FLAG and 
actin. This figure is representative of each repeat in (C). 
 
(C and D) Cells expressing hSSB1 DNA-binding mutants are hypersensitive to 
ionising radiation (IR). The cells plated in (C) were incubated for 24 hours and 
treated with 1, 2, 4 or 6 Gy ionising radiation (IR). Three technical repeats were 
performed per dose. Cells were grown for 10 days prior to staining of colonies with 
methylene blue. Colonies were manually counted and normalised to untreated cells. 
Data is graphed as the mean ± 1 standard deviation from 3 independent experiments 
(D) t tests were used to compare the ‘sihSSB1 + WT hSSB1’ and “sihSSB1 + mutant 
hSSB1’ datasets at each dose. ns = P > 0.05, * = P < 0.05, ** = P < 0.01, *** = P < 
0.001. 
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(E) hSSB1 S134 phosphorylation may not require DNA-binding. Site-directed 
mutagenesis was used to create a 3x FLAG hSSB1 construct lacking each DNA-
binding aromatic residue (4-OB-A). HeLa cells expressing this mutant, WT hSSB1 
or an empty control vector for 24 hours were treated with 3 mM HU for 4 hours. 
Whole cell lysates were then prepared and immunoblotted for pS134 hSSB1, FLAG, 
pS345 and total Chk1 and actin (loading control). Densitometry of pS134 hSSB1 
bands was performed as per (A). These results are representative of two independent 
experiments 
 
These findings suggest that W55, Y74, F78 and Y85 may be required for hSSB1 
function in cells, presumably by facilitating DNA binding. 
 
Although the data above suggests that each OB aromatic residue is important for 
hSSB1 function, it should be noted that in vitro, some residual DNA binding of each 
mutant to DNA is still observed (which may or may not be physiologically relevant) 
(Ren et al., 2014). To ensure the full disruption of hSSB1 DNA-binding, a quadruple 
mutant was therefore prepared where each of the established DNA-binding aromatic 
residues was mutated to alanine and this construct used to assess S134 
phosphorylation in response to hydroxyurea treatment. For this, HeLa cells 
expressing WT or 4-OB-A hSSB1 were treated with 3 mM hydroxyurea for 4 hours 
and then whole cell lysates immunoblotted for hSSB1 S134 phosphorylation (Figure 
4.8E). Similarly to the PAR-binding mutants, only a minimal decrease in hSSB1 
S134 phosphorylation was however observed for the OB-fold quadruple mutant, 
suggesting that DNA-binding also may not be required for phosphorylation of hSSB1 
S134. 
 
4.2.9 hSSB1-INTS3 binding promotes clonogenic survival of cells in response to 
replication stress  
Numerous reports have suggested that hSSB1 may associate with INTS3 and SOSS-
C in cells to form a complex referred to as SOSS1 (Li et al., 2009b; Skaar et al., 
2009; Zhang et al., 2009; Zhang et al., 2013). Here, INTS3 directly interacts with the 
hSSB1 OB-fold on the opposing surface to the DNA-binding groove such that 
hSSB1 may bind ssDNA and INTS3 simultaneously. In addition to binding hSSB1, 
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INTS3 also directly interacts with SOSS-C (Ren et al., 2014). Although the precise 
function of the INTS3 complex remains unclear, it is likely that INTS3 is required 
for the full activity of hSSB1 in the repair of double-strand DNA breaks. Indeed, 
hSSB1 INTS3-binding mutants seem unable to rescue the hypersensitivity to ionising 
radiation caused by hSSB1 depletion (Ren et al., 2014). As INTS3 has been found to 
co-localise with hSSB1 following hydroxyurea treatment (Bolderson et al., 2014), it 
is therefore interesting to consider whether INTS3-binding may also be required for 
hSSB1 function following replication inhibition. 
 
Although the VL23AA and TG47AA hSSB1 mutants used in section 4.2.7 have been 
described not to bind INTS3, PAR-binding for these proteins was also diminished 
(Zhang et al., 2014). Helpfully, the recently solved crystal structure of hSSB1 
demonstrated that the OB-fold residues E97, F98 and E104 are predominantly 
responsible for INTS3 binding. Furthermore, mutation of these residues was 
demonstrated to disrupt this interaction (Ren et al., 2014). To validate this directly, 
E97, F98 and E104 of the WT 3x FLAG hSSB1 construct were individually mutated 
to alanine and these constructs, as well as WT and S134A hSSB1, expressed in HeLa 
cells. After 24 hours, cells were lysed and FLAG-tagged proteins 
immunoprecipitated with magnetic M2 anti-FLAG beads. Immunoprecipitated 
proteins were then separated by gel electrophoresis and immunoblotted for FLAG 
and INTS3 (Figure 4.9A). By doing so, INTS3 was immunoprecipitated in cells 
expressing WT hSSB1, although not in those transfected with an empty control 
plasmid. Of the hSSB1 mutants expressed, INTS3-association was undetectable for 
the F98A mutant and markedly reduced for E104A 3x FLAG hSSB1. By contrast, 
however, only a barely detectable decrease in INTS3 association was observed for 
E97A hSSB1. These results are largely consistent with previous findings, where 
hSSB1-INTS3 binding was predominantly disrupted by F98A and E104A mutation 
and partially by mutation of E97 (Ren et al., 2014). As the greatest reduction in 
INTS3-binding was however observed with the F98A hSSB1 mutant, this construct 
was used in subsequent experiments. It is also worth noting that in this assay, INTS3 
was immunoprecipitated with S134A 3x FLAG hSSB1 similarly to that seen with 
WT, suggesting that S134 phosphorylation is not required for INTS3 binding. 
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Figure 4.9 hSSB1-INTS3-binding promotes clonogenic survival of cells in 
response to replication stress, although may not be required for S134 
phosphorylation  
 
(A) F98 is required for hSSB1-INTS3 association in cells. Site-directed 
mutagenesis was used to individually mutate hSSB1 E97, F98A and E104A of the 3x 
FLAG hSSB1 construct to alanine residues. HeLa cells were transiently transfected 
with WT, E97A, F98A, E104A or S134A 3x FLAG hSSB1, or an empty control 
plasmid, and incubated for a further 24 hours. Cells were then harvested and 500 µg 
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of whole cell lysate incubated with M2 FLAG magnetic beads for 2 hours at 4 oC. 
Beads were then washed and protein elutated by heating to 90 oC for 10 minutes in 
SDS loading buffer. Eluent was immunoblotted with antibodies against FLAG and 
INTS3. These results are representative of three independent experiments. 
 
(B) Expression of F98A hSSB1 in HeLa cells depleted of endogenous hSSB1. 
HeLa cells were depleted of endogenous hSSB1 by double transfection with siRNA. 
Cells were then transfected with WT or F98A siRNA-resistant 3x FLAG hSSB1, or 
an empty plasmid, 6 hours prior to seeding into wells of a 6-well plate at a density of 
400 cells per well. Remaining cells were grown for an additional 24 hours and lysed 
in RIPA buffer. 15 µg of whole cell lysate was immunoblotted and probed with 
antibodies against hSSB1, FLAG and actin. This figure is representative of each 
repeat in (C). 
 
(C) HeLa cells expressing F98A hSSB1 are hypersensitive to hydroxyurea (HU). 
The cells plated in (B) were incubated for 24 hours and treated with 3 mM HU for 4, 
8, 12, 16 or 20 hours. Three technical repeats were performed per dose. Cells were 
grown for 10 days prior to staining of colonies with methylene blue. Colonies were 
manually counted and counts normalised to untreated cells. Data is graphed as the 
mean ± 1 standard deviation from 3 independent experiments. t tests were used to 
compare the ‘sihSSB1 + WT hSSB1’ and “sihSSB1 + F98A hSSB1’ datasets at each 
dose.  ns = P > 0.05, * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
 
(D) hSSB1 S134 phosphorylation may not require INTS3-binding. HeLa cells 
expressing WT, F98A or S134A 3x FLAG hSSB1, or an empty control vector, for 24 
hours were treated with 3 mM HU for 4 hours. Whole cell lysates were then prepared 
and immunoblotted for pS134 hSSB1, FLAG, pS345 Chk1, total Chk1 and actin 
(loading control). Densitometry of pS134 hSSB1 bands was performed using ImageJ, 
normalised to FLAG, and expressed relative to untreated WT 3x FLAG hSSB1-
expressing cells. These results are representative of three independent experiments. 
 
It was also noted that F98A 3x FLAG hSSB1 was detected at a slightly higher 
molecular weight than the WT, consistent with prior observations (Ren et al., 2014). 
Although it remains unclear why this may be, it is noted that hSSB1 K94, a recently 
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described residue of acetylation (Wu et al., 2015), is seemingly localised to this same 
hSSB1-INTS3 interface. The increased occurrence of this or other post-translational 
modifications on the F98A mutant may therefore offer some explanation for the 
difference in observed migration when compared to the WT protein. 
 
To determine whether INTS3 binding is required for hSSB1 function following 
replication inhibition, HeLa cells were depleted of endogenous hSSB1 over 48 hours 
using siRNA and WT or F98A siRNA-resistant 3x FLAG hSSB1 transiently re-
introduced (Fig 4.9B). Cells were then seeded into wells of a 6-well plate and after 
24 hours treated with 3 mM HU for 4, 8, 12, 16 or 20 hours. Cells were then released 
into fresh media and grown for 10 days before the surviving fraction of cells at each 
dose calculated relative to the survival of untreated cells (Fig 4.9C). Consistent with 
Figure 4.2C, cells depleted of hSSB1 were hypersensitive to hydroxurea treatment, 
which could be rescued by expression of WT 3x FLAG hSSB1. By contrast, F98A 
hSSB1 was unable to rescue cells from hSSB1-depletion and a statistically 
significant difference in surviving fraction was calculated when compared to WT at 
multiple HU time-points. These data suggest that INTS3-binding is required for 
hSSB1 function following replication stress. 
 
As the data presented here has suggested that both hSSB1 S134 phosphorylation and 
INTS3-binding promote clonogenic survival in response to hydroxyurea treatment, it 
is tempting to speculate that these requirements are related. As Figure 4.8A indicated 
that S134 phosphorylation is not required for INTS3 binding, it was therefore of 
interest to determine whether INTS3-binding may be required for S134 
phosphorylation. To assess this, HeLa cells transiently expressing WT, F98A or 
S134A hSSB1 were treated with 3 mM hydroxyurea for 4 hours and then whole cell 
lysates prepared and immunoblotted for hSSB1 S134 phosphorylation. (Figure 
4.9D). As WT and F98A 3x FLAG hSSB1 were however similarly phosphorylated at 
S134 in response to hydroxyurea treatment, these data suggest that S134 
phosphorylation and INTS3 binding are regulated independently. 
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4.2.10 A phosphorylated S134 peptide does not interact with pS/T reader 
proteins  
The data presented in previous sections suggests that DNA-PK-mediated 
phosphorylation of hSSB1 S134 is enhanced in response to replication disruption and 
that this modification promotes clonogenic survival under such conditions. 
Furthermore, hSSB1 S134 phosphorylation may be dynamically regulated in 
undamaged cells. As yet, however, the mechanism through which S134 may function 
remains unclear. 
 
The phosphorylation of specific amino acids in some proteins facilitates a direct 
interaction with one of many phospho-serine/threonine binding domain-containing 
proteins, numerous of which function in DNA repair. This includes members of the 
14-3-3 family, the FHA domain proteins MDC1, RNF8, NBS1 and Chk2, the BRCT 
(BRCA1 c-terminus) repeat proteins, MDC1, NBS1, BRCA1, MCPH1, 53BP1, PTIP 
and TopBP-1, the WW domain protein PIN1, the polo-box protein polo-like kinase 1 
(PLK1) and the WD repeat proteins βTrCP, CDC4 and FBW7 (Mohammad and 
Yaffe, 2009; Reinhardt and Yaffe, 2013). It was therefore interesting to consider 
whether hSSB1 S134 phosphorylation may promote binding to one of these proteins. 
Indeed, whilst S134 does not recognisably constitute a specific consensus-binding 
motif, ‘non-consensus’ substrate binding is not uncommon for many phospho-
serine/threonine binding proteins (Madeira et al., 2015).  
 
To assess whether S134 phosphorylation may promote such an interaction, control 
and phosphorylated hSSB1 biotinylated peptides representing amino acids K123 to 
S141 (Biotin-KAVQNDSNPSASQPTTGPS and Biotin-KAVQNDSNPSA{pSer}QP 
TTGPS) were designed and purchased. These peptides were then sent to the “protein 
array and analysis core” at the University of Texas MD Anderson Cancer Centre. 
Here, peptides were labelled with a Cy3-streptavidin label and used to probe a micro 
array of GST-fusion phospho-serine/threonine binding domain-containing proteins. 
Arrays were then washed and the fluorescent signal measured using a slide scanner 
equipped with a 550 nm long pass filter (Figure 4.10A). As each microarray 
contained proteins arrayed in duplicate, two fluorescent signals (dots) are expected 
for a positive interaction. Additionally, for an S134-specific interaction, a signal 
would be expected for the phosphorylated and not for the control peptide.  
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Figure 4.10 A pS134 peptide does not interact with pS/T reader proteins 
 
(A) Schematic of the pS/T reader protein micro array. The numbered squared at 
the top represents how each GST-fusion peptide listed was arrayed in duplicate. M = 
GST alone. The rectangles labelled with letters at the top of the page correspond with 
those listed below it. Each rectangle represents a different protein array.  
 
(B) A pS134 peptide does not detect pS/T reader proteins. 10 or 100 µg of control 
(Biotin KAVQNDSNPSASQPTTGPS) and phosphorylated (Biotin-
KAVQNDSNPSA{pSer}QPTTGPS) hSSB1 biotinylated peptides were pre-bound 
with a Cy3-streptavidin label and incubated with each chip of the pS/T reader micro 
array. A duplicate microarray was also probed with a GST antibody and detected 
using a FITC-conjugated secondary antibody. Fluorescent signals were detected 
using a slide scanner equipped with a 550 nm long pass filter. As each microarray 
contained proteins arrayed in duplicate, two fluorescent signals (dots) were expected 
for positive interactions. Although faint fluorescent signals were detected, these were 
not specific to the phosphorylated peptide. 
 
(C) Positive interactions were detected for a set of control peptides. 10 µg of the 
indicated peptides (white text) were incubated with each microarray as per (B). 
Positive signals are indicated with red lines and the corresponding GST-proteins 
listed below each image. 
 
In doing so, however, a signal specific to the S134 phosphorylated peptide was not 
observed (Figure 4.10B). This is unlikely to be due to an issue with the arraying of 
pS/T reader proteins, as demonstrated by the detection of these proteins using a GST 
antibody. In addition, a panel of positive control peptides screened inline with the 
S134 peptides were able to interact with their respective binding partner and 
produced the expected fluorescent signals (Figure 4.10C).  
 
Although these data most likely suggest that S134 may not mediate a direct 
interaction with one of these phospho-serine/threonine binding domain-containing 
proteins, it should be noted that due to the recent establishment of this microarray, 
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few positive interactions have as yet been identified with many of the proteins 
outside of the 14-3-3 family. It is therefore possible (or probable) that not all of the 
proteins on the array are folded correctly (M. Bedford, personal communication, 
November 11 2014).  In addition, even if S134 phosphorylated hSSB1 does mediate 
a direct protein interaction, this may not necessarily be supported by a 
phosphorylated peptide. 
 
4.2.11 Multiple SQ/TQ motifs are found in the SSB1 C-terminus of animal 
species  
In the previous chapter (Figure 3.4E) it was observed that S134 and T117, despite 
being of importance for hSSB1, were only partially conserved amongst the species 
examined. The relatively close proximity of these motifs is however of some interest 
and it was proposed that these amino acids may form part of a DNA damage 
responsive regulatory region. As the previous alignment was relatively limited in the 
number of species examined, a larger alignment of SSB1 sequences was undertaken. 
For this, the hSSB1 amino acid sequence was entered as a query sequence in the 
blastn program and searched against the NCBI ‘nucleotide collection nr/nt’ database 
for ‘highly similar sequences’. The 69 unique sequences returned were then collected 
and the region of each corresponding to hSSB1 residues 110 to 160 aligned using 
Clustal Omega. Sequences were manually ordered and grouped to reflect their 
common phylogenetic clades (Figure 4.11A).  
 
In the mammalian species examined, an SQ motif homologous to hSSB1 S134 was 
predominantly identified in the simian primates (infraorder Simiiformes; higher 
primates) as well as in the Lagomorpha species (suborder of Gliriform; rabbits, 
pikas) O. princeps (American pika).  
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Figure 4.11
H.sapiens             EPNPEYSTQQAPNKAVQNDSNPSASQPTTGPSAASPASENQNGNGLSAPP
P.paniscus            EPNPEYSTQQAPNKAVQNDSNPSASQPTTGPSAASPASENQNGNGLSAPP
C.atys                EPNPEYSTQQTPNKAVQNDSNPSASQPTTGPSAASPASESQNGNGLSAPT
M.fascicularis        EPNPEYSTQQTPNKAVQNDSNPSASQPTTGPSAASPASESQNGNGLSAPT
C.sabaeus             EPNPEYSTQQTPNKAVQNDSNPSASQPTTGPSAASPASESQNGNGLSAPT
C.angolensis          EPNPEYSTQQAPNKAVQNDSNSSASQPTTGPSAASPASESQNGNGLSAPT
M.leucophaeus         EPNPEYSTQQTPNKAVQNDSNPSASQPTTGPSAASPASESQNGNGLSAPT
P.anubis              EPNPEYSTQQTPNKAVQNDSNPSASQPTTGPSAASPASESQNGNGLSAPT
C.jacchus             EPNPEYSTQQAPNKAVQNDSNPSASQPTTGPPAASPASESQNGNGLSAPS
A.nancymaae           EPNPEYSTQQAPNKAVQNDSNPSASQPTTGPPAASPASESQNGNGLSAPS
S.boliviensis         EPNPEYSTQQAPNKAVQNDSNPSASQPTTGPPAASPALESQNGNGLSAPS
T.syrichta            EPNPEYSTQQAPNKAVQNDSSPTAPQTTIGPPAASPASESQNGNGLSATP
O.garnettii           EPNPEYSTQQAPNKVVQNDSSPTTPQPTTGPPATSPASESQNGNGLSAPP
T.chinensis           EPNPEYSTQQAPNKAVQNDSTPTAPQPSTGPPAASPASESQNGNGLNAPP
G.variegatus          EPNPEYNTQQAPNKAVQNDNSPTAPQPTTGPPAAPPASESQNGNGLSTSP
O.princeps            EPNPEYGTQQAPNKAVQNDSCPPASQPPTGPPAASPASENQNGNGLSTPS
O.cuniculus           EPNPEYSTQQAPNKAVQNDSSPTAPQPAGGPPASSPASENQNGNGLSAPS
I.tridecemlineatus    EPNPEYSTQQAPNKAGQNDSSPTAPQATTGPPAASPASENQNGNGLSTPP
H.glaber              EPNPEYSTQQAPNKAVQNDSSPPATQAATGSPSVSPASENQNGNGLSAPQ
F.damarensis          EPNPEYSTQQAPNKTVQNDSSLPATQAATGPPSVSPASENQNGNGLSVPP
C.porcellus           EPNPEYSTQQAPNKAGQNDSSPTATQAATGSSAVSPASESQNGNGLSTPP
O.degus               EPNPEYSTQQAPNKAVQNDSSPTATQAATGPPSVSPASESQNGNGPSAPP
M.musculus            EPNPEYNTQQAPNKSVQNDNSPTAPQATTGPPAASPASENQNGNGLSTQL
R.norvegicus          EPNPEYNTQQASNKSVQNDSSPTAPQATTGPPAASPASESQNGNGLSTQP
C.griseus             EPNPEYNTQQAPNKSVQSDSSPATPQATTGPPAASPASESQNGNGPSTQP
M.auratus             EPNPEYNTQQAPNKSVQSDSSPAAPQATTGAPAGSPASESQNGNGPSTQP
P.maniculatus         EPNPEYNTQQAPNKSVQNDSSPTAPQAATGPPAASPASESQNGNGLSTQP
M.ochrogaster         EPSPEYNTQQAPNKSVQNDSGPAAPPATTGPPAASPASESQNGNGLSTPP
N.galili              EPNPEYSTQQMPNKPVQNDSNPSAPQATTGPPAASPASESQNGNGLSTPP
J.jaculus             EPNPEYSTQQAPNKVVQNDSSPTAPQPTTGPPATSPASESQNGNGLSTSS
S.scrofa              EPNPEYSAQQAPNKTVQNDSSPTAPQPATGPPAASPASESQNGNGLSAPP
B.bison               EPNPEYSAQQAPNKTVQNDSGPAAPQPPTGPPATSPASESQNGNGLSAPP
B.taurus              EPNPEYSAQQAPNKTVQNDSGPAAPQPPTGPPATSPASESQNGNGLSAPP
B.mutus               EPNPEYSAQQAPNKTVQNDSGPAAPQPPTGPPATSPASESQNGNGLSAPP
C.hircus              EPNPEYSAQQAPNKTVQNDSGPAAPQATTGPPATSPASESQNGNGLSAPP
P.hodgsonii           EPNPEYSAQQAPNKTVQNDGGPVAPQPTTGPPATSPASESQNGNGLSAPP
V.pacos               EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSTASESQNGNGLSAPP
C.bactrianus          EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSTASESQNGNGLSAPP
C.ferus               EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSTASESQNGNGLSAPP
O.orca                EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSPASESQNGNGLSTPP
T.truncatus           EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSPASESQNGNGLSTPP
P.catodon             EPNPEYSAQQAPNKTVQNDSSPTAPQPTAGPPATSPASESQNGNGLSTPP
B.acutorostrata       EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSPASESQNGNGLSTPP
C.simum               EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSPASESQNGNGLSAPP
E.caballus            EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPATSPASESQNGNGLSTPP
F.catus               EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPAVSPASETQNGNGLSAPP
C.lupus               EPNPEYSAQQAPNKTVQNDSSPTAPQPATGPPAVSPASENQNGNGLSAPP
A.melanoleuca         EPNPEYSAQQAPNKTVQNDSSPTAPQPTTGPPAVSPASENQNGNGLSAPP
M.putorius            EPNPEYSAQQAPNKVVQNDSSPPAPQPTTGPPAVSPASENQNGNGLSAPP
E.fuscus              EPNPEYSAQQAPNKTVQNDSSPTAPQPTPGGPAVSPASENQNGNGLSAPP
M.lucifugus           EPNPEYSAQQAPNKTVQNDSSPAAPQPTTGPPAVSPASESQNGNGLSAPP
P.alecto              EPNPEYSAQQAPNKTVQD-NSPTAPQPTTGTPAASPASESQNGNGLSTPP
C.cristata            EPNPEYSAQQAPSKMVQNDSSPAAPTPATGPSAASPASESQNGNGLNAPP
E.europaeus           EPNPEYNAQQPPNKTVQSDSSPTAPQPPAGSPATPPVSENQNGNGLSVPP
S.araneus             EPNPEYSTQQAPSKTVQNDNSPTASPPTTGAPTAPTASENQNGNGLNAPA
L.africana            EPNPEYSAQQAPNKVVQNDSSPSALQPTTGPPAASPASESQNGNGLSAPP
T.manatus             EPNPEYSAQQAPNKAVQNDSSPSAPPPTTGPPAASPASESQNGNGLSTPP
O.afer                EPNPEYSAQQTPNKAVQNDSSPAAPQPTTGPPAASPASESQNGNGLSTLP
C.asiatica            EPNPEYSSQQAPNKAVQNDSNPATPQPTTGPPATSPASESQNGNGLSPLP
E.telfairi            EPNPEYSTQQAPNKAVQNDSSPAAPQPPTGPPAASPATENQNGNGLSALP
E.edwardii            EPNPEYNAQQAPNKAVQNDSSSSAPQPPAGPPAASPASENQNGNGLSALP
D.novemcinctus        EPNPEYSAQQAPSKAVQLDSSPGAPQPPSGPPAAPPASESQNGNGLSTPP
A.carolinensis        EPNPEYVAQQSQNKNTQNNAAPTSSQTVPGPPTSSAATDNQNGNGLITSG
P.bivittatus          EPNPEYVAQQSQNKNTPNNAAPAASQTTPGPSTS-AAAENQNGNGLIPSG
O.hannah              EPNPDYVAQQSQNKNTPNNAAPTASQTTPGST-S-TAAENQNGNGLIPSG
P.sinensis            EPNPEYVNQPSQSKAAQNNATPAASQTTPGPSASSPAADNQNSNGLGAPG
C.mydas               EPNPEYVTQQSQSKAAPNNVTPAASQTTPGPAASSPAADNQNGNGLSAPS
C.picta               EPNPEYVTQQSQTKAAQNNATPAASQTTPGPAASSPAAESQNGNGLSAPG
A.sinensis            EPNPEYVAQQSQSKAAQNNATPAASQTAQGPSAPSPAADSQNGNGLSAPG
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H.sapiens              TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
P.paniscus             TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
C.atys                 TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
M.fascicularis         TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
C.sabaeus             TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
C.angolensis           TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
M.leucophaeus          TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
P.anubis               TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
C.jacchus              TP--SHPPSTRITRSQPNHTPAGPP--GPSSNAVSNGKETRRSSKR
A.nancymaae            TP--SHPPSTRITRSQPNHTPAGPP--GPSSNTVSNGKETRRSSKR
S.boliviensis          TP--SHPPSTRITRSQPNHTPAGPP--GPSSNAVSNGKETRRSSKR
T.syrichta             TP--SHPPSTRITRSQPNHTPAGLP--GSSSNPVSNGKETRRSSKR
O.garnettii            AP--SHTPSTRITRSQPNHTPAGPP--GPSNNPVSNGKETRRSSKR
T.chinensis            AP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
G.variegatus           TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
O.princeps             TP--SHPPSTRITRSQPNHTPAGTP--GPSSNPVSNGKETRRSSKR
O.cuniculus            TP--SHPPSTRITRSQPNHTPAGTP--GPSSNPVSNGKETRRSSKR
I.tridecemlineatus     TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPISNGKETRRSSKR
H.glaber               AP--THPPSTRITRSQPNHTPAAPP--GSSSNPVSNGKETRRSSKR
F.damarensis           TP--AHPPSTRITRSQPNHTPAAPP--GSSSNPVSNGKETRRSSKR
C.porcellus            TP--SHPPSTRITRSQPNHTAAGPP--GSSSNPVSNGKETRRSSKR
O.degus                TP--SHPPSTRITRSQPSHTAAGPP--GSSSNPVSNGKETRRSSKR
M.musculus             TP--SHPPSTRITRSQPNHTPSGPP--GPSSNPVSNGKETRRSSKR
R.norvegicus           AP--SHPPSTRITRSQPNHTPSGPP--GPSSSPVSNGKETRRSSKR
C.griseus              TA--SHAPSTRITRSQPNHTPSGPP--GPSSNPVSNGKETRRSSKR
M.auratus              TA--SHAPSTRITRSQPNHTPSGPP--GPSSNPVSNGKETRRSSKR
P.maniculatus          TP--SHPPSTRITRSQPNHTPAGPP--GPSGNPVSNGKETRRSSKR
M.ochrogaster          TP--SHPPSTRITRSQPNHTPSGLP--GPSSNPVSNGKETRRSSKR
N.galili               TP--SHPPSTRITRSQPNHTPSGPP--GPSSNPVSNGKETRRSSKR
J.jaculus              TP--SHPPSTRITRSQPSHTPAGPP--GPSSNPVSNGKETRRSSKR
S.scrofa               TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
B.bison                TP--SHPPSTRITRSQPNHTAAGPP--GPSSNPVSNGKETRRSSKR
B.taurus               TP--SHPPSTRITRSQPNHTAAGPP--GPSNNPVSNGKETRRSSKR
B.mutus                TPSPPHPPSTRITRSQPNHTAAGPP--GPSSNPVSNGKETRRSSKR
C.hircus               TSPASESQNGNGLSAPPNHTPAGPP--GPSSNAVSNGKETRRSSKR
P.hodgsonii            TP--SHPPSTRITRSQPNHTPAGPP--GPSSNAVSNGKETRRSSKR
V.pacos                TP--SHPPSTRITRSQPNHTPAGPS--GPSSNPVSNGKETRRSSKR
C.bactrianus           TP--SHPPSTRITRSQPNHTPAGPS--GPSSNPVSNGKETRRSSKR
C.ferus                TP--SHPPSTRITRSQPNHTPAGPS--GPSSNPVSNGKETRRSSKR
O.orca                 TP--PHPPTPRITRSQPNHTPAGPP--GPSSSPVSNGKETRRSSKR
T.truncatus            TP--PHPPTPRITRSQPNHTPAGPP--GPSSSPVSNGKETRRSSKR
P.catodon              TP--XHPPTPRITRSQPNHTPAGPP--GPSSSPVSNGKETRRSKR-
B.acutorostrata        TP--SHPPTPRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
C.simum                TP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
E.caballus             TP--SHPPSTRITRSQPNHTAAGPP--GPSSNPVSNGKETRRSSKR
F.catus                AP--SHPPSTRITRSQPNHTAAGPP--GPSSNPVSNGKETRRSSKR
C.lupus                HP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
A.melanoleuca          AP--SHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
M.putorius             TP--SHPPSTRITRSQPNHTPAGPP--GPSSSPVSNGKETRRSSKR
E.fuscus               TP--SHPPSTRITRSQPNHTPAGPP--GPSNNPVSNGKETRRSSKR
M.lucifugus            AP--SHPPSTRITRSQPNHTPAGPP--GPSNNPVSNGKETRRSSKR
P.alecto               TP--SHAPSTRITRSQPNHTPAGPP--GPSNNPVSNGKETRRSSKR
C.cristata             TP--PHPPSTRITRSQPNHAPAGPP--GPSSTAASNGKETRRGSKR
E.europaeus            TP--SHPPITRITRSQPNHTASGPP--GPSSNPVSNCKETRRSSKR
S.araneus              AP--PHPPSTRITRSQPNHTPAGPP--GPSSNPVSNGKETRRSSKR
L.africana             TP--SHPPSTRITRSQPNHTSAGPP--GPTSNPVSNGKETRRSSKR
T.manatus              TP--SHPPSTRITRSQPNHTSAGPP--GPTSNSVSNGKETRRSSKR
O.afer                 AP--SHPPSTRITRSQPNHTSAGPP--GPTSNPVSNGKETRRSSKR
C.asiatica             AP--SHPPSTRITRSQPNHTSAGPP--GSTSNSVSNGKETRRSSKR
E.telfairi             AP--SHPPSTRITRSQPNHTSAAPP--GPTSNPVSNGKETRRSSKR
E.edwardii             AP--SHPPSTRITRSQPNHTTPGPP--GPASNPVSNGKETRRSSKR
D.novemcinctus         AT--PHPPSTRITRSQPNHTPAGPA--GAPNNSVSNGKETRRSSKR
A.carolinensis         VP--THPTSGRITRSQPNHQSGSSTGTGSSSNAVSNGKETRRSSKR
P.bivittatus           IP--THPTSGRITRSQPNHQGGSSSGIGSSSNPVSNGKETRRSSKR
O.hannah               IS--THPTTGRITRSQPNHQGGSSSSIGSSSNPVSNGKETRRSSKR
P.sinensis             GP--AHPTSGRITRSQPNHQGAGSAGSGSSSNPVSNGKETRRSSKR
C.mydas                VP--SHPTSGRITRSQPNHQGVGSAGSGSSSNPVSNGKETRRSSKR
C.picta                VP--SHPTSGRITRSQPNHQGAGSAGSSSSSSPISNGKETRRSSKR
A.sinensis             PPAAPHPASGRITRSQPNHAST--------AGAVSNGKETRRSSKR
170 211182 209
hSSB1  ----MTTETFVKDIKPGLKNLNLIFIVLETGRVTKTKDGHEVRTCKVADKTGSINISVWDDVGNLIQPGDIIRLTKGYASVF  78
hSSB2  MNRVNDPLIFIRDIKPGLKNLNVVFIVLEIGRVTKTKDGHEVRSCKVADKTGSITISVWDEIGGLIQPGDIIRLTRGYASMW  82
hSSB1  KGCLTLYTGRGGDLQKIGEFCMVYSEVPNFSEPNPEYSTQQAPNKAVQNDSNPSASQPTTGPSAASPASENQNGNGLSAPPG  160
hSSB2  KGCLTLYTGRGGELQKIGEFCMVYSEVPNFSEPNPDYRGQQNKGAQSEQKNNSMNSNM---------------GTGTFGPVG  149
hSSB1  PGGGPHPP---HTPSHPPST-RITRSQPNHTPAGPPGPSSNPVSNGKETRRSSKR  211
hSSB2  NGVHTGPESREHQFSHAGRSNGRGLINPQLQGTASNQTVMTTISNGRDPRRAFKR  204
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Figure 4.11 Multiple SQ/TQ motifs are found in the SSB1 C-terminus of animal 
species 
 
(A) A SQ/TQ motif homologous to hSSB1 S134 is conserved in simiiform 
primates, some gliriformes, and numerous reptiles. The amino acid sequence of 
hSSB1 was entered as a query sequence in the blastn program 
(https://blast.ncbi.nlm.nih.gov) and searched against the NCBI ‘nucleotide collection 
nr/nt’ database for ‘highly similar sequences’ (megablast). Unique sequence matches 
were collected and labelled by species name. The region of each sequence 
corresponding to hSSB1 residues 110 to 160 was isolated and aligned using Clustal 
Omega (ebi.ac.uk) with default parameters. Sequences were manually ordered and 
grouped based on currently accepted phylogenetic clades. SQ/TQ motifs are outlined 
by rectangles with numbers corresponding to the hSSB1 protein sequence. 
  
(B) An SQ/TQ motif homologous to hSSB1 S182, as well as an RXXS motif 
homologous with hSSB1 S209, is highly conserved in animal species. Amino acid 
sequences corresponding to hSSB1 residues 170-211 from each sequence in (A) were 
similarly isolated, ordered and aligned. SQ and RXXS motifs are outlined by 
rectangles with numbers corresponding to the hSSB1 protein sequence. 
 
(C) SQ/TQ and RXXS motifs are not conserved in hSSB2. The amino acid 
sequences of hSSB1 and hSSB2 were isolated and aligned using EMBOSS Needle 
(ebi.ac.uk) with default parameters. SQ/TQ and RXXS motifs are outlined by 
rectangles with numbers corresponding to the hSSB1 protein sequence 
 
In addition, a TQ motif was observed at this site in a small number of other Gliriform 
species within the Rodentia (Rodents) suborder Hystricomorpha (guinea pigs, 
porcupines etc.). Strikingly, whilst a S134 homologous motif was not observed in the 
remainder of mammalian species examined, this motif was identified in all of the 
aligned reptilia species (reptiles; including snakes, lizards, turtles and crocodiles). It 
is also interesting to note that in the majority of species that did not contain an SQ 
motif at S134, a proline residue was almost invariably observed.  
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Similarly to S134, a TQ motif homologous to hSSB1 T117 was only observed in a 
subset of mammals, as well as in two species of turtle (Reptilia, Testudines). 
Interestingly, neither SQ nor TQ motifs homologous to S134 or T117 were observed 
in the mammalian Laurasiatheria superorder (shrews, bats, carnivorans and odd and 
even-toed ungulates), with the single exception of S. araneus (the common shrew), 
which contained a motif homologous to T117. In addition, an S134 SQ motif was not 
observed in the Afrotheria superorder (elephants, sea cows, Aardvaks), while an 
SQ/TQ motif homologous to T117 was only observed in the order Afrosoricida 
(golden moles and tenrecs). An unexpected observation was the detection of a SQ 
motif corresponding to hSSB1 residue 149, which was more highly conserved than 
T117 or S134, although was not identified in humans. Indeed, this motif was 
identified in all other primate sequences aligned other than of the Hominini subgroup 
(humans and chimpanzees). Additional other SQ/TQ motifs were identified in a 
small number of non-human species at positions corresponding to hSSB1 residues 
120, 125 and 158.  
 
Outside of this ~ 50 amino acid region, it is interesting to note that only a single 
other SQ motif was observed in any of the aligned sequences. Furthermore, this 
motif, which in humans is found at S182, was conserved in 68 of the 69 species 
examined (Figure 4.11B). This may however reflect the overall high sequence 
conservation of the SSB1 far C-terminus. Indeed, an RXXS motif (the consensus 
phosphorylation sequence of Chk1 and Chk2) was also observed in all species 
examined at residues corresponding to hSSB1 R206 to S209. 
 
It is also noteworthy that while hSSB1 contains three SQ motifs (T117, S134, S182) 
and one RXXS motif (R206-S209) no such sequences were observed in hSSB2 
(Figure 4.11C). 
 
4.2.12 S134 phosphorylation may not affect hSSB1 protein half-life or poly-
ubiquitination 
In the previous section it was noted that while an SQ motif homologous to S134 was 
observed in simian primates, few other animals contained this specific motif at this 
position. Indeed, specific SSB1 SQ/TQ motifs within an ~ 50 amino acid section of 
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the C-terminus in general were only intermediately conserved. Despite this, the 
majority of animal species examined did contain one or more SQ/TQ motifs 
somewhere within this region. It was therefore interesting to consider that while 
phosphorylation of a specific residue may not be essential, selective pressure may 
exist for the conservation of a phosphorylation site within this region of the protein. 
If this possibility is considered, it may therefore seem reasonable to conclude that 
phosphorylation of any of these residue may have a similar effect. Such a conclusion 
does however require the assumption that SSB1 proteins function similarly in various 
animal species. 
 
The phosphorylation of hSSB1 T117 has previously been postulated to affect protein 
activity by interfering with proteasome-targeting poly-ubiquitination and thereby 
limiting protein turnover (Chen et al., 2014; Richard et al., 2008). Here, hSSB1 T117 
was suggested to be phosphorylated by the ATM kinase in response to double-strand 
DNA break formation to thereby increase the concentration of hSSB1, thus 
facilitating DNA repair. Indeed, even in undamaged cells, a T117A hSSB1 
phosphomutant was found to be hyper-poly-ubiquitinated, whilst ubiquitination was 
barely detected for a T117E phosphomimetic (that mimics phosphorylated hSSB1) 
(Chen et al., 2014). Although an increase in hSSB1 protein levels following 
hydroxyurea treatment has not been observed in previous sections, or in other reports 
(Bolderson et al., 2014), it seemed possible that the proportional increase in 
phosphorylated hSSB1 following damage may be too low for such changes to be 
observed simply by immunoblotting.  
 
A time course assay using the inhibitor of protein biosynthesis, cycloheximide, has 
previously been employed to demonstrate the reduced half-life of K94R (acetylation 
mutant) FLAG-tagged hSSB1 (Wu et al., 2015). It was therefore reasoned that a 
similar experiment could also be performed with S134A phosphomutant and S134E 
phosphomimetic 3x FLAG hSSB1. For comparison with phosphorylation of T117, 
T117A and T117E hSSB1 were also included. Here, WT or mutant 3x FLAG hSSB1 
was transiently expressed in HeLa cells for 24 hours, prior to addition of 50 µg mL-1 
cycloheximide or DMSO. Cells were then harvested 4, 8, 12, 16 or 20 hours post 
treatment. Whole cell lysates prepared from these cells were then immunoblotted for 
the FLAG epitope, as well for PARP1, the cleavage of which was used a positive 
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control (Chen et al., 2013c) (Figure 4.12A, B and C). A similar half-life was 
however consistently observed between the WT protein and the S134 mutants. In 
contrast to previous studies (Chen et al., 2014), a substantial difference in the half-
life of T117A or E hSSB1 was also not observed.  
 
Although the data above suggests that S134 phosphorylation may not affect protein 
half-life, the observation that T117A and E hSSB1 are also similarly stable may 
suggest that cycloheximide time courses are not the optimal assessment means. As 
hexa-His-ubiquitin pull-down assays have previously been employed to assess poly-
ubiquitination of T117A and E hSSB1 (Chen et al., 2014), these assays were also 
performed with S134A and E hSSB1. Based on the findings in section 3.2.2 that the 
3x FLAG tag of hSSB1 may be poly-ubiquitinated, these assays instead used HA-
tagged hSSB1 phosphorylation mutants. 
 
His-ubiquitin pull-down assays were performed in the same manner as in chapter 3 
by co-transfecting HEK293T cells with plasmids expressing hexa-His ubiquitin and 
HA-tagged hSSB1. After 24 hours, cells were then treated with 50 µM MG-132 and 
harvested after 4 hours. Cells were then lysed in 8 M urea and hexa-His-tagged 
ubiquitinated proteins captured on Ni-NTA agarose beads. Proteins were then eluted 
and immunoblotted with a HA antibody (Figure 4.12D). In doing so, no consistent, 
sizeable differences in the ubiquitination of WT, S134 or T117 phosphomutant 
hSSB1 was observed. These data further support that S134 phosphorylation does not 
regulate hSSB1 protein turnover. In addition, the observations of this section are in 
disagreement with the attributed role of hSSB1 T117 phosphorylation to the 
regulation of protein half-life. It cannot however be excluded that these discrepancies 
represent variations in experimental conditions. Indeed, whilst the experiments 
conducted here employed HeLa cells for CHX experiments and HEK293T cells for 
hexa-His-ubiquitin pull down assay, earlier works have used a combination of A549, 
NCI-H23 and NCI-H460 cell lines (Chen et al., 2014). Nevertheless, these data may 
suggest that T117 and S134 phosphorylation regulate hSSB1 through a means 
independent of, or in addition to, protein stabilisation in DNA repair processes. 
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Figure 4.12 S134 phosphorylation may not affect hSSB1 protein half-life or 
poly-ubiquitination 
 
(A, B and C) S134 and T117 phosphorylation mutants have a similar half-life to 
WT hSSB1. WT (A), S134A, S134E (B), T117A and T117E (C) 3x FLAG hSSB1 
constructs were transiently expressed in HeLa cells for 24 hours, prior to addition of 
50 µg mL-1 cycloheximide or DMSO. Cells were harvested 4, 8, 12, 16 or 20 hours 
post treatment. Cells pellets were resuspended and lysed in RIPA buffer and 15 µg of 
whole cell lysate immunoblotted with antibodies against FLAG, PARP1 (CHX 
positive control), or actin (loading control). * = Full-length PARP1, < = cleaved 
PARP1. Densitometry of FLAG bands was performed using ImageJ and expressed 
relative to untreated 3x FLAG hSSB1-expressing cells. These results are 
representative of three independent experiments. 
 
(D) S134 and T117 hSSB1 phosphorylation mutants are poly-ubiquitinated 
similarly to WT. HA-tagged S134 and T117 phosphorylation mutant (S134A and 
T117A) and mimetic (S134E and T117E) constructs were prepared by site-directed 
mutagenesis of the corresponding 3x FLAG hSSB1 plasmids. Each construct was co-
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transfected into HEK293T cells with a plasmid encoding hexa-His tagged ubiquitin 
and expressed for 24 hours. Cells were treated with 25 µM MG132 for 4 hours, 
harvested, and lysed in a buffer containing 8 M urea. 1000 µg of whole cell lysate 
was incubated with 20 µl of Ni-NTA agarose beads for 2 hours at room temperature, 
washed 3x with 8 M urea and eluted by heating to 90 oC for 10 minutes in SDS 
loading buffer. Eluent was immunoblotted and probed with antibodies against the 
HA tag. 15 µg of whole cell lysate (input) was immunoblotted and probed with 
antibodies against HA and actin. These results are representative of three 
independent experiments. 
 
4.2.13 Phosphorylation of hSSB1 S134 may alter the affinity of hSSB1 for 
replication fork junctions 
In a recent publication, the C-terminus of hSSB1 (and hSSB2) was found to be 
important for efficient binding to DNA substrates (Vidhyasagar et al., 2016). Indeed, 
truncation of this region of the protein (residues 138 - 211) reduced hSSB1 DNA 
binding by ~ 4-fold. As S134 is situated at the start of this region, it was therefore 
interesting to consider that phosphorylation of this residue may affect the C-terminus 
of the protein in such a way as to alter DNA substrate binding.  
 
The disruption of replication forks results in the accumulation of leading and lagging 
strand ssDNA (Sogo et al., 2002). To test whether S134 phosphorylation may alter 
hSSB1 binding to such substrates, electrophoretic mobility shift assays (EMSAs) 
were performed using recombinant WT or S134E phosphomimetic hexa-His hSSB1. 
Dr Nicolas Paquet performed this work. Here, WT and S134E hexa-His-hSSB1 were 
purified as per section 2.2 and increasing concentrations of these proteins incubated 
for 20 minutes at 37 oC with 10 nM of FAM-labelled ssDNA oligonucleotides. 
Reactions were then separated by electrophoresis on 10% polyacrylamide/TBE gels 
and the FAM label visualised using a Typhoon FLA 7000 laser scanner (GE 
healthcare) (Figure 4.13A and B). Protein-DNA binding was quantified as a 
function of the disappearance of free DNA, using ImageQuant TL software (GE 
Healthcare).  
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Figure 4.13 S134 phosphorylation may alter the affinity of hSSB1 for replication 
fork junctions 
 
(A and B) WT and S134E hexa-His-hSSB1 binding to a ssDNA substrate. WT 
and S134E hexa-His-tagged hSSB1 were expressed in SHuffle T7 E. coli and 
purified by anion exchange chromatography, followed by Ni-NTA affinity capture, 
and size exclusion chromatography. Increasing concentrations of hSSB1 (0, 0.025, 
0.05, 0.1, 0.25, 0.5, 0.75, 1, 1.5 and 2 µM) were incubated with 10 nM of synthetic 
substrates, in 10 µL of binding buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 100 
µg ml-1 BSA) for 20 min at 37 oC. Samples were separated on 10% polyacrylamide 
gels for 90 min at 90 V and visualized using a Typhoon FLA 7000 laser scanner (GE 
healthcare). Densitometry was performed on the free FAM labelled substrate using 
ImageQuant TL and calculated as a percentage of the 0 µM hSSB1 lane. Data is 
graphed as the mean ± 1 standard deviation from a minimum of 4 independent 
experiments. 
 
(C and D) WT and S134E hexa-His-hSSB1 bind to ssDNA similarly. Non-linear 
regression analysis was performed on the data generated in A using GraphPad Prism 
version 6 software and the equation ‘one site: specific binding with Hill slope’. 
BMax, Kd and h values were in this way calculated, as well as the corresponding 
standard error and 95% confidence intervals. Bmax and Kd values for WT and 
S134E hexa-His hSSB1 are graphically represented by Scatchard plots (C). The solid 
line represents best-fit Bmax and Kd values, whilst the dotted lines represent 95% 
confidence intervals. The calculated values are also tabulated (D). 
 
Figure 4.13
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(E and F) WT and S134E hexa-His-hSSB1 binding to a fork substrate. 
Electrophoretic mobility shift assays were performed and visualised as per (A) using 
WT and S134E hexa-His-tagged hSSB1 and increasing concentrations (0, 0.05, 0.1, 
0.25, 0.5, 0.75, 1, and 2 µM) of synthetic fork substrate. Data is graphed as the mean 
± 1 standard deviation from a minimum of 4 independent experiments. 
 
(G and H) S134E hexa-His-hSSB1 binds to fork substrates with less affinity 
than WT. Non-linear regression analysis was performed on the data generated in (E) 
and presented as per (C and D). 
 
(I) WT and S134E Hexa-His-tagged hSSB1 is similarly folded in vitro. WT and 
S134A hexa-His-tagged hSSB1 was expressed in SHuffle T7 E. coli and purified by 
Ni2+-NTA affinity capture, followed by size exclusion chromatography. 100-200 µM 
of WT or S134A hSSB1 was analysed by one-dimensional NMR and proton 
chemical shifts measured relative to 4,4-dimethyl-4-silapentanesulfonic acid (DSS) 
at 0 ppm. The 1D NMR spectra of amide protons for WT and S134A hSSB1 are 
depicted. This experiment was performed in parallel with Figure 4.2G 
 
Whilst a small difference in the mean Kd (dissociation constant) and Bmax (maximal 
binding) values were calculated, these were however not statistically significant over 
multiple experiments (Figure 4.13C and D). These data therefore suggest that S134 
phosphorylation may not alter the interaction of hSSB1 with ssDNA. 
 
In addition to ssDNA-binding, a number of replication fork proteins have also been 
found to bind to replication fork junctions. To assess whether hSSB1 may bind such 
substrates, EMSA assays were also performed using DNA substrates composed of 
partial DNA duplex fork substrates where the ssDNA of each arm was annealed to a 
separate ssDNA oligo. Unexpectedly, while hSSB1 has previously been shown not to 
bind dsDNA duplexes (Paquet et al., 2015), fork junction binding was readily 
observed for WT hexa-His-hSSB1 (Figure 4.13 E and F). Whilst this substrate was 
also bound by S134E hexa-His hSSB1, this was however with a significantly reduced 
affinity (WT Kd = 0.16 µM, 95% confidence interval (CI) = 0.140 – 0.179 vs S134E 
Kd = 0.34 µM, 95% CI = 0.311 – 0.367) (Figure 4.13 G and H). In addition, a 
 Characterisation of Human Single-Stranded DNA-Binding Protein 1 (hSSB1) Regulation by Post-Translational 
Modifications 145 
significant difference in the Hill coefficient (h) for WT and S134E hexa-His-hSSB1 
was calculated (WT h = 1.508, 95% CI = 1.274 – 1.743 vs S134E h = 2.292, 95% CI 
= 1.924 – 2.660). These data suggest that while S134E hexa-His hSSB1 bound to the 
fork substrate with a lower affinity, it does so with greater co-operativity.  
 
Although these data suggest that S134 phosphorylation may alter the affinity of 
hSSB1 for replication fork junctions, an alternative explanation may include mis-
folding of the S134E phosphomimetic. To ensure this were not the case, the 1D 
NMR spectra of this mutant was determined and compared to that of the WT protein 
(Figure 4.13 I). One-dimensional NMR was again performed by Dr Roland 
Gamsjaeger. The similar spectra observed for WT and S134E hexa-His-hSSB1 
however suggests that the difference in DNA-binding observed was not due to 
misfolding of the mutant. Another alternative explanation that cannot be excluded is 
the possibility that the unmodified serine residue may be required for fork junction 
binding and that the reason for suppressed S134E binding is due not to the mimicked 
phosphorylation of this residue, although simply due to its mutation. Future work 
may therefore benefit from the included study of S134A hSSB1 in the above assays.  
 
4.2.14 hSSB1 may associate with proteins involved in chromatin remodelling, 
RNA metabolism, DNA repair and numerous other functions 
The data presented in this document indicates that hSSB1 may be phosphorylated at 
S134 by the DNA-PK kinase and that this modification may be enhanced following 
replication inhibition. Furthermore, S134 may be required for hSSB1 function under 
these circumstances, potentially by altering its affinity for replication fork junctions. 
Irrespective of this, the role of hSSB1 at sites of stalled forks remains relatively 
unclear. To further elucidate these functions, mass spectrometry was used to detect 
proteins that may associate with chromatin-bound hSSB1. 
 
To achieve this, HeLa cells were treated with 3 mM hydroxyurea, or mock treated, 
for 4 hours prior to enrichment of chromatin-bound proteins by sub-cellular 
fractionation. Here, cells were resuspended in a hypotonic buffer containing 10 mM 
KCl and passed 6 times through a 26-gauge needle. Nuclei were then collected by 
centrifugation and dissolved in a buffer containing 420 mM NaCl. The chromatin-
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bound fraction was then collected by further centrifugation and DNA digested with 
benzonase (a deoxyribonuclease). To assess the purity of this fraction, 10 µg of the 
soluble nuclear and chromatin-bound protein fractions were separated by gel 
electrophoresis and immunoblotted using the indicated antibodies (Figure 4.14A). 
Nucleolin was used as a marker for soluble nuclear protein, while histone H3 was 
used as a marker for proteins bound to chromatin. As depicted in Figure 4.14A, 
nucleolin was readily detected in the soluble nuclear fraction, while was greatly 
reduced in the chromatin fraction. Conversely, histone H3 was detected in the 
chromatin fraction, while not in the soluble nuclear fraction. Together, these markers 
suggest that the chromatin fraction is highly enriched for chromatin-bound protein, 
and contains little contaminating soluble nuclear protein. While much of the soluble 
nuclear protein was likely removed, it should be noted that the ‘chromatin-bound’ 
fraction is likely to also contain nucleolar proteins (discussed further below).  
 
hSSB1 was immunoprecipitated from the chromatin fraction using protein G 
dynabeads bound to a hSSB1 antibody and 10 % of this sample separated by gel 
electrophoresis; proteins were then stained with colloidal coomassie blue (Figure 
4.14B). As a number of unique bands were detected in the hSSB1 
immunoprecipitated lanes when compared to the IgG lanes, the remaining 90% of the 
sample was submitted to the Translational Research Institute mass spectrometry 
facility to allow for identification of co-immunoprecipitating proteins. Here, the 
samples were electrophoresed briefly on a precast SDS-PAGE, until the dye front 
had run ~ 1 cm into the gel. This gel was then stained overnight with colloidal 
coomassie blue (Figure 4.14C). Each lane was then excised from the gel and 
separated into eight individual slices, which were subsequently destained, alkylated, 
and digested with trypsin. Peptides were then separated and detected by tandem mass 
spectrometry. 
 
The mass spectrum data was then extracted and searched against the Swiss Prot 
Human database. This process detected 334 proteins in the hSSB1:IP lanes prior to 
hydroxyurea treatment and 352 proteins after treatment. These proteins, as well as 
the number of unique detected peptides, are listed in Appendix 1.  
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Figure 4.14 hSSB1 may associate with proteins involved in chromatin 
remodelling, RNA metabolism, DNA repair and numerous other pathways 
 
(A) Subcellular fractionation of HeLa cells. HeLa cells were treated with 3 mM 
hydroxyurea (HU), or mock treated, and then harvested after 4 hours. Cells were 
incubated for 10 min at 4 oC in a buffer containing 10 mM KCl and passed through a 
26-gauge needle 6 times to lyse cells. The sample was centrifuged and the pellet 
(containing nuclei) washed once and incubated for 30 min at 4 oC in a buffer 
containing 420 mM NaCl. The supernatant containing soluble nuclear proteins was 
then collected and the remaining precipitate incubated in the 420 mM NaCl buffer 
containing benzonase for 30 min at room temperature. The sample was again 
centrifuged and the supernatant (‘chromatin-bound’) collected. 10 µg of the soluble 
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nuclear and chromatin-bound protein fractions were separated by PAGE and 
immunoblotted with antibodies against pS345 and total Chk1 (HU treatment positive 
control) nucleolin (soluble-nuclear marker) and H3 (chromatin marker).  
 
(B) Immunoprecipitation of chromatin-bound hSSB1 500 µg of chromatin-bound 
protein was incubated overnight at 4 oC with protein G dynabeads bound to a hSSB1 
antibody, or a sheep isotype control IgG. Beads were washed five times and protein 
eluted by heating to 90 oC in SDS loading buffer for 10 minutes. 10% of the eluent 
was separated by PAGE and stained overnight in colloidal coomassie brilliant blue 
G-250.   
 
(C) SDS-PAGE separation of immunoprecipitated proteins for in-gel digestion. 
Upon confirmation of successful immunoprecipitation, the remaining eluent was 
resolved on a 10% acrylamide SDS-PAGE gel to a depth of 6 mM and stained 
overnight in colloidal coomassie brilliant blue G-250. The top, fainter section of the 
image represents the stacking gel.  
 
(D) Proteins involved in numerous pathways were detected by mass 
spectrometry. The gel-embedded, coomassie blue-stained proteins in (C) were 
divided into eight 1 mM gel slices, digested with trypsin and extracted. Peptides were 
separated and detected using an Agilent HPLC CHIP QTOF 6530 system. The mass 
spectrum data was extracted and searched against the Swiss Prot Human database. 
Proteins for which corresponding peptides were identified, as well as the number of 
unique detected peptides, are given in appendix 1. Proteins were manually sorted 
based on their predominant known biological process as given by UniProt 
(www.uniprot.org). Proteins identified from either hSSB1:IP sample were pooled 
and are summarised as the number of unique proteins identified for each biological 
process. 
 
(E) hSSB1 may associate with proteins composing numerous chromatin-
remodelling complexes. From the proteins grouped in the ‘chromatin remodelling’ 
biological process in appendix 1 and (B), components of numerous chromatin-
remodelling complexes were identified. Protein components of each identified 
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complex are listed in columns and those identified in the hSSB1:IP mass 
spectrometry shown in bold font.  
 
(F) Co-immunoprecipitation of chromatin remodelling proteins with hSSB1. 
HeLa cells were treated with 3 mM hydroxyurea (HU), or mock treated, and 
harvested after 4 hours. Whole cell lysates were prepared and 500 µg incubated for 2 
hours at 4 oC with protein G dynabeads bound to a hSSB1 antibody, or a sheep 
isotype control IgG. Beads were washed five times and protein eluted by heating to 
90 oC in SDS loading buffer for 10 minutes. Eluent was immunoblotted with 
antibodies against BAZ1B, SMARCA5, MTA2, RBBP4 and hSSB1 as indicated. 15 
µg whole cell lysate (input) was immunoblotted with antibodies against hSSB1, 
pS345 and total Chk1 (HU positive control) and actin (loading control). The gel 
shown here are from an experiment performed concurrently with that in Figure 4.6 E. 
 
10 proteins were detected in the IgG lane and included peptides belonging to three 
keratin sub-types, two IgG molecules, two histones (one peptide each), Annexin A2, 
GAPDH and a member of the POTE Ankyrin domain family. The small number of 
proteins detected in the IgG:IP sample suggests that those identified by hSSB1 
immunoprecipitation were so specifically. 
 
Only minor variation in the hSSB1-associating proteins was observed following 
hydroxyurea treatment. Regardless of this, it was interesting to note that the majority 
of detected proteins did seem to belong to one of a number of different groups when 
categorised by their known biological function (Figure 4.14D).  
 
Surprisingly, of the proteins identified, only a relatively small number are known to 
have a direct role in DNA repair or replication. These included the minichromosome 
maintenance complex subunits 6 and 7 (MCM6 and MCM7) both of which form part 
of the helicase complex required for unwinding duplex DNA during replication 
(Bochman and Schwacha, 2009). In addition, numerous peptides were identified 
which may belong to DNA topoisomerase II alpha or beta. Both of these enzymes 
function to alter the superhelical state of DNA by cleaving and subsequently re-
ligating DNA following helicase winding or unwinding of the DNA and are required 
 Characterisation of Human Single-Stranded DNA-Binding Protein 1 (hSSB1) Regulation by Post-Translational 
Modifications 151 
for DNA replication as well as for mRNA transcription (Wendorff et al., 2012). 
Consistent with the observation that hSSB1 S134 phosphorylation may be regulated 
by PPP-family phosphatases, the catalytic subunit of PP1 and the regulatory subunit 
of PP2 was also detected. 
 
The largest group of proteins identified contained 77 ribosomal proteins, 
either belonging to the 40S or 60S subunit. In addition, 23 proteins involved in 
ribosome biosynthesis were also detected. As these proteins are not known to bind 
chromatin, it is likely they were instead identified due to the co-isolation of nucleoli 
as well as chromatin following the nuclear lysis step of the subcellular fractionation; 
proteins from these structures were most likely liberated during the subsequent 
incubation. Interestingly, nucleophosmin, one of the ribosome biogenesis proteins 
identified, has previously been identified by our group as a direct hSSB1-interacting 
protein. Although this has previously been considered as evidence that 
nucleophosmin may have a role in DNA repair, it is tempting to consider that the 
identification of numerous other ribosomal biogenesis proteins in this study may 
instead reflect a novel role for hSSB1 in this process. Alternatively, due to the high 
abundance of ribosomal components in the cell, these proteins are frequent 
contaminants of mass spectrometry datasets that have been generated from affinity-
isolated samples (Mellacheruvu et al 2013). It therefore cannot be excluded that 
although these proteins were not identified in the IgG sample, their detection may be 
due to non-specific electrostatic interaction with hSSB1 or other proteins.  
 
RNA metabolism proteins were also highly represented in the data sets, including a 
number of components of the cleavage and polyadenylation specificity factor 
complex (CPSF), as well as numerous other ancillary proteins involved in 
polyadenylation and 3`-end cleavage of mammalian pre-mRNAs (Murthy and 
Manley, 1995). A number of proteins known to promote pre-mRNA splicing were 
also detected and were represented by subunits and interacting partners of the 
U4/U6-U5 tri-snRNP complex, as well as other spliceosome factors. Numerous 
ATP-dependent RNA helicases were also detected, many of which were of unknown 
physiological function, although include subunits of the exon junction complex, 
which marks the position of exon-exon junctions in mature mRNA and promotes 
mRNA export and translation (Le Hir et al., 2001). Components of heterogeneous 
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nuclear ribonucleoprotein (hnRNP) complexes were also detected which provide 
similar pre-mRNA processing functions to those mentioned above (Carpenter et al., 
2006).  
 
Numerous proteins involved in chromatin remodelling and modification were also 
detected in the mass spectrometry data set and represented a number of known 
protein complexes (Figure 4.14E). These included the WICH complex components 
BAZ1B and SMARCA5, the two proteins for which the greatest number of peptides 
were detected in the hydroxyurea treated sample. Importantly, while the precise role 
of this complex remains unclear, both of these proteins have recently been found to 
associate directly with stalled replication forks (Sirbu et al., 2013). In addition to the 
WICH complex, peptides corresponding to each component of the NuRD 
remodelling complex were also observed, with MTA2, RBBP4 and β-actin amongst 
the highest ‘hits’ post-damage. The essential role of this complex for replication fork 
integrity has also been documented (Aranda et al., 2014; Errico et al., 2014; Sims 
and Wade, 2011). To further validate the association of hSSB1 with WICH and 
NuRD complex proteins, hSSB1 was immunoprecipitated from whole cell lysate of 
HeLa cells that had been treated with or without 3 mM hydroxyurea for 4 hours. 
Proteins were then eluted and immunoblotted with antibodies against BAZ1B, 
SMARCA5, MTA2 and RBBP4 (Figure 4.14F). Consistent with the mass 
spectrometry data, each of these proteins was specifically immunoprecipitated with 
hSSB1 both before and after hydroxyurea treatment. These data thereby support that 
hSSB1 may associated with these chromatin remodelling complexes in cells. 
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4.4 Discussion 
 
Enzymatically active DNA-PK is a central component of the cellular response to 
replication fork inhibition (Lin et al., 2014). Indeed, cells depleted of endogenous 
DNA-PKcs, or expressing an enzymatically deficient kinase mutant, show reduced 
clonogenic survival when treated with hydroxyurea (Ying et al., 2015). With the 
notable exception of RPA32 (Liu et al., 2012), as well as auto-phosphorylation (Ying 
et al., 2015), few relevant DNA-PK substrates have however been identified in the 
response to replication stress. It was therefore interesting to observe that hSSB1 S134 
phosphorylation is required for clonogenic survival of cells treated with the 
replication stress compounds hydroxyurea and aphidicolin (Figure 4.2) and establish 
that phosphorylation is primarily a result of DNA-PK activity (Figure 4.4 and 4.7). A 
decrease in basal and HU-induced hSSB1 S134 phosphorylation was also observed 
following inhibition, although not depletion, of the ATM and ATR kinases, 
potentially indicating a secondary role for these enzymes in hSSB1 S134 
phosphorylation. Such overlap between the PI3K-like kinases is indeed not 
uncommon in the phosphorylation of DNA repair proteins and is exemplified by the 
HU-induced phosphorylation of numerous RPA32 residues by the overlapping 
activities of ATM, ATR and DNA-PK (Liu et al., 2012). Another example is the 
phosphorylation of Chk1 S317. Whilst this residue is primarily phosphorylated by 
the ATR kinase (Zhao and Piwnica-Worms, 2001), ATM and DNA-PK have recently 
been implicated in a ‘back-up’ pathway in cells where ATR function is suppressed 
(Buisson et al., 2015). Although a similar scenario may explain the suppression of 
hSSB1 S134 phosphorylation observed following ATM and ATR inhibition, an 
alternative explanation may instead include cross talk between these enzymes and 
DNA-PK as has been suggested in numerous DNA repair pathways (Chen et al., 
2007; Vidal-Eychenié et al., 2013; Yajima et al., 2006). Such an explanation may 
indeed be more likely than a direct role for ATM and ATR in the phosphorylation of 
hSSB1 S134, especially given the almost complete reduction in phosphorylation 
observed following DNA-PK inhibition or depletion (Figure 4.4).  
 
While hSSB1 S134 is also phosphorylated by DNA-PK in undamaged cells, this may 
be maintained at steady-state levels by the opposing activities of PPP-family protein 
phosphatases. This family includes numerous members that are inhibited by okadaic 
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acid in cells, including PP2A, PP4, PP5, and PP6 (Swingle et al., 2007). The increase 
in hSSB1 phosphorylation observed following treatment of cells with okadaic acid 
(Figure 4.6) therefore suggests the potential involvement of one of these enzymes in 
the dephosphorylation of hSSB1. Indeed, each of these enzymes has previously been 
implicated in the regulation of DNA repair pathways (Lee and Chowdhury, 2011) 
and may represent plausible regulators of hSSB1. Although an additional increase in 
hSSB1 phosphorylation was observed when calcyculin A was added to cells, a 
compound that additionally inhibits PP1, it is unclear whether the greater affect 
observed here with comparison to okadaic acid treatment is due to PP1 involvement. 
Indeed, calyculin A also shows increased potency towards PP5, another plausible 
candidate phosphatase of hSSB1, especially considering the involvement of this 
protein in the regulation of DNA-PK (Wechsler et al., 2004). It was however 
interesting to note the detection of PP1 and PP2A phosphatase peptides in the mass 
spectral analysis of hSSB1 interacting proteins (Figure 4.14; as well as the 
immunoprecipitation of PP2A-C with hSSB1 in Figure 4.6). Although this detection 
does not necessarily implicate an involvement of these phosphatases in hSSB1 
dephosphorylation, a shared role may explain the okadaic acid-induced increase in 
S134 phosphorylation, as well as the greater effect of calyculin A addition. Further 
studies will however be required to dissect the individual roles of the PPP-family 
phosphatases in the regulation of hSSB1 phosphorylation and would most likely 
require the individual depletion of one or more of the subunits (numerous isozymes 
of which exist) of each of these phosphatases. Dominant-negative mutants of PP1 
(Gallego et al., 2006), PP2A (Kins et al., 2001), PP4 (Zhou et al., 2002), PP5 (Chen 
et al., 1996) and PP6 (Kajihara et al., 2010) have also been described previously, the 
exploitation of which may represent another means of assessing the involvement of 
these phosphatases in hSSB1 dephosphorylation. 
 
It may be useful to consider the reason why hSSB1 phosphorylation could increase 
following replication inhibition. DNA-PK is stimulated by the interaction with 
dsDNA that contains short ssDNA overhangs, such as may form at double-strand 
DNA breaks (Carter et al., 1990; Vidal-Eychenié et al., 2013). As double-strand 
breaks do occur following hydroxyurea treatment as a result of replication fork 
collapse (Cobb et al., 2005), the hydroxyurea-induced increase in hSSB1 S134 
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phosphorylation may therefore be explained by DNA-PK activation as a result of the 
accumulation of these lesions. Indeed, as replication fork collapse is unlikely to 
occur immediately after hydroxyurea-induced fork disruption, but instead 
progressively after a period of fork ‘stalling’, the gradual increase in the number of 
double-strand breaks may offer an explanation for the time-dependent increase in 
hSSB1 S134 phosphorylation observed for up to 20 hours post-hydroxyurea 
treatment (Figure 4.3). This is likely to be compounded by the increase in the number 
of cells entering S phase over this 20 hour period. The phosphorylation of hSSB1 
S134 in response to double-strand DNA break formation is also supported by the 
increase in phosphorylation observed after the treatment of cells with aphidicolin or 
camptothecin, compounds which also cause replication fork collapse (Ozeri-Galai et 
al., 2008). This is especially true of camptothecin treatment, which unlike treatment 
with hydroxyurea and aphidicolin, induces the formation of double-strand DNA 
breaks without a lengthy period of fork stalling (Saleh-Gohari et al., 2005). Given 
that hSSB1 S134 may therefore be phosphorylated in the response to these lesions, it 
is also interesting to consider the pathway through which this occurs. Indeed, whilst 
double-strand DNA breaks caused by fork collapse have traditionally been thought to 
be repaired solely by homologous recombination (HR) (Arnaudeau et al., 2001; 
Lundin et al., 2002), this has been challenged by the implication of numerous non-
homologous end-joining (NHEJ)-related proteins (e.g. DNA-PK, KU, Artmeis, DNA 
ligase IV) in the replication stress response (Allen et al., 2011). Nevertheless, it is 
unclear how NHEJ could function in the repair of collapsed forks, as this would 
produce a ‘one-ended double-strand break’, without providing a second dsDNA end 
NHEJ could utilise. Furthermore, whilst NHEJ could theoretically function in the re-
joining of adjacent collapsed forks, this would result in the loss of genetic material. It 
therefore seems plausible that if hSSB1 is phosphorylated by DNA-PK at S134 as a 
result of fork collapse, this is more likely to occur as a result of DNA-PK activity 
during HR. In this pathway, DNA-PK likely functions through overlap and cross-talk 
with ATM (Shrivastav et al., 2009), potentially also explaining the involvement of 
this enzyme as discussed above. 
 
If hSSB1 is indeed phosphorylated at S134 during the repair of collapsed replication 
forks by HR or NHEJ, it is curious to note that the exposure of HeLa cells to ionising 
radiation, which causes both direct and indirect double-strand DNA break formation 
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(Vignard et al., 2013), did not markedly increase the detection of S134 
phosphorylation (Figure 4.5). Unlike double-strand DNA breaks that accumulate and 
persist in cells whilst they are treated with hydroxyurea, conditions under which 
homologous recombination cannot function, double strand breaks caused by ionising 
radiation can be freely repaired. Therefore, while hSSB1 S134 may indeed not be 
phosphorylated during the repair of ionising radiation-induced breaks, it is also 
possible that it is dynamically phosphorylated and dephosphorylated, such that an 
increase in phosphorylation was not detected at the time-points chosen. This may be 
consistent with the observation that, unlike transiently expressed WT 3x FLAG 
hSSB1, an S134A mutant was not able to rescue cells from the sensitivity to ionising 
radiation caused by the depletion of endogenous hSSB1.  
 
In the above paragraphs it is suggested that hSSB1 S134 may be phosphorylated 
following replication fork collapse. Although hydroxyurea does cause the formation 
of such lesions, the accumulation of which has been detected within 2 - 6 hours of 
treatment, the vast majority of replication forks are likely to remain stable for greater 
than 12-18 hours, with many not collapsing for up to 48 hours (Petermann et al., 
2010; Saintigny et al., 2001). In addition, whilst replication forks are progressively 
‘inactivated’ following hydroxyurea treatment, many may restart following short 
disruptions (~ 80% of stalled forks may restart after 2 hours of HU treatment, 
compared to < 20% after 20 hours) (Petermann et al., 2010). As both hSSB1 and 
DNA-PK have been suggested to function in the stabilisation and restart of stalled 
replication forks (Bolderson et al., 2014; Ying et al., 2015), it is therefore also likely 
that hSSB1 may be phosphorylated during these processes, rather than, or in addition 
to, in the repair of double-strand DNA breaks caused by fork collapse. Such 
implications would however require further experimentation. Specifically, DNA 
fibre analysis could be employed to assess the ability of cells depleted of endogenous 
hSSB1 and transiently expressing WT or S134A hSSB1 to restart replication 
following a period of fork disruption. In addition, techniques such as pulse-field gel 
electrophoresis would allow the monitoring of double-strand DNA break formation 
in S134A hSSB1-expressing cells following replication inhibition. 
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In section 4.2.2, clonogenic survival assays were performed, where HeLa cells 
depleted of endogenous hSSB1 and transiently expressing WT or S134A 3x FLAG 
hSSB1 were treated with 3 mM hydroxyurea or 6 µg µL-1 aphidicolin for 4, 8, 12, 16 
or 20 hours. In these assays, cells that were depleted of endogenous hSSB1 were 
found to be hypersensitive to either drug, which was alleviated by the expression of 
WT, although not S134A, 3x FLAG hSSB1. Whilst a statistically significant 
difference in survival was observed between the two groups (siControl and sihSSB1 
+ WT hSSB1 vs sihSSB1 and sihSSB1 + S134A hSSB1) when treated for 4, 8, 12, or 
16 hours, it was interesting to note that similar survival was observed for those cells 
treated for 20 hours, regardless of hSSB1 status. Although by no means as conclusive 
as the experiments suggested in the previous paragraph, these observations may 
provide insight as to how hSSB1 functions following replication disruption. The cell 
death observed following hydroxyurea treatment is likely to occur through an 
apoptotic response (Gui et al., 1997), most probably due to the formation of double-
strand DNA breaks. Indeed, in a recent publication (Couch et al., 2013), rapid 
hydroxyurea-induced cell death was observed following inhibition of the ATR 
kinase, conditions under which double-strand DNA breaks rapidly formed. Whilst 
the reported hydroxyurea sensitivity observed following ATR inhibition is much 
greater than observed here for cells depleted of hSSB1, or expressing S134A hSSB1, 
it is tempting to consider this may occur for a similar reason. Here, S134 
phosphorylation may be required for the prevention of double-strand DNA break 
formation, resulting in reduced cell survival of S134A hSSB1-expressing cells at 
early time-points. By 20 hours of hydroxyurea treatment, the presence or absence of 
hSSB1, as well as phosphorylation status, may however be irrelevant due to the 
increase in fork collapse that is likely to occur in control cells by this time, 
independently of hSSB1 function (Petermann et al., 2010).  
 
Although DNA-PK is thought to be predominantly activated by binding to ssDNA at 
double-strand DNA breaks ends, its activity may also be stimulated by binding 
ssDNA gaps within dsDNA substrates, as well as unbound DNA within structured 
ssDNA (Vidal-Eychenié et al., 2013). The binding to such substrates within 
disrupted replication forks is therefore likely to explain the activation of DNA-PK at 
sites of stalled replication forks, as well as provide a rationale for subsequent hSSB1 
S134 phosphorylation. Additionally, the further regulation of hSSB1 phosphorylation 
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by PPP-family phosphatases may however suggest that, aside from increased DNA-
PK activity, hSSB1 S134 phosphorylation may also be stimulated by the suppression 
of these enzymes. This could, for instance, involve a dissociation of hSSB1 and the 
PPP-family protein phosphatase, or inactivation of the phosphatase, either as a result 
of signalling activation or the stimulation of phosphatase inhibitors proteins. 
 
Given the requirement for activated DNA-PK in the phosphorylation of hSSB1 S134, 
its might be worthwhile to consider that hSSB1 is evidently also phosphorylated in 
undamaged cells. Indeed, as basal hSSB1 phosphorylation seems to involve DNA-
PK function, this scenario suggests that a pool of activated DNA-PK must also exist 
in non-exogenously damaged cells. This is supported by the similar increase in 
DNA-PK auto-phosphorylation observed following okadaic acid treatment of cells 
(Douglas et al., 2002), or depletion of PP5 (Wechsler et al., 2004). It is worth noting 
that basal phosphorylation of RPA32 S33 was also observed in cells, which increased 
at a similar rate to hSSB1 S134 phosphorylation following hydroxyurea treatment 
(Figure 4.3). RPA32 S33 phosphorylation in undamaged cells has previously been 
found to occur in the late S- and G2 phases of the cell cycle and has been attributed 
to the persistence of endogenously stalled replication forks (Vassin et al., 2009). A 
similar scenario may thereby also explain the detection of S134 phosphorylated 
hSSB1 in undamaged cells. As these experiments were conducted at 21% O2 and 
therefore cells were likely to experience significant stress (Jagannathan et al., 2016), 
the formation of numerous oxidative lesions may also offer an explanation for basal 
hSSB1 S134 phosphorylation. This could include through the formation of oxidative 
lesions such as thymine glycol, the most common oxidation product of thymine, 
which has been found to efficiently block replicative polymerases (Aller et al., 2007). 
Although such lesions are likely to be rapidly bypassed by translesion synthesis 
(Kirouac and Ling, 2009; Kusumoto et al., 2002), transient replication fork stalling 
may represent a stimuli for hSSB1 phosphorylation. In addition, unrepaired oxidative 
lesions may eventually generate more disruptive species, such as DNA breaks, that 
could also disrupt replication forks to a substantial degree (Maynard et al., 2009). In 
addition, hSSB1 has recently been demonstrated to function directly in the repair of 
oxidised guanine residues (Paquet et al., 2015), a repair process during which hSSB1 
could theoretically also be phosphorylated. Further, DNA-PK has been suggested to 
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also function in the BER pathway (through an as yet unclear mechanism) (Chen et 
al., 2012), which may explain the DNA-PK-dependency of basal S134 
phosphorylation. As detection of S134 phosphorylation predominantly required 
transient overexpression of hSSB1, it cannot however be ruled out that the high 
degree of basal hSSB1 phosphorylation observed was due the equilibrium between 
S134 phosphorylation and dephosphorylation being somewhat altered from 
endogenous ratios. The deregulation of hSSB1 signalling as a result of transient over-
expression may indeed be an appealing explanation, especially considering the 
hyper-ubiquitination of 3x FLAG hSSB1 described in the previous chapter. Unlike 
the non-specificity described for poly-ubiquitination, phosphorylation of S134 is 
however unlikely to be purely an artefact of over-expression, especially considering 
the detection of endogenous phosphorylated hSSB1 in Figure 4.3, the cell survival 
defect of S134A-expresing cells in Figure 4.2, as well as the specific nature of DNA-
PK and PPP-family phosphatase regulation of this event in Figures 4.4 and 4.6. 
 
A potentially informative finding regarding the regulation of hSSB1 by PPP-family 
protein phosphatases comes from the observation that while hSSB1 phosphorylation 
is enhanced following okadaic acid or calcyulin A treatment, this is further enhanced 
by the prior treatment of cells with hydroxyurea (Figure 4.6). While hydroxyurea-
induced phosphorylation is not an unexpected finding, it was surprising to note that 
the relative ratio of phosphorylation in phosphatase inhibitor-treated cells +/- 
hydroxyurea treatment was similar to that observed for hydroxyurea-treated control 
cells. This is interesting, as it would be expected that if hSSB1 is stably 
phosphorylated following hydroxyurea treatment that the same overall increase in 
hSSB1 phosphorylation would be observed regardless of phosphatase inhibition. 
Indeed, a similar relative increase in hydroxyurea-induced S134 phosphorylation 
following phosphatase inhibition instead suggests that a large amount of the hSSB1 
that is phosphorylated in response to hydroxyurea treatment is subsequently 
dephosphorylated, even in the presence of hydroxyurea. These findings may suggest 
that hSSB1 is both phosphorylated and dephosphorylated in the response to 
replication inhibition. 
 
Despite the likelihood of S134 phosphorylated hSSB1 functioning at sites of 
replication fork inhibition, the mutation of hSSB1 DNA or PAR-binding residues did 
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not markedly alter S134 phosphorylation (Figure 4.8). One possible explanation for 
this could be that while hSSB1 does at some stage bind to DNA or PAR at disrupted 
replication forks, this interaction may not be required for its retention at chromatin. 
Indeed, as hSSB1 is likely to interact directly with numerous other proteins at these 
sites, it may still be ‘held’ in position to be phosphorylated by these interacting 
partners, irrespective of substrate binding. A similar situation has previously been 
demonstrated at sites of double-strand DNA breaks. In these experiments, the PAR-
binding mutant WD55AA, which is also likely to be deficient for DNA-binding (our 
collaborator Dr Roland Gamsjaeger recently calculated a 10-fold difference in Kd for 
ssDNA-binding of W55A hSSB1 compared to WT), was still recruited to DNA 
damage sites induced by laser micro-irradiation, albeit at a slower rate (Zhang et al., 
2014). Here, PAR-independent chromatin localisation was suggested to require the 
hSSB1 binding-partner INTS3, a protein the authors found localised to DNA damage 
sites independently of hSSB1. As INTS3-binding may also be required for hSSB1 
function following replication fork inhibition (Figure 4.9), an interaction with this 
protein may at least partially explain how hSSB1 could be localised to disrupted 
replication forks and subsequently phosphorylated at S134. Indeed, whilst disruption 
of INTS3-binding by mutation of residue F98 did not prevent S134 phosphorylation 
of otherwise WT hSSB1, it is tempting to consider whether disruption of this 
interaction may prevent phosphorylation of DNA-binding deficient hSSB1. The 
interaction with numerous other proteins is however of course likely to be important 
for hSSB1 function following fork disruption, these proteins of which may also 
mediate chromatin-localisation of DNA-binding deficient hSSB1. It is also possible 
that non-chromatin bound hSSB1 may be phosphorylated at S134, potentially as a 
means of regulating soluble pools of the protein. This however would require the 
activation of DNA-PK independently of DNA-binding, a means of which are not 
readily apparent. 
 
The interaction of hSSB1 with fork substrates was an unexpected observation (Figure 
4.13) as it has previously been shown that hSSB1 is unable to effectively bind 
dsDNA duplexes (Paquet et al., 2015). Interestingly, a similar observation was 
recently reported for the annealing helicase SMARCAL1, a protein that also has 
minimal affinity for dsDNA, although which readily binds model replication forks 
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lacking exposed ssDNA (Betous et al., 2012). In this work, the authors suggested that 
SMARCAL1 might capture small amounts of ssDNA that are exposed due to 
‘breathing’ of the dsDNA regions adjacent to the fork junction. It is tempting to 
consider that hSSB1 may bind this structure through a similar means. Indeed, these 
results are somewhat reminiscent of the finding that hSSB1 is able to bind a dsDNA 
substrate containing a single 8-oxoguanine modification, potentially due to a similar 
localised de-stabilisation of the DNA duplex (Paquet et al., 2015). Although the 
localisation of hSSB1 with disrupted replication forks has previously been 
demonstrated (Bolderson et al., 2014), the mechanistic consequence of fork-junction 
binding remains unclear. The decreased affinity of the hSSB1 S134E phospho-
mimetic for a model fork substrate does however suggest that phosphorylation may 
act to suppress this function of hSSB1 following replication inhibition. A possible 
explanation for this may be that while hSSB1 is involved in the initial recruitment 
and initiation of the replicative stress response (Bolderson et al., 2014), the 
persistence of hSSB1 at the fork junction may be detrimental to the subsequent 
restart of the fork. Given that hSSB1 S134 may be both phosphorylated and de-
phosphorylated in the response to replication inhibition, it is also tempting to 
consider that this modification may mediate a dynamic mode of fork junction 
binding. The increased sensitivity of cells expressing S134A hSSB1 to hydroxyurea 
and aphidicolin treatment may therefore be explained not only by a need for hSSB1 
to bind replication forks junctions, which S134A hSSB1 would be expected to be 
capable of, but also to be subsequently removed. S134A hSSB1 may therefore be 
‘disruptive’ to the replicative stress response, rather than just functionally deficient. 
In this way, the similar hydroxyurea and aphidicolin sensitivity observed for hSSB1-
depleted cells and those transiently expressing S134A hSSB1 may be due to different 
reasons. Confirmation of this mechanistic role for hSSB1 is however lacking and will 
require further investigation.  
 
Whilst the above hypothesis may be plausible, it however cannot be discounted that 
S134 phosphorylation may alter hSSB1 function through a separate means in cells. 
For instance, while interaction of the S134 phosphorylated peptide with phospho-
domain binding proteins was not detected in Section 4.2.10, it cannot be excluded 
that phosphorylation of S134 may still mediate such an interaction within the context 
of the full-length protein. Phosphorylation could also mediate an interaction with a 
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phospho-binding protein that was not included on the microarray, or with another 
type of protein that does not directly bind the phosphorylated residue, although 
which may bind S134 phosphorylated hSSB1 due to physical changes in the protein 
structure. Similarly, whilst S134E hSSB1 did not appear to be less readily degraded 
than WT hSSB1 (Figure 4.12), it remains possible that glutamic acid is unable to 
accurately mimic phosphorylation of S134 in cells, such that phosphorylation may 
indeed have an effect on hSSB1 half-life. A role for S134 phosphorylation in DNA 
binding may however have informative implications in a phylogenetic context. As 
demonstrated in Figure 4.11, the presence of serine at residue 134 in mammals is 
largely restricted to simiiform primates, whilst proline is found at residue 134 in the 
majority of other species. Although phosphorylation of S134 may alter hSSB1 
through electrostatic means, it may be interesting to consider that its affect may 
instead be exerted through a physical means, similar to what may be expected for a 
proline residue. It is therefore tempting to speculate that while a proline at residue 
134 may similarly prevent binding to fork junctions, the adaptation of a serine at 
residue 134 in primates may have allowed this type of interaction, which could be 
regulated by DNA-PK-mediated phosphorylation. The functional analysis of an 
S134P hSSB1 mutant in future work may therefore be of value and could be tested 
using similar EMSA assays. Alternatively, as many species other than humans 
contain a putative phosphorylation site at residue 149, the phosphorylation of S134 
may have a compensatory role that is similar to phosphorylation of residue 149. 
Further investigation will therefore be required to understand these interspecies 
differences.  
 
Although S134E hSSB1 binds fork substrates with reduced affinity, ssDNA is bound 
similarly to the WT protein. It is therefore possible that while phosphorylated hSSB1 
is displaced from the fork junction, it may still associate with the comparably large 
quantity of ssDNA exposed by replication inhibition (Sogo et al., 2002). 
Confirmation of these hypotheses will however require further investigation in cells. 
Indeed, due to poor specificity of the pS134 hSSB1 antibody in immunofluorescence 
assays, it has been difficult to assess the localisation of phosphorylated hSSB1 to 
replication forks using this approach. An assessment of phosphorylated hSSB1 
binding to replication forks may therefore be more achievable in future experiments 
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through employment of a replication fork pull-down assay, such as via the ‘isolation 
of proteins on nascent DNA’ (iPOND) method. In this assay, cells are pulse labelled 
with the nucleoside analogue Edu, which in later steps is conjugated to biotin in a 
click-chemistry reaction. Replication fork DNA, as well as associating proteins, are 
then isolated by streptavidin purification (Sirbu et al., 2013; Sirbu et al., 2012). Such 
an approach may therefore allow the specific detection of phosphorylated hSSB1 
with replication fork DNA. 
 
Given that hSSB1 seems able to bind replication fork junctions, it is also tempting to 
consider that hSSB1 might bind other related DNA substrates, such as Holliday 
junctions. SMARCAL1, for instance, has been found to bind both of these substrates, 
as well as fork junctions, despite not binding dsDNA (Betous et al., 2012). Each of 
these substrates is further likely to form during the processing of stalled or collapsed 
replication forks. Holliday junctions for instance form as an intermediate during 
helicase-driven fork regression (Machwe et al., 2007; McGlynn et al., 2001), as well 
as during repair by homologous recombination (Liu and West, 2004). A role for 
S134 phosphorylation in mediating the interaction of hSSB1 with each of these 
structures may therefore offer an explanation for the role of this modification in the 
repair of disrupted replication forks. In addition, the mediation of Holliday junction-
binding during homologous recombination-repair may explain the inability of S134A 
hSSB1 to rescue cells of the hypersensitivity to ionising radiation exposure caused 
by hSSB1 depletion.  
 
An unexpected observation from this study was the identification of numerous 
chromatin-remodelling protein complexes by mass spectrometry performed on 
proteins co-immunoprecipitating with chromatin-bound hSSB1 (Figure 4.14). As 
each of these complexes have been suggested to function in replication fork integrity 
and DNA repair, a potential role for hSSB1 with these proteins is an attractive 
proposition. BAZ1B (WSTF) and SNF2H (SMARCA5) (proteins for which the 
highest number of peptides were identified), components of the WICH complex, 
have for instance previously been found to localise with progressing and stalled 
replication forks, mediated by a direct interaction of BAZ1B with PCNA (Poot et al., 
2004; Sirbu et al., 2013). During replication, the WICH complex migrates with 
PCNA, and by virtue of the SNF2H SWI/SNF2 ATPase domain, is able to disrupt 
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DNA-histone interactions and maintain an ‘open’ chromatin structure. The depletion 
of WSTF in cells therefore results in an increase in histone H3 K9 trimethylation and 
K27 dimethylation, epigenetics marks that have been associated with repressive 
chromatin structures (Poot et al., 2004). As histone epigenetic changes are also 
observed following the disruption of other chromatin remodelling complexes, the 
assessment of these marks in cells may therefore represent one means of indirectly 
assessing a role for hSSB1 in these processes. Such assessment could for instance be 
performed either by immunoblotting or immunofluorescence techniques using 
hSSB1-depleted cells and antibodies against specific histone modifications. In 
addition, use of the iPond technique to monitor specific modifications at replication 
forks has previously been described (Sirbu et al., 2013). This technique would also 
allow for an elegant assessment of such roles for hSSB1 at these sites. 
 
Whilst it is tempting to speculate that the immunoprecipitation of numerous 
chromatin-remodelling proteins with hSSB1 may suggest a novel pathway through 
which the hSSB1 functions in the repair of DNA damage, it remains equally 
plausible that these observations may instead reflect an involvement of hSSB1 in 
other chromatin remodelling-dependent pathways. This may include processes such 
as mRNA transcriptional regulation, where chromatin remodelling has an essential 
role. Indeed, the majority of the chromatin-remodelling proteins immunoprecipitated 
with hSSB1 are considered transcription factors. A role for hSSB1 in such 
transactions is supported by a recent publications indicating that hSSB1 (and hSSB2) 
may function in complex with INTS3 to promote transcription termination at 
numerous gene targets (Skaar et al., 2015). These data nevertheless provide new 
information regarding hSSB1 protein associations in cells. 
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Chapter 5:  General Discussion and Concluding Remarks 
Evidence provided both here and elsewhere suggest the involvement of hSSB1 in the 
cellular response to numerous DNA-damaging chemotherapeutics, including 
exposure to the drugs, etoposide (Kar et al., 2015), hydroxyurea and camptothecin 
(Bolderson et al., 2014). In addition, hSSB1-depleted cells are hypersensitive to 
ionising radiation exposure (Richard et al., 2008). It is therefore conceivable that the 
inactivation or depletion of hSSB1 in combination with such treatments may be of 
benefit for the treatment of various cancer types. The feasibility of targetting hSSB1 
directly in cancer is however unclear, especially considering this protein is neither an 
enzyme nor a membrane-bound receptor and so means of targetting hSSB1 by 
classical small molecule-based approaches are less apparent. Indeed, the targetting of 
protein-protein, or protein-substrate interactions with small-molecules is likely to be 
applicable only to the disruption of very narrow interaction surfaces (Makley and 
Gestwicki, 2013), unlike, for instance, the DNA binding groove of the hSSB1 OB-
fold. Targetting hSSB1 at the protein level may therefore require the identification of 
new, high-affinity hSSB1 protein interaction sites, which may represent drugable 
targets. The effective disruption of the p53-MDM2 E3 ubiquitin ligase interaction by 
the small molecular inhibitor Nutlin-3 (Poyurovsky et al., 2010; Vassilev et al., 
2004), for example, may suggest precedence for the inhibition of proteins through 
the disrupted binding of modifying enzymes or other major binding partners. The 
further characterisation of hSSB1 function and regulation may therefore provide a 
means of targeting hSSB1 in cancer. In addition, the further identification of 
enzymes involved in the post-translational regulation of hSSB1 may suggest novel 
anti-cancer targets that may be targetable by classical active site inhibition. For 
instance, a recent publication found that poly-ubiquitination of hSSB1 occurs 
predominantly through SCF complexes containing the F-box protein, FBXL5 (Chen 
et al., 2014). The novel association of this protein with hSSB1 thereby lead the 
authors to also explore and confirm a role for FBXL5 in the response to the DNA 
damaging drug etoposide. These data may thereby demonstrate the strength of 
studying hSSB1 for the identification of new DNA-repair proteins that may be 
effective anti-cancer targets. 
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The major aim of this PhD study was to further characterise the post-translational 
regulation of hSSB1. Data pertaining to this aim have been presented in the 
preceding two chapters. In the first of these (Chapter 3), the regulation of hSSB1 by 
poly-ubiquitination was further explored and included the mutation of each hSSB1 
lysine residue to arginine, both individually and in combination. The disruption of 
hSSB1 ubiquitination however required the complete removal of lysine residues 
from the protein, suggesting that each hSSB1 lysine residue could potentially be 
modified. Indeed, examination of the hSSB1 crystal structure indicated that each 
lysine residue side chain may protrude away from the protein and is likely available 
for modification. The robust poly-ubiquitination of over-expressed hSSB1 may 
therefore suggest a cellular requirement to degrade excess hSSB1, potentially due to 
a detrimental effect of de-regulated hSSB1 to the cell. For instance, it seems probable 
that not all ssDNA-transactions might require hSSB1 and that extensive over-
expression may indeed be disruptive to these processes. Furthermore, even in 
pathways in which hSSB1 is involved, high-level over-expression may prevent 
proper hSSB1 regulation, which potentially also may be disruptive. Future work into 
the characterisation of hSSB1 function may therefore benefit from the use of cell 
lines that express hSSB1 mutants at close-to endogenous levels. Although the 
generation of cell lines that stably express hSSB1 mutants has been relatively 
unsuccessful in our group using standard antibiotic selection methods, potentially 
due to a similar pressure to prevent excess hSSB1 accumulating in the cells as 
discussed above, it is noted that other groups have had success in generating hSSB1 
over-expressing cell lines using a doxycycline-inducible expression system (Ren et 
al., 2014; Wu et al., 2015). The further employment of this technique may therefore 
be of benefit for hSSB1 functional assessment in future studies. 
 
In the latter section of chapter 3, mass spectrometry was employed and numerous 
putative phosphorylation sites detected. One of these, the phosphorylation of serine 
residue 134 (S134), became the central topic of the second data chapter (Chapter 4). 
S134 is a component of an SQ motif, numerous of which are phosphorylated in other 
DNA repair proteins by the P13K-like kinases, ATM, ATR and DNA-PK (Traven 
and Heierhorst, 2005). Indeed, S134 phosphorylation of hSSB1 was predominantly 
mediated by DNA-PK and was enhanced following replication fork disruption. 
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Regulation of hSSB1 by PPP-family protein phosphatases was also observed, 
allowing for the dynamic mediation of hSSB1 phosphorylation. Here, 
phosphorylation of S134 is likely required for the proper function of hSSB1, as an 
S134A hSSB1 mutant was unable to rescue cells from the hydroxyurea and 
aphidicolin sensitivity observed in hSSB1-depleted cells. Consistent with the above 
suggestion that further evaluation of hSSB1 post-translational modifications may 
allow for the identification of anti-cancer targets, the inhibition of DNA-PK has been 
extensively shown to sensitise cancer cells to DNA damaging chemotherapeutics and 
radiotherapy (Elliott et al., 2011; Guo et al., 2011; Leahy et al., 2004; Willmore et 
al., 2004; Zhao et al., 2006). This is also true of the PPP-family protein phosphatases, 
numerous of which regulate members of the DNA repair pathways and are required 
for cell survival in response to ionising radiation exposure and replication fork 
disruption (Ali et al., 2004; Chowdhury et al., 2005; Chowdhury et al., 2008; Keogh 
et al., 2006; Shen et al., 2011). The targetting of DNA-PK or PPP-family protein 
phosphatases in cancer treatment has however been problematic due to numerous 
specificity, stability and pharmacokinetic issues with available inhibitors (Davidson 
et al., 2013; Swingle et al., 2007), issues that will have to be overcome prior to these 
enzymes representing viable anti-cancer targets. 
 
As well as providing further insight into the specific regulation of hSSB1 by 
ubiquitination and S134 phosphorylation, the data provided in this thesis suggests 
that hSSB1 is likely to be more extensively modified than is currently documented. 
This is particularly evident based on the detection of numerous putative 
phosphorylation sites by mass spectrometry, which are likely to be of importance for 
hSSB1 function. Indeed, whilst a projection of how this may occur is unfeasible, 
several of these putative phosphorylation sites are particularly intriguing. Residues 
T53, T76 and T83, for instance, are components of the DNA-binding OB-fold and 
located in close proximity to the important DNA-binding aromatic residues, W55, 
Y74-Y78 and Y85A, respectively. It is therefore tempting to speculate that 
phosphorylation of these sites may affect DNA binding in some way. It was also 
interesting to observe the putative phosphorylation of S182, as not only does this 
residue constitute the remaining uncharacterised hSSB1 SQ motif, unlike S134, it is 
highly conserved amongst animal species. A notable modification not detected by 
mass spectrometry was the phosphorylation of threonine residue 117. As the 
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importance of this modification has however previously be suggested in the response 
to ionising radiation exposure (Richard et al., 2008), detection of this 
phosphorylation event may therefore require such stimuli. These considerations may 
also indicate that other additional hSSB1 phosphorylation may also be detected in the 
response to various forms of DNA damage. This is also likely to be the case with 
hSSB1 acetylation. Indeed, whilst acetylation of K94 has previously been 
demonstrated, mutation of this residue was not able to completely prevent the 
detection of acetylated hSSB1 (Wu et al., 2015). While not yet validated, the 
acetylation of K15 and K203 has for instance previously been detected by mass 
spectrometry (Hornbeck et al., 2015). The validation of these modifications may 
therefore be of value for the further understanding of hSSB1 function. 
 
An interesting finding from the characterisation of hSSB1 S134 phosphorylation was 
the high level of phosphorylation and dephosphorylation observed in undamaged 
cells. Whilst the purpose for this dynamic regulation is unclear, these finding do 
suggest that a pool of phosphorylated hSSB1 exists constitutively in cells. These 
findings are indeed similar to reports of basal hSSB1 acetylation, which is apparently 
suppressed by the Sirt4 and HDAC10 deacetylases prior to ionising radiation 
exposure (Wu et al., 2015). One explanation for the basal phosphorylation and 
acetylation of hSSB1 may be that by maintaining pools of differentially modified 
hSSB1, the cell is able to keep hSSB1 in a ‘primed’ state to rapidly respond to 
various types of DNA lesions. Such an arrangement is indeed consistent with the 
previous description of hSSB1 as an early responder to DNA damage (Bolderson et 
al., 2014; Paquet et al., 2015; Richard et al., 2011b). A similar ‘priming’ approach 
has also been suggested for Chk1, where ATR-mediated phosphorylation is 
maintained under a suppressive state by PP1 during un-perturbed cell cycles to allow 
for rapid checkpoint activation in response to replication fork stalling (Leung-Pineda 
et al., 2006). In future work it may therefore be of interest to determine whether other 
hSSB1 modifications are similarly suppressed, allowing for the formation of various 
types of ‘primed’ hSSB1.  
 
 
 Characterisation of Human Single-Stranded DNA-Binding Protein 1 (hSSB1) Regulation by Post-Translational 
Modifications  169 
In contrast to hSSB1, the post-translational regulation of hSSB2 has remained largely 
unexplored and to date no modifications have been reported. Further, in the one 
study to address hSSB2 regulation, it was noted that while acetylation of hSSB1 was 
readily detected, no such modifications of hSSB2 were found (Wu et al., 2015). The 
authors therefore concluded the regulation of hSSB2 might be less complex than 
hSSB1. Consistent with this suggestion, in section 4.2.11 it was noted that unlike 
hSSB1, hSSB2 does not contain SQ/TQ sequences, the classical phosphorylation 
motifs of ATM, ATR and DNA-PKcs (Traven and Heierhorst, 2005). It is however 
unclear whether the lack of information regarding hSSB2 regulation truly does 
represent that this protein is not modified, or merely that hSSB2 modifications are 
yet to be thoroughly explored. For example, as hSSB2 has also been suggested to 
function during double-strand DNA break repair by homologous recombination, 
most likely by interacting with INTS3 to the mutual exclusion of hSSB1 (Li et al., 
2009b), it seems reasonable that hSSB2 could be phosphorylated by one of the 
numerous DNA repair kinases. A thorough investigation into hSSB2 regulation may 
thereby also be warranted and may provide further insight into the function of this 
protein, as well its interplay with hSSB1. 
 
The data presented in this thesis also provide mechanistic insight into hSSB1 
function. The finding that hSSB1 is able to bind fork substrates lacking ssDNA in 
vitro, for instance, may point to a role for hSSB1 in processing such substrates in the 
restart of stalled replication forks in cells. Further, these findings may indicate that 
hSSB1 can also bind other related substrates, such as Holliday junctions, which 
equally may direct the dissection of hSSB1 function in replication fork restart and 
other DNA repair pathways. These and prior findings regarding hSSB1-binding to 
non-ssDNA substrates (junctions, 8-oxoG (Paquet et al., 2015), poly (ADP)-ribose 
(Zhang et al., 2014)) may also assist in delineating the role of hSSB1 from other OB-
fold containing proteins, such as RPA. Indeed, whilst hSSB1 may be able to 
compensate for RPA depletion in some circumstances (Kar et al., 2015), it has 
remained unclear how hSSB1 may compete with the higher affinity, more stable 
ssDNA binding of RPA in normal cells. The role of hSSB1 in binding a distinct set 
of substrates that are not bound by RPA may therefore suggest that hSSB1 and RPA 
function primarily by complementary, non-overlapping means, rather than, or in 
addition to, by competing for the same substrate. The modulation of hSSB1 substrate 
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binding by post-translational regulation may also provide a tantalising means through 
which hSSB1 function is modulated. Such a model is reflected not only by the 
finding that S134E hSSB1 binds fork junctions with reduced affinity, but also by 
other recent work from our group (Paquet et al. 2016) regarding the binding of 
hSSB1 to 8-oxo-G lesions. Here, 8-oxo-G-binding was found to require the prior 
oxidation of hSSB1 and the formation of higher-order oligomers. It therefore seems 
possible that hSSB1 binding to different substrates may be regulated by distinct post-
translational regulation depending on the type of DNA damage that has occurred and 
the repair pathway that has been activated. 
 
The mass spectrometry data summarised in section 4.2.14 suggests that while 
hSSB1 has predominantly been thought of in a DNA repair context, it is likely to 
have roles in many other cellular processes. In particular, the identification of 
numerous proteins with roles in RNA metabolism and transcriptional transactions 
may suggest these as important areas of hSSB1 function. These findings were 
somewhat pre-empted by reports that hSSB1 and hSSB2 may function in the 
termination of transcription of a wide range of genes (Skaar et al., 2015). Here, both 
proteins seemingly function as components of the integrator complex, presumably 
via an interaction with INTS3 (Zhang et al., 2013). In addition, this interaction 
mediated an association of hSSB1 with RNA polymerase II (Baillat et al., 2005). 
Consistent with these data, the mass spectrometry data presented in this thesis 
identified the integrator complex subunits 1, 3, 5 and 6, and as well six subunits of 
RNA polymerase II, following hSSB1 immunoprecipitation. Components of the 
cleavage and polyadenylation specificity factor (CPSF) were also identified by mass 
spectrometry, consistent with the observation of the integrator complex being 
required for replication-dependent histone mRNA processing (Skaar et al., 2015), 
one of many functions performed by the CPSF. A role in transcriptional termination 
may also explain the observed association of hSSB1 with numerous chromatin 
remodelling complexes, enzymes which are also essential for this process (Alén et 
al., 2002; Morillon et al., 2003). Aside from a role in transcriptional termination, the 
identification of numerous proteins with roles earlier and later to transcriptional 
termination (e.g. transcriptional activation and repression, mRNA splicing, 
processing and transport) may suggest additional functions in RNA processing in 
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which hSSB1 may be involved. The further understanding of hSSB1 protein function 
is therefore likely to benefit not only from the continued study of its role in DNA 
repair, but also by an investigation into its function in other biological processes. 
 
In summary, the data presented in this thesis provide novel insight into the regulation 
of hSSB1 by post-translational modifications. This includes data pertaining to the 
poly-ubiquitination of hSSB1 lysine residues, as well the phosphorylation of S134 in 
the response to replication inhibition. Numerous other putative sites of modification 
are also identified, the characterisation of which is likely to be beneficial for the 
further understanding of hSSB1 function. In addition, findings regarding the 
mechanistic function of hSSB1 are also provided, which will likely assist in precisely 
delineating the placement of hSSB1 in DNA repair. The identification of novel 
protein associations may also suggest new roles for hSSB1 in genome stability 
maintenance, as well as in other cellular pathways. 
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Appendix A 
Table 6.1 Numerous hSSB1-associating proteins were identified by mass 
spectrometry 
 
Proteins for which corresponding peptides were identified in section 4.2.14, as well 
as the number of unique peptides detected before and after hydroxyurea (HU) 
treatment, are listed below. Proteins are grouped based on their predominant known 
biological process as given by UniProt (www.uniprot.org).  
 
 
Protein 
Unique 
peptides 
pre HU 
Unique 
peptides 
post HU 
 
Protein 
Unique 
peptides 
pre HU 
Unique 
peptides 
post HU 
Histones 
Core histone macro-
H2A.1 14 15 Histone H3.2 5 7 
Histone H2A type 2-A 6 5 Histone H4 9 10 
Histone H2B type 1-B 6 0 
Putative histone H2B 
type 2-C 0 3 
Histone H2B type 1-M 0 7    
Chromatin Remodelling/Modifying 
Actin-like protein 6A 2 4 
Polycomb protein 
SUZ12 1 1 
Actin, beta 20 19 Protein AATF 0 1 
Chromodomain-
helicase-DNA-binding 
protein 4 3 4 Protein polybromo-1 2 0 
Histone 
acetyltransferase KAT7 1 1 Protein Wiz 1 5 
Histone deacetylase 1 0 10 
Remodeling and 
spacing factor 1 1 0 
Histone deacetylase 2 9 0 RuvB-like 1 5 7 
Histone deacetylase 
complex subunit 
SAP18 0 2 RuvB-like 2 0 2 
Histone-binding 
protein RBBP4 14 16 
SWI/SNF complex 
subunit SMARCC1 3 4 
Histone-lysine N-
methyltransferase 
EHMT1 2 4 
SWI/SNF-related 
matrix-associated 
actin-dependent 
regulator of chromatin 
subfamily A member 5 16 26 
Histone-lysine N-
methyltransferase 
EHMT2 1 3 
SWI/SNF-related 
matrix-associated 
actin-dependent 
regulator of chromatin 
subfamily D member 1 0 1 
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Histone-lysine N-
methyltransferase 
SUV39H1 0 2 
SWI/SNF-related 
matrix-associated 
actin-dependent 
regulator of chromatin 
subfamily D member 2 1 3 
Metastasis-associated 
protein MTA2 16 18 
SWI/SNF-related 
matrix-associated 
actin-dependent 
regulator of chromatin 
subfamily E member 1 2 2 
Methyl-CpG-binding 
domain protein 2 0 5 
Transcription activator 
BRG1 3 4 
Methyl-CpG-binding 
domain protein 3 1 3 
Tyrosine-protein kinase 
BAZ1B 17 28 
Transcription Factors, Activators and Repressors 
Activity-dependent 
neuroprotector 
homeobox protein 10 14 Parafibromin 0 2 
Alpha-actinin-4 1 0 Periphilin-1 1 4 
ATPase family AAA 
domain-containing 
protein 2 6 10 PHD finger protein 14 1 2 
Bcl-2-associated 
transcription factor 1 4 4 
Polymerase I and 
transcript release factor 2 2 
Catenin delta-1 1 1 
Proline-, glutamic acid- 
and leucine-rich 
protein 1 15 15 
Cell division cycle 5-
like protein 2 3 Protein C3orf33 1 0 
Chromobox protein 
homolog 3 8 9 
RNA-binding protein 
14 2 3 
Chromobox protein 
homolog 8 0 2 
SAFB-like 
transcription modulator 2 0 
Chromodomain Y-like 
protein 1 1 
Scaffold attachment 
factor B1 12 12 
Deoxynucleotidyltransf
erase terminal-
interacting protein 2 0 2 
Serrate RNA effector 
molecule homolog 2 5 
F-box-like/WD repeat-
containing protein 
TBL1XR1 0 1 
Testis-expressed 
sequence 10 protein 10 12 
General transcription 
factor 3C polypeptide 2 0 1 
Transcription factor 
ETV6 1 1 
General transcription 
factor 3C polypeptide 3 0 1 
Transcription 
intermediary factor 1-
alpha 10 2 
High mobility group 
protein 20A 3 2 
Transcription 
intermediary factor 1-
beta 0 16 
M-phase 
phosphoprotein 8 2 2 
Transcriptional 
repressor p66-beta 7 11 
Nuclear receptor 
coactivator 5 4 4 
Unconventional 
myosin-Ic 0 1 
Paired amphipathic 
helix protein Sin3a 3 2 
Zinc finger protein ubi-
d4 0 2 
Transcription 
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CTD small 
phosphatase-like 
protein 2 0 1 
Integrator complex 
subunit 5 1 3 
DBIRD complex 
subunit ZNF326 2 4 
Integrator complex 
subunit 6 0 1 
DNA-directed RNA 
polymerase II subunit 
RPB1 2 0 
Regulation of nuclear 
pre-mRNA domain-
containing protein 1B 0 2 
DNA-directed RNA 
polymerase II subunit 
RPB2 5 6 
Regulation of nuclear 
pre-mRNA domain-
containing protein 2 4 3 
DNA-directed RNA 
polymerase II subunit 
RPB3 3 4 
RNA polymerase-
associated protein 
CTR9 homolog 0 1 
DNA-directed RNA 
polymerase II subunit 
RPB9 1 1 
TATA-binding protein-
associated factor 2N 0 1 
DNA-directed RNA 
polymerases I, II, and 
III subunit RPABC1 1 1 
Transcription 
elongation factor SPT6 5 0 
DNA-directed RNA 
polymerases I, II, and 
III subunit RPABC3 0 2 
Zinc finger CCCH 
domain-containing 
protein 14 2 2 
Integrator complex 
subunit 1 1 0 
Zinc finger CCCH 
domain-containing 
protein 18 1 1 
Integrator complex 
subunit 3 5 12    
RNA Helicases 
ATP-dependent RNA 
helicase DDX18 2 2 
Probable ATP-
dependent RNA 
helicase DDX17 0 11 
ATP-dependent RNA 
helicase DDX24 0 2 
Probable ATP-
dependent RNA 
helicase DDX5 14 0 
ATP-dependent RNA 
helicase DDX39A 0 1 
Eukaryotic initiation 
factor 4A-III 8 10 
ATP-dependent RNA 
helicase DDX3X 0 5 
Putative ATP-
dependent RNA 
helicase DHX30 0 1 
ATP-dependent RNA 
helicase DDX50 1 1 
U5 small nuclear 
ribonucleoprotein 200 
kDa helicase 5 0 
Putative pre-mRNA-
splicing factor ATP-
dependent RNA 
helicase DHX15 12 8 
   
Pre-mRNA 3`-Processing 
Cleavage and 
polyadenylation 
specificity factor 
subunit 2 2 1 
WD repeat-containing 
protein 18 3 4 
Cleavage and 
polyadenylation 
specificity factor 
subunit 5 2 1 
WD repeat-containing 
protein 43 1 0 
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Cleavage and 
polyadenylation 
specificity factor 
subunit 6 2 2 
Pre-mRNA 3'-end-
processing factor FIP1 2 1 
Cleavage and 
polyadenylation 
specificity factor 
subunit 7 1 0 
Protein virilizer 
homolog 4 1 
Cleavage stimulation 
factor subunit 2 1 1 Symplekin 6 2 
ELAV-like protein 1 1 0    
Pre-mRNA Splicing 
116 kDa U5 small 
nuclear 
ribonucleoprotein 
component 15 20 
Serine/arginine-rich 
splicing factor 10 4 4 
Apoptotic chromatin 
condensation inducer in 
the nucleus 14 9 
Serine/arginine-rich 
splicing factor 7 5 5 
Double-stranded RNA-
specific adenosine 
deaminase 1 0 
Serine/arginine-rich 
splicing factor 9 7 8 
Heat shock cognate 71 
kDa protein 12 13 
Small nuclear 
ribonucleoprotein Sm 
D1 2 2 
Heterogeneous nuclear 
ribonucleoprotein A3 5 5 
Small nuclear 
ribonucleoprotein Sm 
D2 2 2 
Heterogeneous nuclear 
ribonucleoprotein H 7 10 
Small nuclear 
ribonucleoprotein Sm 
D3 0 3 
Heterogeneous nuclear 
ribonucleoprotein H3 4 3 
Small nuclear 
ribonucleoprotein-
associated protein N 2 2 
Heterogeneous nuclear 
ribonucleoprotein K 8 12 
SNW domain-
containing protein 1 4 3 
Heterogeneous nuclear 
ribonucleoprotein L 2 4 
Splicing factor 3A 
subunit 1 2 5 
Heterogeneous nuclear 
ribonucleoprotein M 10 8 
Splicing factor 3A 
subunit 3 2 4 
Heterogeneous nuclear 
ribonucleoprotein U-
like protein 1 1 0 
Splicing factor 3B 
subunit 1 16 15 
Heterogeneous nuclear 
ribonucleoprotein U-
like protein 2 13 16 
Splicing factor 3B 
subunit 2 7 7 
Heterogeneous nuclear 
ribonucleoproteins 
C1/C2 12 10 
Splicing factor 3B 
subunit 3 1 0 
Intron-binding protein 
aquarius 1 0 
Splicing factor 3B 
subunit 4 1 2 
KH domain-containing, 
RNA-binding, signal 
transduction-associated 
protein 1 1 0 
Splicing factor U2AF 
65 kDa subunit 6 5 
Matrin-3 14 14 
Splicing factor, 
proline- and glutamine-
rich 2 2 
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Non-POU domain-
containing octamer-
binding protein 1 2 
TAR DNA-binding 
protein 43 0 2 
Nuclease-sensitive 
element-binding 
protein 1 1 2 
Thyroid hormone 
receptor-associated 
protein 3 0 2 
Pre-mRNA-processing 
factor 6 1 0 
Transformer-2 protein 
homolog alpha 2 3 
Pre-mRNA-processing-
splicing factor 8 1 0 
Transformer-2 protein 
homolog beta 2 6 
Pre-mRNA-splicing 
regulator WTAP 1 0 
U2 snRNP-associated 
SURP motif-containing 
protein 2 2 
Protein mago nashi 
homolog 2 4 4 
U4/U6 small nuclear 
ribonucleoprotein 
Prp31 2 1 
RNA-binding motif 
protein, X chromosome 9 8 
U4/U6 small nuclear 
ribonucleoprotein Prp4 0 1 
RNA-binding protein 
12B 2 2 
U4/U6.U5 tri-snRNP-
associated protein 1 1 3 
RNA-binding protein 
Raly 6 7 
U5 small nuclear 
ribonucleoprotein 40 
kDa protein 4 3 
Serine/arginine-rich 
splicing factor 1 10 10 
   
Mature mRNA Export 
Ataxin-2-like protein 3 0 
RNA-binding protein 
8A 2 2 
Caprin-1 1 1 
THO complex subunit 
2 0 3 
Nuclear cap-binding 
protein subunit 1 4 2 
THO complex subunit 
5 homolog 1 0 
Plasminogen activator 
inhibitor 1 RNA-
binding protein 1 1 
THO complex subunit 
6 homolog 1 1 
Translation 
Elongation factor 1-
alpha 1 1 2 
Eukaryotic translation 
initiation factor 3 
subunit I 1 1 
Elongation factor 1-
delta 0 1 
Eukaryotic translation 
initiation factor 3 
subunit L 6 3 
Elongation factor 1-
gamma 1 1 
Eukaryotic translation 
initiation factor 3 
subunit M 3 2 
Eukaryotic translation 
initiation factor 3 
subunit A 11 9 
Eukaryotic translation 
initiation factor 4B 1 2 
Eukaryotic translation 
initiation factor 3 
subunit B 1 4 
Fragile X mental 
retardation protein 1 2 2 
Eukaryotic translation 
initiation factor 3 
subunit C-like protein 1 3 
Fragile X mental 
retardation syndrome-
related protein 1 2 2 
Eukaryotic translation 
initiation factor 3 
subunit D 0 2 La-related protein 1 4 4 
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Eukaryotic translation 
initiation factor 3 
subunit E 2 5 
Polyadenylate-binding 
protein 1 5 7 
Eukaryotic translation 
initiation factor 3 
subunit F 3 6 
Polypyrimidine tract-
binding protein 1 1 1 
Eukaryotic translation 
initiation factor 3 
subunit G 3 5 
   
Ribosomal Proteins 
28S ribosomal protein 
S27, mitochondrial 1 0 
60S ribosomal protein 
L11 2 2 
28S ribosomal protein 
S30, mitochondrial 0 1 
60S ribosomal protein 
L12 5 5 
39S ribosomal protein 
L38, mitochondrial 1 0 
60S ribosomal protein 
L13 6 8 
40S ribosomal protein 
S10 2 4 
60S ribosomal protein 
L13a 5 5 
40S ribosomal protein 
S11 2 6 
60S ribosomal protein 
L14 3 4 
40S ribosomal protein 
S12 5 4 
60S ribosomal protein 
L15 5 5 
40S ribosomal protein 
S13 4 4 
60S ribosomal protein 
L17 5 5 
40S ribosomal protein 
S14 4 4 
60S ribosomal protein 
L18 5 4 
40S ribosomal protein 
S15 1 4 
60S ribosomal protein 
L18a 5 5 
40S ribosomal protein 
S15a 2 2 
60S ribosomal protein 
L19 3 2 
40S ribosomal protein 
S16 5 4 
60S ribosomal protein 
L21 1 2 
40S ribosomal protein 
S17 6 5 
60S ribosomal protein 
L22 3 2 
40S ribosomal protein 
S18 8 7 
60S ribosomal protein 
L23 1 1 
40S ribosomal protein 
S19 4 5 
60S ribosomal protein 
L23a 3 3 
40S ribosomal protein 
S2 10 11 
60S ribosomal protein 
L24 3 3 
40S ribosomal protein 
S20 1 2 
60S ribosomal protein 
L26 2 2 
40S ribosomal protein 
S21 1 2 
60S ribosomal protein 
L27 3 4 
40S ribosomal protein 
S23 1 1 
60S ribosomal protein 
L27a 4 4 
40S ribosomal protein 
S24 3 3 
60S ribosomal protein 
L28 2 2 
40S ribosomal protein 
S25 3 4 
60S ribosomal protein 
L29 1 2 
40S ribosomal protein 
S26 3 4 
60S ribosomal protein 
L3 11 14 
40S ribosomal protein 
S27-like 1 2 
60S ribosomal protein 
L30 3 5 
40S ribosomal protein 
S28 2 2 
60S ribosomal protein 
L31 1 1 
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40S ribosomal protein 
S29 0 1 
60S ribosomal protein 
L32 1 4 
40S ribosomal protein 
S3 13 14 
60S ribosomal protein 
L34 2 2 
40S ribosomal protein 
S3a 6 7 
60S ribosomal protein 
L35 1 3 
40S ribosomal protein 
S4, X isoform 10 12 
60S ribosomal protein 
L35a 2 1 
40S ribosomal protein 
S5 2 4 
60S ribosomal protein 
L36 2 3 
40S ribosomal protein 
S6 5 4 
60S ribosomal protein 
L36a-like 1 1 
40S ribosomal protein 
S7 7 8 
60S ribosomal protein 
L37a 1 0 
40S ribosomal protein 
S8 7 7 
60S ribosomal protein 
L38 0 1 
40S ribosomal protein 
S9 7 10 
60S ribosomal protein 
L4 14 17 
40S ribosomal protein 
SA 13 14 
60S ribosomal protein 
L5 7 7 
60S acidic ribosomal 
protein P0 13 13 
60S ribosomal protein 
L6 9 10 
60S acidic ribosomal 
protein P1 2 2 
60S ribosomal protein 
L7 12 13 
60S acidic ribosomal 
protein P2 4 5 
60S ribosomal protein 
L7a 7 9 
60S ribosomal protein 
L10 6 5 
60S ribosomal protein 
L8 6 8 
60S ribosomal protein 
L10a 5 4 
60S ribosomal protein 
L9 3 4 
Ribosome Biogenesis 
Bystin 1 1 
Ribosomal biogenesis 
protein LAS1L 2 6 
Nucleolar complex 
protein 2 homolog 2 1 
Ribosomal L1 domain-
containing protein 1 6 9 
Nucleolar complex 
protein 4 homolog 0 1 
Ribosomal RNA-
processing protein 7 
homolog A 0 1 
Nucleolar GTP-binding 
protein 1 4 5 
Ribosome biogenesis 
protein BRX1 homolog 9 8 
Nucleolar GTP-binding 
protein 2 2 1 
Ribosome biogenesis 
regulatory protein 
homolog 1 1 
Nucleolar protein 58 1 1 
Ribosome production 
factor 2 homolog 0 1 
Nucleolar protein 6 2 5 
rRNA 2'-O-
methyltransferase 
fibrillarin 1 2 
Nucleophosmin 4 6 
Sentrin-specific 
protease 3 1 0 
Polynucleotide 5'-
hydroxyl-kinase NOL9 3 4 
Superkiller viralicidic 
activity 2-like 2 3 4 
Probable 28S rRNA 
(cytosine(4447)-C(5))-
methyltransferase 0 1 
U3 small nucleolar 
ribonucleoprotein 
protein MPP10 0 1 
Probable rRNA-
processing protein 
EBP2 7 9    
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Cell Cycle and DNA Repair 
Cullin-4A 6 5 
Serine/threonine-
protein phosphatase 2A 
65 kDa regulatory 
subunit A beta isoform 0 1 
DNA damage-binding 
protein 1 4 4 
Serine/threonine-
protein phosphatase 
PP1-beta catalytic 
subunit 2 5 
DNA replication 
licensing factor MCM6 1 0 
Cyclin-dependent 
kinase inhibitor 2A, 
isoform 4 2 1 
DNA replication 
licensing factor MCM7 1 1 
Tyrosine-protein kinase 
Yes 1 0 
DNA topoisomerase 2-
alpha 14 16 
Enhancer of 
rudimentary homolog 2 3 
E3 ubiquitin-protein 
ligase RING1 1 2 NEDD8 2 2 
Serine/threonine-
protein kinase mTOR 1 1 
Transitional 
endoplasmic reticulum 
ATPase 3 0 
Centromere Proteins and Regulation 
Aurora kinase B 2 3 
Kinesin-like protein 
KIF23 1 1 
Borealin 2 5 
Major centromere 
autoantigen B 0 1 
Centromere protein V 1 2 
MAU2 chromatid 
cohesion factor 
homolog 3 4 
Condensin-2 complex 
subunit G2 0 2 
Microfibrillar-
associated protein 1 0 1 
Emerin 2 3 
Mitotic interactor and 
substrate of PLK1 1 1 
Inner centromere 
protein 0 3 
Structural maintenance 
of chromosomes 
protein 1A 1 0 
Kinesin-like protein 
KIF20A 0 3 
Ubiquitin carboxyl-
terminal hydrolase 10 0 1 
Nuclear Structure and Scaffolding Proteins 
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A-kinase anchor 
protein 8 1 1 Lamin-B1 1 0 
Actin-related protein 3 0 1 
LIM domain and actin-
binding protein 1 1 0 
Barrier-to-
autointegration factor 2 2 
Nuclear mitotic 
apparatus protein 1 1 0 
Flotillin-1 4 0 Prelamin-A/C 8 7 
Flotillin-2 2 2 Vimentin 1 4 
Miscellaneous 
1-phosphatidylinositol 
4,5-bisphosphate 
phosphodiesterase eta-
2 0 1 
Importin subunit alpha-
3 2 6 
4F2 cell-surface 
antigen heavy chain 3 3 Junction plakoglobin 1 2 
60 kDa heat shock 
protein, mitochondrial 1 2 
Kelch repeat and BTB 
domain-containing 
protein 3 0 0 
Alkaline phosphatase, 
tissue-nonspecific 
isozyme 2 0 Kelch-like protein 35 1 1 
Annexin A2 6 9 
Keratin, type I 
cytoskeletal 10 10 1 
ATP synthase subunit 
alpha, mitochondrial 2 1 
Keratin, type I 
cytoskeletal 9 5 14 
ATP synthase subunit 
beta, mitochondrial 1 2 
Keratin, type II 
cytoskeletal 1 13 9 
ATP-binding cassette 
sub-family E member 1 1 1 
Keratin, type II 
cytoskeletal 7 1 16 
BAG family molecular 
chaperone regulator 2 1 1 Latrophilin-3 0 1 
Bone marrow stromal 
antigen 2 0 1 
Microsomal 
glutathione S-
transferase 1 0 1 
Brain acid soluble 
protein 1 3 5 
Mitochondrial carrier 
homolog 2 1 2 
Cadherin-13 0 1 
Myb-binding protein 
1A 3 1 
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Calcium homeostasis 
endoplasmic reticulum 
protein 0 2 
Myosin light 
polypeptide 6 0 2 
Caveolin-1 2 2 Myosin-9 4 0 
CD109 antigen 4 4 Nebulin 1 0 
CD44 antigen 2 2 Peroxiredoxin-1 1 0 
CD59 glycoprotein 2 4 Peroxiredoxin-2 1 3 
Coiled-coil domain-
containing protein 25 1 0 PH-interacting protein 1 1 
Complement 
component 1 Q 
subcomponent-binding 
protein, mitochondrial 2 4 Protein FAM208A 5 4 
Complement decay-
accelerating factor 3 3 
Protein Hook homolog 
3 0 1 
CSC1-like protein 2 0 1 
Protein kinase C and 
casein kinase substrate 
in neurons protein 3 1 1 
Desmoglein-2 3 1 Protein Red 1 0 
Dihydrolipoyllysine-
residue 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase 
complex, mitochondrial 2 1 
PWWP domain-
containing protein 
MUM1L1 1 1 
DnaJ homolog 
subfamily A member 1 0 3 
Ras GTPase-activating 
protein-binding protein 
2 2 3 
Dolichyl-
diphosphooligosacchari
de--protein 
glycosyltransferase 48 
kDa subunit 2 1 
Regulator of 
microtubule dynamics 
protein 3 0 1 
Drebrin 2 5 
Solute carrier family 12 
member 2 1 1 
Dynein light chain 1, 
cytoplasmic 0 2 
Stomatin-like protein 2, 
mitochondrial 2 1 
Erlin-1 1 0 
SUN domain-
containing protein 2 1 0 
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Erythrocyte band 7 
integral membrane 
protein 5 0 
Thy-1 membrane 
glycoprotein 1 0 
Erythrocyte band 7 
integral membrane 
protein 0 6 Titin 1 0 
Glioma tumor 
suppressor candidate 
region gene 2 protein 1 1 
tRNA-splicing ligase 
RtcB homolog 1 1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1 4 Tubulin alpha-1B chain 1 2 
Glypican-1 1 0 
Ubiquitin-associated 
protein 2-like 0 1 
GRAM domain-
containing protein 1B 0 1 
V-type proton ATPase 
subunit d 1 1 0 
Guanine nucleotide-
binding protein G(i) 
subunit alpha-2 6 6 
V-type proton ATPase 
subunit E 1 1 0 
Guanine nucleotide-
binding protein 
G(I)/G(S)/G(T) subunit 
beta-1 3 4 
Very-long-chain enoyl-
CoA reductase 0 1 
Guanine nucleotide-
binding protein subunit 
beta-2-like 1 0 15 
Vesicle-associated 
membrane protein-
associated protein B/C 1 0 
Guanine nucleotide-
binding protein-like 3 2 1 
Voltage-dependent 
anion-selective channel 
protein 1 2 3 
Importin subunit alpha-
1 2 4 
Voltage-dependent 
anion-selective channel 
protein 2 2 4 
 
